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Summary
Cytochrome P-4-50 is only produced during growth of Saccharomyces 
cerevisiae at high glucose concentrations, and not at low glucose 
concentrations even under semi-anaerobic conditions. The removal 
of oxygen during exponential growth phase of S. cerevisiae leads 
to a repression of cytochrome P-4-50 synthesis. Oxygen may be 
acting as a substrate inducer of yeast cytochrome P-4-50.
Genetic analysis of yeast cytochrome P-4-50 production has revealed 
that biosynthesis of this enzyme is regulated by a single nuclear 
gene and one or more modifying factors. This regulatory gene 
may exert its effect through the intracellular cyclic AMP level.
Growth of yeast in the presence of benzo(a)pyrene and several 
other compounds results in only a small change in cytochrome 
P-4-50 levels yet a dramatic increase in the activity of benzo(a)- 
pyrene hydroxylase as demonstrated by an increased Vmax and a 
decreased Km. This is interpreted as being due to the induction 
of a new cytochrome P-450 enzyme, demonstrating that multiple 
forms of cytochrome P-4-50 can occur in yeast.
Yeast cytochrome P-4-50 has been purified to homogeneity and 
found to have a molecular weight of 55>500. Purified enzyme 
showed a spectral carbon monoxide peak at 4-4-8nm, and could 
undergo both type I and type II spectral interactions. The 
mid-point redox potential of yeast cytochrome P-4-50 is close to 
that of both mammalian and bacterial cytochrome P-4-50.
(ii)
The substrate specificity of yeast cytochrome P-4-50 was found 
to be limited to benzo(a)pyrene hydroxylase. Some biphenyl 
hydroxylase activity was found in yeast spheroplasts but could 
not be recovered after cell disruption. Benzo(a)pyrene hydroxy­
lase was inhibited by compounds which give binding spectra with 
cytochrome P-4-50 and by flavonoids.
Microsomal cytochrome P-4-50 was more stable towards thermal 
denaturation than solubilized or purified enzyme. Triton X-100 
was shown to protect cytochrome P-4-50 against thermal denaturation.
(iii)
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Note on Nomenclature
The discovery of multiple forms of cytochrome P-4-50 has led 
to considerable confusion in the literature concerning the 
cytochrome P-450 nomenclature. The term fcytochrome: P-450’ is 
now recognized as a collective name for a family of enzymes 
with Soret peaks in their reduced carbon monoxide difference 
spectra around 450nm. This includes cytochrome P-448 forms 
of the enzyme.
The major cytochrome P-450 in uninduced yeast has a peak in 
the reduced carbon monoxide difference spectrum at 44-8nm. 
However, multiple forms of the enzyme are also thought to 
occur in yeast and thus the general name Tcytochrome P-450’ 
has been used throughout this thesis, except for the major 
form of the enzyme from uninduced yeast in very highly 
purified form which has been called by its more specific 
name ’cytochrome P-448’.
(vi)
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CHAPTER 1
INTRODUCTION
(2)
1.1. Oxygenase Enzymes
Molecular oxygen interacts with only two groups of enzymes, 
oxid'ases and oxygenases. Oxidases use oxygen as a hydrogen 
acceptor, the oxygen being reduced to water or hydrogen 
peroxide as follows:
SH2 + i02 --- > S + H 20
SH2 + °2--- » 3 + H2°2
(where SH^ represents substrate)
Oxygenases are a group of enzymes which are responsible for 
the incorporation of molecular oxygen into organic substrates. 
Oxygenase enzymes are divided into two groups, those that 
incorporate one atom of the oxygen molecule, monooxygenases, 
and those that incorporate both atoms of the oxygen molecule, 
dioxygenases. The reaction catalyzed by dioxygenases is thus:
S + 02 ------->so2
(where S represents substrate)
Dioxygenase enzymes are more common in bacteria than in 
eukaryotic organisms, and are very important in the bacterial 
degradation of aromatic compounds (Wiseman & King, 1982).
Monooxygenases incorporate only one atom of the oxygen molecule 
into the organic substrate, the other being reduced to water. 
Monooxygenases therefore require a reducing agent, which is 
often a reduced pyridine nucleotide. The general equation of
(3)
a typical monooxygenase reaction is thus:
S + o2 + h2x ----- > SO + h2o + X
(where S represents substrate, H2X the reducing agent).
As both oxidation and oxygenation are involved in monooxygenase 
reactions, these enzymes are often referred to as mixed function 
oxidases. The monooxygenase enzymes can be subdivided into two 
groups, external monooxygenases and internal monooxygenases.
Most monooxygenases are of the external type, which require an 
added reductant. However, in some cases the substrate itself 
can act as the reductant, these cases being the internal 
monooxygenase reactions. Internal monooxygenases result in the 
concomitant decarboxylation of substrate.
Many monooxygenase enzymes are poorly characterized, though 
some of these are the basis of industrial processes, for example 
in steroid transformations. Several external monooxygenases 
operate via an electron transport chain of two or three protein 
components (for review see Wiseman & King, 1982). One group 
of these external monooxygenases are the cytochrome P-4-50 
dependent monooxygenases. Cytochrome P-4-50 monooxygenases are 
very widely distributed throughout nature and have been shown to 
occur in organisms from all animal and most plant phyla as well 
as. both prokaryotic and eukaryotic microorganisms. These are 
probably the best characterized of all the oxygenase enzymes, 
particularly in the case of the microsomal cytochrome P-4-50- 
enzymes from mammalian hepatic tissue. Cytochrome P-4-50 enzymes 
are of great importance not only in the metabolism of endogenous 
compounds, but also in the metabolism of many xenobiotic compounds,
U)
resulting in the detoxification of many drugs but the activation 
of many carcinogens. Also the cytochrome P-4-50 enzymes have 
several unique biochemical features, such as their very wide 
substrate specificity. Therefore, cytochrome P-4-50 monooxygenases 
are now probably the most widely studied enzymes in the world.
1.2. Mammalian Cytochrome P-4-50 Enzymes
Within mammalian tissues, cytochrome P-4-50 enzymes are most 
abundant in the liver, but they have also been demonstrated 
in most other body tissues. Most of the cytochrome P-4-50 of 
a eukaryotic cell is located in the smooth endoplasmic reticulum, 
which is usually isolated in the form of small vesicles termed 
microsomes. There are also cytochrome P-4-50 systems in mammalian 
mitochondria, particularly in the liver and adrenal cortex.
These mitochondrial cytochrome P-4-50 enzymes .are involved in 
steroid metabolism and although membrane bound, are more 
similar in terms of the electron transport chain to soluble 
cytochrome P-4-50 enzymes of bacteria, rather than to those 
found in the endoplasmic reticulum of the same mammalian cells 
(see on). Cytochrome P-4-50 enzymes have also been demonstrated 
in the nuclear envelope where they are thought to be important 
in the metabolism of carcinogens (Bresnick, 1978), and in the 
cell membrane (Stasiecki _et al., 1980).
The haemoprotein cytochrome P-4-50 was first discovered in 
liver microsomal fraction by Klingenberg (1958) and by Garfinkel 
(1958). This enzyme was termed cytochrome P-4-50 due to the 
unique spectral absorption at 4-50nm in the reduced-carbon
(5)
monoxide difference spectrum of the protein. This spectral 
property is the basis of the spectrophotometric determination 
of cytochrome P-4-50 (Omura & Sato, 1964.).
Cytochrome P-4-50 is the terminal oxidase of the monooxygenase 
system which operates via an electron transport chain to catalyze 
the general reaction:
SH + NADPH + H+ + 02---- ^ SOH + NADP+ + H20
(where SH represents substrate)
The first evidence for the involvement of cytochrome P-4-50 in 
the monooxygenase system came from studies on the inhibition 
of monooxygenase reactions by carbon monoxide which binds to 
the haem group of cytochrome P-4-50 preventing oxygen binding 
to the enzyme and thus inhibiting its catalytic activity.
Conney ejb al. (1957) showed that the oxidative demethylation 
of 3-methylaminoazobenzene was inhibited by carbon monoxide. 
Orrenius .et al. (1964.) later demonstrated that the oxidative 
metabolism of other substrates by liver microsomes was also 
inhibited by carbon monoxide. These results suggested the 
involvement of a haemoprotein in hydroxylation reactions, and 
subsequent work by Cooper _et al. (1965) resulted in direct 
evidence for the involvement of cytochrome P-4-50. These 
workers showed that several microsomal monooxygenation reactions 
were inhibited by carbon monoxide, and that this inhibiton 
could be relieved by monochromatic light at 4-50nm. The 
resultant photochemical action spectrum was identical to the 
spectrum of the reduced microsomal carbon monoxide binding 
pigment, cytochrome P-4-50. Therefore cytochrome P-4-50 was
(6)
established as required for monooxygenase activity. This has 
now been well established through much subsequent work on this" 
system including the purification of cytochrome P-4-50 and its 
use in the reconstitution of active monooxygenase systems 
(see on).
The mammalian microsomal monooxygenase system has more than 
a thousand substrates already identified. These include endog­
enous substrates such as steroids, fatty acids and bile acids, 
but the majority of substrates are xenobiotic compounds such as 
drugs, carcinogens, insecticides and herbicides. The reaction 
catalyzed depends upon the chemical nature of the substrate 
and may be, for example, aromatic ring hydroxylation, oxidation 
of an aliphatic side chain, dealkylation of a secondary or 
tertiary amine, deamination of dehalogenation. In all of these 
cases, the first step can be visualized as a hydroxylation 
(Gillette, 1966)* For aromatic hydroxylation, the mechanism 
involves the incorporation of one atom of oxygen into the 
substrate to form an epoxide which can undergo one of three 
transformations: (a) spontaneous isomerization to phenolic 
products, (b) enzymic hydration by the enzyme epoxide hydrase 
to form trans-dihydrodiols or (c) formation of conjugates, e.g. by 
reaction with glutathione (Jerina & Daly, 1974-)* The rearrange­
ment of epoxide intermediates results in the 'NIH shift’ shown 
for p-hydroxylation of anisole in figure 1.1..
The components of the microsomal monooxygenase system are well 
established. Two proteins are involved, cytochrome P-4-50, a 
haemoprotein containing the protoporphyrin IX group and
(7)
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NADPH:cytochrome P-4-50 (c) reductase, a flavoprotein containing 
one FAD and one FMN group. Cytochrome P-4-50 contains the substrate 
and oxygen binding sites, whilst the reductase serves to transport 
elections from NADPH to the cytochrome P-450 component, forming 
an electron transport chain as shown in figure 1.2.. Phospho­
lipid is also required for a fully functional system, where it 
may have a structural role in associating the protein components 
together, although the actual role of phospholipid is unknown.
These components have been purified and reconstituted into an 
active monooxygenase system by many workers. This was first 
achieved by Lu & Coon (1968) who reconstituted a system capable 
of oxidizing fatty acids, steroids, drugs and other xenobiotics 
from components isolated from rabbit liver microsomes.
Although only three components are necessary for the reconstitu­
tion of a functional monooxygenase system, the situation in vivo 
is usually more complex. In addition to the NADPH dependent 
cytochrome P-450 system, liver microsomes also contain an 
NADH dependent electron transfer system (involved in fatty acid 
desaturation) consisting of a haemoprotein, cytochrome b^ and 
a flavoprotein, NADH:cytochrome b^ reductase (Shimakata et al., 
1972). Lipid is also essential for this system (Holloway, 1971). 
NADH alone cannot support microsomal monooxygenation of drugs, 
but when both NADH and NADPH are present a synergistic effect 
is usually observed, with a faster rate of monooxygenation being 
achieved than with NADPH alone. Cytochrome b^ has been shown to 
be required for maximal activity of several (though not all) 
cytochrome P-450 reactions including chlorobenzene hydroxylase 
(Lu £t al., 1974)> testosterone l6a-hydroxylase (Lu et al., 1974)*
(9)
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7-ethoxycoumarin deethylase (Imai, 1979)» benzo(a)pyrene 
metabolism (BrunstrSm & Ingelman-Sundberg, 1980) and 
p-nitroanisole 0-demethylase (Sugiyama et al., 1980). The 
synergistic effect of NADH in these cases is thought to be due 
to the cytochrome b^ mediated donation of the required 'second 
electron' to cytochrome P-4-50 during the catalytic cycle 
(Hildebrandt & Estabrook, 1971; Correia & Mannering, 1973)• 
However, cytochrome b^ is not an absolute requirement for 
activity in these cases (although required for maximum rate) 
so the second electron may also come from NADPH:cytochrome 
P-4-50 (c) reductase when cytochrome b^ is absent, as in the 
NADPH supported purified reconstituted systems mentioned earlier. 
Not all cytochrome P-4-50 activities are stimulated by the 
cytochrome b^ system, and in some cases this can inhibit 
monooxygenase activity due to competition for electrons 
(Bosterling _et al., 1982). It seems therefore that for some 
cytochrome P-4-50 dependent monooxygenations, cytochrome b^ 
is involved in vivo in transfer of the second electron, yet 
for other activities this is not the case. Immunological 
evidence also suggests a role for cytochrome b^ in only some 
cytochrome P-4-50 mediated reactions (Noshiro et al., 1980).
The occurrence of multiple forms of cytochrome P-4-50 is now 
very well established (see on) and it seems that some forms 
of cytochrome P-4-50 use cytochrome b^ mediated transfer of 
the second electron for oxygenation of some substrates, whereas 
others use NADPH: cytochrome P-4-50 (c) reductase for the 
donation of both electrons (Chiang, 1981; Bosterling et al., 
1982).
(11)
The mechanism of the cytochrome P-4-50 monooxygenase reaction 
is not fully understood, but the major sequence of events is 
known and is shown in figure 1.3. (Schenkman & Gibson, 1981).
The Mechanism involves firstly binding of substrate to the 
enzyme, followed by one electron transfer from NADPH via 
NADPH:cytochrome P-4-50 (c) reductase. Oxygen is then bound to 
this complex and another one electron reduction occurs from 
either NADPH via NADPH:cytochrome P-4-50 (c) reductase or NADH 
via NADH:cytochrome b^ reductase and cytochrome b^ (see above).
This leads to the activation of oxygen so that reaction with 
the substrate can occur. The nature of the active oxygen species 
is currently the subject of extensive research, but is thought 
to involve a number of radical species (White & Coon, 1980;
Castro, 1980). The product then dissociates from the complex, 
regenerating the. ferric haemoprotein.
The mechanism of cytochrome P-4-50 reactions would be expected
+
to produce a stoichiometry of one mole of NADPH +H and one 
mole of oxygen consumed per mole of product formed. However, 
with both microsomal and purified reconstituted systems, this 
is often not observed and excessive amounts of oxygen and NADPH 
are consumed (Powis & Jansson, 1979). This has been shown to 
be associated with concomitant production of peroxide, and it is 
now thought that extra oxygen and NADPH are used to form oxygenated 
cytochrome P-4-50 which then acts as an oxidase, forming hydrogen 
peroxide as shown (Lichtenberger & Ullrich, 1977).
, cytochrome
°2 + NADPH + H --- — T----» H O + HADP+
P-4-50 ^ <•
(12)
SO H SH
P-450(Fe4TO ”)SH
P-450(Fe )SH
P-450 (Fe -Q)SH
2H
P - 4 5 0 ( F e 0 o~)SH
P-450(Fe )SH
>11 2 -
P-450(Fe 0o )SH
P - 4 5 0 ( F e 0 o )SH
P - 4 5 0 ( F e 0 o~)SH
is transferred fr:om NADPH via NADPH:cytochrome P-450 reductase
2
e is transferred from either NADPH via NADPH:cytochrome P-450 
reductase or from NADH via NADH:cytochrome b~ reductase and 
cytochrome b^.
Figure 1.3. The cytochrome P-450 reaction cycle
(13)
Thus the expected stoichiometry of the monooxygenase reaction 
is not observed in all cases due to the 'siphoning off’ of 
electrons and oxygen into this peroxide producing pathway.
The requirement of the mammalian cytochrome P-4-50 dependent 
monooxygenase system for NADPH and oxygen can be replaced by 
a variety of peroxides. Hrycay & O ’Brien (1972) were the first 
to demonstrate this cytochrome P-4-50 shunt mechanism with 
peroxides by measuring rates of tetramethyl-p-phenylenediamine 
oxidation with cytochrome P-4-50 and various organic hydroperox­
ides. Kadlabur et al* (1973) demonstrated that cytochrome P-4-50 
could catalyze the C-oxidation of several amine substrates 
when NADPH was replaced by a variety of organic hydroperoxides. 
The maximum rate was observed with cumene hydroperoxide.
Rahimtula & O ’Brien (1974-) showed that cytochrome P-4-50 dependent 
hydroxylation of aniline, benzo(a)pyrene, coumarin and biphenyl 
could be supported by cumene hydroperoxide in rabbit liver 
microsomes. Cumene hydroperoxide will also support cytochrome 
P-4-50 linked fatty acid hydroxylation in liver microsomes 
(Ellin & Orrenius, 1975).
Other oxidizing agents have also been described which can act 
as artificial oxygen and electron donors to cytochrome P-4-50 
in the same way as peroxides. These include sodium periodate, 
and to a lesser extent sodium chlorite (Hyrcay e^t ad.., 1975; 
Gustafsson et ad.., 1976; Gustafsson _et al., 1979). Nordblom 
et al. (1976) demonstrated that a purified rabbit liver micro­
somal cytochrome P-4-50 could metabolize benzphetamine and 
other substrates in the absence of NADPH and reductase when
(u)
certain peroxides were added to the system, although the lipid 
requirement was retained. In this system, several alkyl 
hydroperoxides, hydrogen peroxide, peroxy acids and sodium 
chlorite were all shown to be capable of supporting benz- 
phetamine demethylation by the purified cytochrome P-4-50, 
although high concentrations of some of these compounds, 
necessary to achieve benzphetamine demethylation, also resulted 
in an irreversible oxidation of the cytochrome P-4-50 haem 
group, leading to destruction of the enzyme after a few minutes. 
Rahimtula _et al. (1978) compared cytochrome P-4-50 reactions 
supported by NADPH with cumene hydroperoxide supported reactions. 
It was found that NIH shifts were observed with both systems, 
which therefore were thought to operate via a common inter­
mediate. Capdevila e_t al. (1980) have also studied differences 
in the mechanism of cytochrome P-4-50 dependent monooxygenases 
when supported by NADPH and cumene hydroperoxide. These workers 
demonstrated that different patterns of benzo(a)pyrene metabol­
ites were produced in the NADPH and cumene hydroperoxide 
supported reactions, with a preponderance of phenols and 
dihydrodiols in the former and a preponderance of quinones 
with the latter. These results raise doubts as to the 
'commonness1 of the NADPH and cumene hydroperoxide supported 
oxygenation of benzo(a)pyrene. However, MacDonald _et al. (1982) 
have recently presented evidence that the cytochrome P-4-50 • 
catalyzed hydroxylation of cyclohexane is achieved by a similar 
mechanism when supported by NADPH or iodosobenzene.
Several workers have studied the interaction between the 
components of the monooxygenase system and their orientation
(15)
in the microsomal membrane. The microsomal membrane, which is 
formed by a pinching off process from the endoplasmic reticulum 
during homogenization, is believed to retain the same orientation 
as the endoplasmic reticulum, with evidence for this coming from 
the localization of several marker enzymes (DePierre & Ernster,
1980). More than three quarters of the molecule of NADPH: 
cytochrome(c) reductase is believed to sit free of the lipid 
bilayer; however, cytochrome P-4-50 molecules are deeply embedded 
in the membrane, thereby making solubilization of these 
haemoproteins very difficult (Vermillion & Coon, 1978).
Consistent with these results, DePierre & Ernster (1980) found 
evidence that cytochrome P-4-50 is associated with both sides 
of the microsomal membrane, and thus claimed that cytochrome 
P-4-50 transverses the lipid membrane whereas NADPH: cytochrome 
P-4-50(c) reductase is only associated with the cytoplasmic 
surface. Cytochrome b^ and NADH:cytochrome b^ reductase are 
also associated with the cytoplasmic surface, and are also 
thought to be largely free of the membrane with only a small 
part of the molecule embedded in it (DePierre & Ernster, 19*2#) •
The stoichiometry of cytochrome P-4-50 molecules to NADPH: 
cytochrome P-4-50(c) reductase molecules in the intact 
endoplasmic reticulum is between 10:1 and 100:1 (Estabrook 
et al., 1971; Sato & Omura, 1978). Nebert (1979) has suggested 
that one cytochrome P-4-50 molecule may donate electrons to 
another form of cytochrome P-4-50 as in mitochondrial cytochromes 
during oxidative phosphorylation. Two models of the membrane 
arrangement of cytochrome P-4-50 and its reductase have been 
proposed, a rigid model where 8-12 molecules of cytochrome
(16)
P-4-50 are arranged in a cluster around the reductase molecule 
(Peterson et al., 1976) and a non-rigid model allowing free 
diffusion of both enzymes in the lateral plane of the membrane 
(Yang, 1975). There is some experimental data for both models, 
yet little reliable evidence to choose between them. When 
cytochrome P-4-50 is purified, the enzyme exists as a hexamer 
in solution, and when reconstituted with the reductase forms 
a molecular aggregate with an apparent molecular weight of
800,000, the two proteins combining in a 1:1 molar ratio 
(French et al., 1980). McIntosh et al. (1980) concluded from 
cross-linking and ro'tational diffusion studies that cytochrome 
P-4-50 has a tendency to form aggregates in the microsomal 
membrane. Recently, Schwarz et al. (1982) have presented 
evidence for the cluster-like organization of cytochrome P-4-50 
molecules around the reductase in the microsomal membrane from 
studies with saturation transfer EPR spectroscopy, showing a 
very slow rotation of cytochrome P-4-50 molecules in the form of 
large aggregates, although these workers have yet to show the 
involvement of the reductase in these aggregates.
The binding of substrates and other compounds to cytochrome 
P-4-50 has been widely studied using the technique of difference 
spectrophotometry (Schenkman et al.., 1967). Three different 
types of spectrum result from binding interactions with cytochrome 
P-4-50: type I (spectral max. 385-390nm, minimum 4-20nm), 
type II (spectral max.. 4-25-4-30nm, minimum 390-4-1 Onm) and reverse 
type I which is the mirror image of the type I spectrum. These 
spectral changes on binding are not fully understood. The 
type I spectrum is thought to result from binding of a substrate
(17)
to the substrate binding site in the cytochrome P-4-50 apoprotein. 
The type II spectrum is due to the binding of a compound to a 
site near the haem group, possibly at the site of the fifth 
ligand to the haem iron, occupied by oxygen during catalysis 
(Schenkman _et al., 1967). The causes of the spectral changes 
observed on binding are now interpreted in terms of spin-state 
changes and are discussed fully in chapter 4-»
The active cytochrome P-4-50 molecule contains a haem group with 
iron in the ferric form. This means that the iron atom has five 
electrons in the d-orbitals and depending on the extent of 
spin-pairing of these, can exist in two spin states, high spin 
and low spin. The low spin form results when four of the five 
d-electrons are paired and corresponds to a six coordinated 
haem iron.. The high spin form results when the five electrons 
are in separate energy levels and not paired, and corresponds 
to a five coordinated haem iron. In intact microsomal membranes, 
a mixture of the two spin-states occurs, with approx. equal 
amounts of each, the ratio of the two forms being in a 
temperature-dependent equilibrium (Cinti et al., 1979)*
It has been shown that substrates of cytochrome P-4-50 cause 
a change in the spin state in vivo f.rom low to high-spin 
(Kumaki e_t al., 1978). Ristau jet al. (1979) have also demon­
strated that substrates induce a spin-state transition from 
low to high-spin. It has also been shown that the spin-state 
of cytochrome P-4-50 controls the redox potential of the 
molecule, with the high-spin form having a less negative redox 
potential (Sligar, 1976). Substrate binding thus not only
(18)
results in a transition from low to high-spin, but also a 
change in the redox potential, making it less negative and 
hence allowing electrons to flow to the cytochrome P-4-50 
molecule more easily (Sligar et al., 1979)* Thus the substrate 
induced spin-state change results, in an acceleration of 
reduction rate of the cytochrome (Misselwitz _et al., 1980).
This reveals a mechanism whereby the substrate facilitates 
the electron flow to cytochrome P-4-50, hence enabling the reaction 
to proceed. The role of lipids in the membrane may also be 
important in holding the enzyme in a high-spin configuration 
and facilitating the monooxygenase reaction (Gibson el al., 1980).
1.3. The. Induction of Mammalian Cytochrome P-4-50 Enzymes 
and the Presence of Multiple Forms
The activity of the liver microsomal monooxygenase system is 
increased by the treatment of the animal with a wide variety 
of drugs, pesticides, food additives, carcinogens and other 
compounds. This increased activity results from an increase 
in the concentration of the cytochrome P-4-50 enzyme involved, 
by de novo protein synthesis. This was shown to be by de novo 
synthesis as it can be blocked by inhibitors of protein synthesis 
such as puromycin and inhibitors of nucleic acid synthesis such 
as actinomycin D (Conney, 1967).
Two of the most widely studied inducers of the mammalian liver 
cytochrome P-4-50 system are phenobarbital and 3-methylcholan- 
threne. After induction with these compounds, different forms 
of the enzyme are observed in each case, with different substrate
specificities. Phenobarbital induces a form of the enzyme 
with a very wide substrate specificity, the rate of metabolism 
of many substrates (e..g. aminopyrine, benzphetamine and 
ethylmorphine) being increased. However, these activities 
are unchanged or decreased by 3-methylcholanthrene pretreatment, 
which induces an enzyme with a relatively narrow substrate 
specificity with high activity towards carcinogens such as 
benzo(a)pyrene. The metabolism of some other compounds 
(e.g. acetanilide) is increased by both inducers. These 
observations led to the classification of inducers into two 
broad categories. The first group of these, exemplified by 
phenobarbital, induced cytochrome -P-4-50 with a very wide 
substrate specificity with a peak in the reduced carbon 
monoxide difference spectrum at 4-50nm. The second group, 
including 3-methylcholanthrene and other polycylic hydrochrbons, 
induced an enzyme with relatively narrow specificity, particularly 
aryl hydrocarbon hydroxylase activity. This narrow specificity 
enzyme had a Soret peak in the reduced carbon monoxide difference 
spectrum at 4-4-8nm, and so was termed cytochrome P-4-&8* These 
groups were thus termed phenobarbital-like or cytochrome P-4-50 
inducers, and 3-methylcholanthrene-like or cytochrome P-4-4-8 
inducers (Conney,. 1967). Initially, it was thought that 
cytochrome P-4-50 and cytochrome P-4-4-8 might be interconvertible 
forms of the same enzyme (Schenkman ejb al., 1969)> but it was 
quickly established that these two enzymes arose from distinct 
gene products (Lu et al., 1973; Conney ^t al., 1973; Levin
(20)
Several hundred inducers of cytochrome P-4-50 enzymes are now- 
known and some examples are listed in table 1.1.. As further 
work on the induction of microsomal enzymes was carried out, 
it became apparent that more newly discovered inducers were 
neither phenobarbital-like nor 3-methylcholanthrene-like.
For example, ellipticine induced its own cytochrome P-4-50 
mediated metabolism better than phenobarbital or 3-methylchol- 
anthrene (Lesca et al., 1977) and isoniazid induced enflurane 
metabolism, which is not induced by phenobarbital or 3-methyl- 
cholanthrene (Rice & Talcott, 1979). Similar observations 
have now been made with more than 60 inducers (including safrole 
and pregnenolone l6d-carbonitrile - see table 1.1.) (see 
Nebert et al., 1981).
These observations are now understood in terms of multiple 
forms of cytochrome P-4-50. It has become well established 
that more than two forms of the enzyme exist with different 
yet overlapping substrate specificities. The evidence for this 
has come from several types of study, including studies with 
inducers, isolation and purification of different forms, 
immunological differences and kinetic and substrate binding 
studies (Guengerich, 1979). Also, sequencing studies have 
recently revealed distinct amino acid differences between 
cytochrome P-4-50 isozymes (Coon et al., 1982). The discovery' 
of multiple forms of cytochrome P-4-50 has led to considerable 
confusion in the literature. Both cytochrome P-4-50 and 
cytochrome P-4-4-8 are now known to exist as a mixture of 
isoenzymes, and are thus general terms for a range of enzyme 
species. Cytochrome P-4-50 is now used as a collective name
(21)
StructureDescriptionInducer
SedativePhenobarbital
OIOIQ3-methylcholanthrene Carcinogen
Benzo(a)pyrene Carcinogen
Hydrocarbon
analog
B-naphthoflavone
Polychlorinated 
biphenyls(aroclors)
Insulators, 
lubricants, 
heat exchange 
fluids (Cl)(Cl)
Safrole Carcinogen 
(formerly a 
flavouring 
agent)
2,3,7,8-tetrachloro- 
dibenzo-p-dioxin 
(TCDD)
Herbicide 
impurity Cl Cl
Cl
Pregnenolone
l6a-carbonitrile
steroidal
derivative
HO
Table 1.1. Mammalian cytochrome P-4-50 inducing agents
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for all haemoproteins with a Soret peak in the reduced carbon 
monoxide difference spectrum around 4-50nm (including cytochrome 
P-4-4-8) and attempts are being made to devise a nomenclature 
for' these enzymes based on their electrophoretic mobilities 
(Nebert, 1980).
The effect of inducers is now thought to be in inducing a 
range of cytochrome P-4-50 enzymes, the combined properties of 
which make up the characteristic properties of the 'induced 
enzyme1. Some of these enzyme species may be present in 
uninduced animals. Ryan et al. (1979) purified three forms 
of cytochrome P-4-50 from rat liver microsomes, designated 
cytochrome P-4-50a, b and c. These three enzymes were disting­
uished by differences in molecular weight, immunological proper­
ties and peptide mapping. In addition, partial amino acid 
sequences revealed that these enzymes were distinct gene products 
and hot due to post-translational modifications of one primary 
gene product (Bothelo,_et al., 1979). Cytochrome P-4-50a and c 
were found after induction with 3-methylcholanthrene. Cytochrome 
P-4-50b is the major form induced by phenobarbital and cytochrome 
P-4-50c the major form induced by 3-methylcholanthrene. After 
induction with aroclor 1254- (a mixture of polychlorinated 
biphenyls, known to induce both cytochrome P-4-50 and cytochrome 
P-4-4-8 activities), cytochrome P-4-50a, b and c were all present. 
Cytochrome P-4-50a has a Soret peak in the reduced carbon 
monoxide difference spectrum at 4-52nm, cytochrome P-4-50b at 
4-50nm and cytochrome P-4-50c at 4-4:7nm. These enzymes were 
observed to have different yet. overlapping substrate specificit­
ies. Aniline was hydroxylated equally well by all three
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enzymes. Cytochrome P-4-50a hydroxylated testosterone at the 
7 position but had low activity towards benzphetamine, benzo(a)- 
pyrene and 7-ethoxycoumarin. Cytochrome P-4-50b hydroxylated 
testosterone at the 16a position and was very active towards 
benzphetamine demethylation. Cytochrome P-4-50c hydroxylated 
testosterone preferentially at the 6B position, had low activity 
towards benzphetamine demethylation but had very high activity 
for benzo(a)pyrene metabolism and 7-ethoxycoumarin O-dealkylation 
(Ryan et al., 1979).
Colbert £t al. (1979) showed that cytochrome P-4-50b, induced 
by phenobarbital, was produced as a result of an increased 
level of mRNA specific for this protein, as early as 6 hours 
after administration. Similarly, Bresnick e_t al. (1981) 
showed an increased level of cytochrome P-4-50c mRNA 7 hours 
after treatment with 3-niethylcholanthrene, showing that these 
enzymes are coded by distinct mRNA species which are increased 
on induction.
The mechanism of induction by phenobarbital has been studied 
by several groups. The administration of phenobarbital has 
been shown to result in an increased level of mRNA specific 
for inducible cytochrome P-4-50 forms (Colbert e^t al., 1979;
Kumar ^t al., 1980). Phillips jet al.; (1981) showed that the 
mRNA level for the major phenobarbital inducible cytochrome 
P-4-50 in rat liver was increased 20-fold, whilst the level of 
this protein was induced 24--fold. Adesnick ejb al. (1981) 
found that the mRNA level for phenobarbital inducible cytochrome 
P-4-50 was increased 30-fold on induction. Recently, Fujii- 
Kuriyama _et al. (1982) have sequenced the coding nucleotides
(24)
of copy DNA to mRNA of phenobarbital inducible cytochrome P-450 
from rat liver, and have used this to predict the amino acid 
sequence of the cytochrome. The predicted molecular weight and 
amirio acid composition agreed with those of the purified enzyme. 
These workers sequenced three copy DNA1s to phenobarbital 
induced mRNA and one of these, although similar, was not 
identical to the other two. Several amino acid substitutions 
occur in a limited portion of the sequence, perhaps indicating 
a fvariable region1.
Vlasuk jet al. (1982) have shown that four immunochemically 
identical forms of phenobarbital induced rat liver cytochrome 
P-4-50 exist in unique combinations, which characterize different 
strains of rats and may partially explain the well-known strain 
differences in cytochrome P-4-50 enzymes (Hodgson, 1979).
Walz et al. (1982) have characterized the mRNA from two of 
these different cytochrome P-4-50 isozymes and found that they 
are different species. When translated in vitro, they give 
rise to distinct isozymes corresponding exactly to the enzyme 
characterizing the group of rats from which they were isolated.
The group of Coon and co-workers have worked extensively on 
the multiple forms of cytochrome P-4-50 in rabbit liver microsomes 
(Haugen & Coon, 1976; Coon ^t al.,1978, 1980; Koop et al., 1981, 
1982). These workers have labelled their cytochrome P-4-50 
enzymes with numbers, LM 1-7 (LM=liver microsomal) based on 
their relative electrophoretic mobilities, with the lower 
numbers given to those forms with the highest mobility towards 
the anode. Cytochrome P-4-50 LM2 is the major form isolated
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from phenobarbital treated animals and has a peak in the reduced 
carbon monoxide difference spectrum at 451nm and a molecular 
weight of 48,000 (Haugen & Coon, 1976). Cytochrome P-450 LM 4 
is the major form induced by 3-methylcholanthrene, benzo(a)pyrene 
B-naphthoflavone and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 
and has also been detected in small amounts in untreated 
animals (Coon et al., 1978; 1980). The enzyme from all of these 
sources is indistinguishable by several criteria, has a molecular 
weight of 54*000 and a Soret peak in the reduced carbon monoxide 
spectrum at 448nm.
The major cytochrome P-450 proteins present in uninduced rabbit 
liver are LM 3b and LM 3c, a small amount of LM 3a and LM 4 
also being detectable (Koop e_t al., 1981). LM 3c is also found 
alongside LM 2 in phenobarbital induced rabbits (Coon jet al.,
1980). Cytochrome P-450 LM 3b and LM 3c have molecular weights 
of 52,000 and 53*000 and Soret peaks at 450nm and 449nm 
respectively. Other workers have also described LM 3 enzymes 
in uninduced rabbit liver (Ingelman-Sundberg e^t al., 1980; 
Johnson, 1980). Cytochrome P-450 LM 3a has recently been shown 
to be the major form present after induction with ethanol 
(Koop jet al., 1982). This enzyme has a molecular weight of 
51,000, a Soret peak at 452nm and is very active in the oxidation 
of ethanol and the p-hydroxylation of aniline.
Cytochrome P-450 LM 6 has been found as a minor component after 
induction with TCDD in adult rabbits, but is the major component 
after TCDD induction of neonatal rabbits (Norman jet al., 1978). 
This enzyme has a molecular weight of 57,000 and a Soret peak
(26)
in the reduced carbon monoxide spectrum at 448nm, and is also 
the major form after induction with isosafrole (Koop ejb al, , 
1982). Cytochrome P-450 LM 1 and LM 7 have also been observed, 
but ’as yet have not been purified and are poorly characterized. 
The characteristics of the major rabbit liver cytochrome P-450 
enzymes are summarised in table 1.2.. These enzymes have also 
been shown to have different but overlapping substrate 
specificities.
Although extensive work has already gone into characterization 
of forms of cytochrome P-450, the exact number of isozymes is 
not known. Current estimates range from 12-20 enzymes present 
in rabbit liver microsomes (Koop _et al. , 1982) and a similar 
number has been postulated for rat liver microsomes and other 
microsomal systems (Guengerich, 1982). Some workers believe 
that hundreds or even thousands of cytochrome P-450 molecules 
may exist, although not all at one time, produced in a manner 
analogous to antibody synthesis (Nebert et al., 1981). At 
any one time, an organism may be exposed to 10-20 important 
inducers, so that 10 or 20 forms of induced cytochrome P-450 
would exist in quantities sufficient to be detected. At a 
later time, the organism might be exposed to a different range 
of inducers and thus a different profile of cytochrome P-450 
enzymes may be produced (Nebert ejt al., 1981). For this system 
it is necessary to postulate induction of cytochrome P-450 
enzymes in control organisms, presumably by endogenous substrates 
such as fatty acids and steroids. Nebert and co-workers have 
also worked extensively on the mechanism of induction of 
cytochrome P-450 by polycyclic hydrocarbons. This occurs via
(27)
Cytochrome
Pt4-50
Molecular
weight
ISoret peak 
(carbon monoxide 
bound)
Reference
LM 2 4.8,000 4-51 Haugen & Coon (1976)
LM 3a 51,000 4-52 Koop _et al. (1982)
LM 3b 52,000 4-50 Koop et, al. (1981)
LM 3c 53,000 4-4-9 Koop _et al. (1981)
LM 4- 54-, 000 U 8 Coon e_t al. (1978;
1980)
LM 6 57,000 4-4-8 Norman ejfc al. (1978)
Table 1.2. Major rabbit liver cytochrome P-4-50 enzymes
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the ’Ah locus’; the inducer binds to a cytosolic receptor which 
is translocated to the nucleus where several cytochrome P-4-50 
structural genes are switched on. This model is discussed 
more’ fully in chapter 2.
1.4-. Cytochrome P-4.50 from Prokaryotic Microorganisms
Cytochrome P-4-50 has been found in several species of bacteria. 
These are listed in table 1.3. along with the reported role 
of the enzyme in each case. By far the best characterized of 
these enzymes is that, from Pseudomonas putida. This organism 
produces a cytochrome P-4-50 enzyme when grown on D( + )-camphor 
which metabolizes camphor, hence enabling growth of the organism 
on this compound as sole carbon and energy source (Yu et al., 
1974-). This enzyme (termed cytochrome P-4-50cam) hydroxylates 
the 5-methylene carbon of camphor to form the exo-5-alcohol 
(Gunsalus et al., 1975). Studies on cytochrome. P-4-50cam have 
been greatly facilitated as, unlike mammalian cytochrome P-4-50 
enzymes, it is a soluble enzyme and not membrane bound. This 
enzyme has been purified to homogeneity and crystallized; it has 
a molecular weight of 4-4--4-6,000 and has a Soret peak in the 
reduced carbon monoxide difference spectrum at 4-4-6nm (O’Keefe 
et al., 1978).
The cytochrome P-4-50cam electron transport chain, shown in 
figure 1.4-., contains an extra protein component, putidaredoxin, 
a small iron-sulphur protein. Also the flavoprotein reductase 
contains only one flavin group, an FAD (Dus, 1975). In these 
respects, this system differs from microsomal cytochrome P-4-50
(29)
Organism Role References
Pseudomonas putida camphor hydroxylation Gunsalus .et al. 
0 1 Keefe .et al.
1975
1978
Ba c i11 u s me sateriurn steroid Bers et al. 1979
ATCC 13368 15B-hydroxylation Berg & Rafter, 1981
Bacillus mesaterium hydroxylation of Matson et al. 1977,
ATCC 14-581 fatty acids, alcohols and amides
1980
Corynebacterium sp.
7E1C
hydroxylation 
of alkanes
Cardini & Jurtshuk,
1970
Acinetobacber sp. hydroxylation 
of alkanes
Asperger et al. 1981
Nocardia NHI p-O-dealkylation Broadbent &
Cartwright, 1974
Rhizobium .iaponicum Role in fixation?
p-nitroanisole
dealkylation
Appleby, 1978
Escherichia coli Edelson & McMullen,
1977
Photobacterium-
fischeri
aliphatic 
hydroxylation 
(in bacterial 
luminescence)
Ismailova jet al. 
Danilov _et al.
1981
1982
Table 1.3. Bacterial cytochrome P-450 systems
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but is very similar to mammalian mitochondrial cytochrome P-4-50 
systems, which also contain an extra iron-sulphur protein and 
a reductase with one flavin group (Suhara et al., 1978).
Dus et al. (1980) have compared the immunochemical properties 
of cytochrome P-4-50cam with cytochrome P-4-50scc, the mitochon­
drial cytochrome P-4-50 from adrenal cortex of mammals responsible 
for side chain clearage of cholesterol. Antibodies to one of 
these proteins could inhibit the activity of the other, and the 
two antibodies showed a high degree (approx. 75$) of cross­
reactivity, indicating one or more antigenic determinants in 
common. In these experiments, cytochrome P-4-50 LM 2 from 
phenobarbital induced rabbit liver microsomes also showed 60$ 
cross-reactivity with antibody to cytochrome P-4-50cam. Recently, 
the primary strcture of cytochrome P-4-50cam has been completely 
elucidated (Haniu et al., 1982). The enzyme consists of a chain 
of 4-12 amino acid residues, and detailed comparisons with other 
cytochrome P-4-50 enzymes will now be possible oxice their sequence 
becomes available.
Two cytochrome P-4-50 species with different specificities have 
been reported in different strains of Bacillus megaterium. The 
strain ATCC 14-581 produces a cytochrome P-4-50 with UJ-2 hydroxy­
lase activity towards fatty acids (with some U>=1 and OJ-3 activity) 
which can also hydroxylate corresponding amides and alcohols 
(Matson et al.’, 1977). This enzyme can also catalyze the 
epoxidation of unsaturated fatty acids (Reuttinger & Fulco, 1981). 
Substrates of this enzyme were unable to induce the enzyme to 
higher levels, but when phenobarbital was tested, a 28-fold 
induction was observed (Narhi & Fulco, 1982).
(32)
Bacillus megaterium ATCC 13368 also contains a cytochrome P-4-50 
monooxygenase system, which has very different properties to 
that of. ATCC 14-581 described above. This enzyme is mainly a 
15B-hydroxylase (with .some 6B-hydroxylase activity) for 
3-oxo-A^-steroids such as progesterone (Berg e_t aJ.., 1977).
This cytochrome P-4-50 (termed cytochrome P-4-50meg) is also 
a soluble enzyme and has been purified to homogeneity and found 
to have a molecular weight of 52,000 and an amino acid composition 
similar to that of cytochrome P-4-50cam (Berg eit al., 1979)*
The reduced carbon monoxide difference spectrum reveals a peak 
at 4-50nm. This system also contains a three-protein component 
electron transport chain similar to that in P. putida, as do 
all the bacterial cytochrome P-4-50 monooxygenase systems 
investigated so far.. One difference in the cytochrome P-4-50meg 
system is that the reductase contains FMN and not FAD as the 
prosthetic group (Gustafsson et al., 1980)* Studies on the small 
iron-sulphur protein (ferredoxin) component have revealed that 
its molecular weight and. amino acid composition closely resemble 
those of putidaredoxin and adrenodoxin, the corresponding proteins 
in P. putida and mammalian adrenal cortex mitochondria (Berg, 
1982). It has been found that in common with other bacterial 
systems (and mammalian mitochondrial systems), the substrate 
specificity of this enzyme is very narrow, with only 
3-oxo-A^-steroids acting as substrates (Berg & Rafter, 1981).
In addition, these workers found that no induction of cytochrome 
P-4-50meg could be detected with either substrates or classical 
inducers of mammalian cytochrome P-4-50.
(33)
A cytochrome P-4-50 system has also been detected in 
Corynebacterium species grown on n-octane, which hydroxylates 
n-octane and allows growth on this compound as sole carbon and 
energy source (Cardini & Jurtshuk, 1970). This cytochrome 
P-4-50 can also oxygenate several other hydrocarbon substrates 
such an benzene, toluene and other aliphatic hydrocarbons.
This enzyme is induced by its substrate in similar fashion to 
cytochrome P-4-50cam and is not found in the same organism grown 
on non-hydrocarbon substrates. Asperger ^t al. (1981) have 
shown that several strains of Acinetobacter contain cytochrome 
P-4-50 when grown on n-alkanes. These cytochrome P-4-50 enzymes 
are also thought to be involved in alkane hydroxylation as the 
first step in their complete oxidation (Asperger _et al., 1981). 
A similar hydrocarbon inducible cytochrome P-4-50 dependent 
alkane hydroxylase is also observed in several species of 
yeast (see on).
Broadbent & Cartwright (1974-) have purified and characterized 
a soluble cytochrome P-4-50 from a Nocardia species (NHI) grown 
on iso-vanillate, which can 0-dealkylate p-alkylphenyl ethers. 
This enzyme (termed cytochrome P-4-50npd) has a molecular weight 
of 4-2-4-5>000 and has many properties in common with the cytor 
chrome P-4-50cam enzyme, although a major difference is that 
cytochrome P-4-50npd does not appear to undergo a low to high- 
spin transition on substrate binding (Broadbent & Cartwright, 
1974).
Appleby (1978) purified three cytochrome P-4.50 enzymes from 
Rhizobium japonicum grown symbiotically on soybean root nodules.
(34-)
The three enzymes designated cytochrome P-450a, b and c had 
Soret peaks in the reduced carbon monoxide difference spectrum 
at 4-4-9nm, 4-4-9nm and 4-4-7nm for cytochromes P-4-50a, b and c 
respectively. The role of these R. .japonicum enzymes is unknown, 
but they may have a role in the removal of oxygen in this 
strictly anaerobic system, or in electron transport at very 
low oxygen tension to generate ATP required for nitrogenase 
activity (Bergersen & Turner, 1975).
Edelson & McMullen (1977) examined Escherichia coli for 
cytochrome P-4-50 activity. This organism contained an enzyme, 
inhibited by carbon monoxide, which could dealkylate p-nitro- .
anisole. This activity could be induced by phenobarbital, as is 
the case for the fatty acid hydroxylase from B. megaterium 
described above.
Cytochrome P-4-50 has also been reported to be involved in the 
bacterial luminescence of Photobacterium fischeri (Baranova 
et al., 1979). The luciferase complex of this organism is 
thought to consist of four protein components in a multienzyme 
complex, one of which is cytochrome P-4-50. The role of cytochrome 
P-4-50 in this process is thought to be in hydroxylation of 
aliphatic aldehydes, substrates of the luminescence reaction 
(Ismailova _et al*, 1980).. Danilov ejfc al. (1982) have shown • 
that the cytochrome P-4-50 from Photo bacterium f i s cheri gives 
rise to a type 1 binding spectrum with camphor, and that this 
compound can inhibit the luminescence system by competitive 
inhibition of cytochrome P-4.50.
(35)
In all of the bacterial cytochrome P-4-50 systems characterized 
so far, the cytochrome P-4-50 is soluble and operates via an 
electron transport chain of three protein components. Thus the 
bacterial systems are very similar to those of mammalian 
mitochondria, but unlike those in mammalian microsomes. This 
is evidence in favour of the hypothesis that mammalian mitochondria 
evolved from symbiotic microorganisms (Hodgson, 1980).
1.5- Cytochrome P-4-50 from Eukaryotic Microorganisms
1.5.1. Fungi
Cytochrome P-4-50 enzymes have been detected in several eukaryotic 
microorganisms. In contrast to bacterial systems, the electron 
transport chain in these eukaryotic systems is similar to 
microsomal systems in mammals, and contains only two protein 
components - a reductase (with two flavin groups, one FAD and 
one FMN) and a cytochrome P-4-50. Eukaryotic microorganism 
(fungi and yeast) cytochrome P-4-50 systems have all been found 
to be membrane bound to endoplasmic reticulum, as in mammalian 
systems. The fungal species known to produce a cytochrome P-4-50 
system are listed in table 1.4-..
Cl a vi ceps purpurea possesses a microsomal cytochrome P-4-50 
which is induced two-fold by phenobarbital (Ambike & Baxter,
1970). When treated with 3-methylcholanthrene, only a small 
increase in cytochrome P-4-50 level is observed yet a shift in 
the Soret peak of the reduced carbon monoxide difference spectrum 
takes place, from 4-50nm to 4-4-8nm. Evidence from the use of
(36)
Organism Role References
Claviceps purpurea
Rhizopus nigricans
Cunninghamella
bainieri
Cunninghamella
elegans
alkaloid biosynthesis
steroid hydroxylation
aromatic hydroxylation 
N- and 0- 
demethylation
aromatic hydroxylation
Ambike & Baxter, 1970
Breskvar & 
Hudnik-Plevnik,
1977; 1981
Ferris et al., 1973; 
1976.
Cerniglia & Gibson, 
1978; 1979
Table 1.4-. ■ Fungal cytochrome P-4-50 systems
(37)
protein synthesis inhibitors showed that this shift in wavelength 
is a result of de novo protein synthesis. Ambike & Baxter (1970) 
also showed a direct correlation between alkaloid production 
and'cytochrome P-450 monooxygenase levels, and suggested that 
this enzyme is involved in alkaloid biosynthesis, although the 
exact reaction(s) catalyzed is unknown.
Rhizopus nigricans has also been shown to possess a cytochrome 
P-450 enzyme which is capable of catalyzing the lla-hydroxylation 
of progesterone. This activity is inhibited by carbon monoxide 
and this inhibition could be removed by light at 450nm 
(Breskvar & Hudnik-Plevnik, 1977). This enzyme is induced by 
added substrate and this induction was due to d,e novo enzyme 
synthesis (Breskvar & Hudnik-Plevnik, 1977). Later studies 
showed that this enzyme system contains two protein components, 
an NADPH:cytochrome P-450 reductase and the cytochrome P-450, 
similar to other eukaryotic microsomal systems (Breskvar & 
Hudnik-Plevnik, 1981).
A cytochrome P-450 monooxygenase is also present in Cunninghamella 
bainieri which is capable of N-demethylation of aminophenazone, 
O-demethylation of p-nitroanisole and the hydroxylation of 
anisole, aniline and naphthalene (Ferris et al., 1973; 1976).
Ferris et al. (1976) also described an NIH shift during anisole 
hydroxylation, an observation which is supported by■the previous 
work of Auret et al. (1971), which showed the NIH shift during 
aromatic hydroxylation by nine fungal species. The NIH shift 
is evidence for an epoxide intermediate, and is well established 
for mammalian cytochrome P-450 catalyzed aromatic hydroxylation 
(see section 1.2. and figure 1.1.).
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Cunninghamella elegans possesses a cytochrome P-450 capable of 
hydroxylation of naphthalene which can be induced to five times 
its original level by naphthalene (Cerniglia & Gibson, 1978).
This enzyme can also hydroxylate benzo(a)pyrene in a pattern 
very similar to that observed with the mammalian monooxygenase 
system (Cerniglia & Gibson, 1979)» Hydroxylation of benzo(a)- 
pyrene is also inducible in Neurospora crassa (Lin & Kapoor,
1979) and is well established for the cytochrome P-450 system 
of Saccharomyces cerevisiae (see on). C. elegans has also been 
shown to hydroxylate biphenyl, a well known substrate of mammalian 
cytochrome P-450 enzymes, although the involvement of cytochrome 
P-450 in this reaction is not known (Dodge _et al., 1979)*
1.5.2. Yeasts
A cytochrome P-450 has been demonstrated in several yeast species 
when grown on n-alkanes as sole carbon source (table 1.5*)*
These organisms use cytochrome P-450 as an alkane hydroxylase 
catalyzing the first step in the degradation of alkanes for 
growth, in a fashion similar to the bacterial systems in 
Corynebacterium and Acinetobacter described in section 1.4»*
The first report of an alkane grown yeast containing cytochrome 
P-450 was for Candida tropicalis grown on n-tetradecane as sole 
carbon source (Gallo et al., 1971). This enzyme catalyzes the 
OJ-hydroxylation of alkanes and of lauric acid, and is also 
capable of N-demethylation of aminopyrine, hexobarbital, 
benzphetamine and ethylmorphine (Lebeault _et al., 1971). This 
enzyme is dependent on oxygen and NADPH, is inhibited by carbon 
monoxide, is bound to microsomal membrane and requires two
(39)
Organism References
Candida tropicalis Duppel ejb al., 1973; 
Gallo ejb al., 1976
Candida
ffuilliermondii
Muller e_t al., 1979
Candida lipolytica Mauersberger & 
Matyashova, 1980
Torulopsis Candida Il’chenko e*t al., 1980
Lodderomyces
eloneisporus
Riege _et al., 1981
Saccharomycopsis
lipolytica
Marchal et al., 1982
Table 1.5. Alkane utilizing yeasts shown to contain 
cytochrome P-4-50
(4-0)
protein components (cytochrome P-450 and its reductase) and 
lipid for full activity (Duppel at al. , 1973; Gallo jet al. ,
1976). Surprisingly, both the reductase and the lipid components 
could be replaced by the corresponding fractions from rat liver 
microsomes (Duppel _et al., 1973). Hexadecane has also been 
shown to be a potent inducer of this system, as have all 
n-alkanes tested with more than 10 carbon atoms, and also long 
chain alkenes and alcohols (Gilewicz _et al., 1979). The 
components of the electron transport chain from Cl. tropicalis 
have been purified and reconstituted into an active hydroxylase 
system (Bertrand et al., 1979a; 1979b). Mansuy et al. (1980) 
have shown that cytochrome P-4-50 from G.. tropicalis is in a 
spin-state equilibrium similar to that of mammalian microsomal 
cytochrome P-4-50 and that this enzyme can also undergo spectral 
changes on binding.
A similar enzyme has been described in Candida guilliermondii 
grown on n-alkanes which hydroxylates long-chain alkanes 
(preferably hexadecane to octadecane) to their primary alcohols 
(Muller et al., 1979). This microsomal enzyme also produces 
binding spectra with several compounds including a type I 
spectrum with the substrate hexadecane (Muller _et aJ.. , 1979).
It was also shown that CL guill-iermondii could not produce 
cytochrome P-4-50 during growth on glucose, nor when glucose was 
added together with the hydrocarbon inducer. Mauersberger 
et al. (1980) have shown that the level of alkane-induced 
cytochrome P-4-50 in C. guilliermondii is higher when the oxygen 
level is low. These workers suggested that this effect might
(a)
be due to oxygen limitation causing a decreased alkane hydroxy- 
lation rate, to which the yeast responds by increasing biosynthesis 
of the monooxygenase.
Mauersberger & Matyashova (1980) reported the occurrence of 
cytochrome P-450 also in Candida lipolytica grown on n-alkanes 
and Il’chenko et- al (1980) demonstrated a similar system in 
Torulopsis Candida. Lodderomyces elongisporus is also capable 
of producing a cytochrome P-450 when grown on n-alkanes, 
particularly tetradecane (Mauersberger ^t al., 1981). This 
enzyme and its reductase have recently been purified and 
reconstituted into an active hydroxylating system which requires 
phospholipid (Riege et al., 1981; Muller _et al., 1982). 
Saccharomycopsis lipolytica also .produces a cytochrome P-4-50 
alkane hydroxylase when grown on n-alkanes, which is very 
active towards lauric acid hydroxylation (Marchal ejt al., 1982).
The occurrence of cytochrome P-4.50 in Saccharomyces yeasts is 
now well established. Lindenmayer & Smith (1964) were the first 
to demonstrate the occurrence of this haemoprotein in Saccharo- 
myces cerevisiae grown anaerobically in a medium containing 
k% glucose and to a lesser extent when grown aerobically in 
the same medium. Cytochrome P-4-50 has now been demonstrated 
in several species of Saccharomyces and related species of. 
yeasts (table 1.6.).
Ishidate -et- al. (1969a) showed that cytochrome P-450 was located 
in the microsomal fraction of S. cerevisiae, and that its spectral 
properties were similar to those of mammalian microsomal
U2)
Organism References
Saccharomyces cerevisiae Lindenmay.er & Smith, 1964-; 
Wiseman et al. ,  1975
Saccharomyces uvarum 
(formerly S. carlsbergensis)
Cartledge e_t a l . 1972; 
Sauer _et al. ,  1982
Schizosaccharomyces pombe Poole ejb al., 1974-; 1979
Saccharomyces bayanus K&renlampi e_t al. ,  1980
Saccharomyces chevalieri V
S chi z o sa ccharomyce s .i aponi cu s n
Pichia fermentans it
Debaryomyces hansenii i i
Hansenula anomala i i
Kluyveromyces fraerilis 
(formerly S. fragilis)
it
Brettanomyces anomalus i i
Torulopsis dattila it
Table 1.6. Saccharomyces and related species of yeast 
which contain cytochrome P-4-50 during growth on glucose media
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cytochrome P-4-50. These findings were later verified by 
Yoshida et al. (1974-a). Ishidate _et al. (1969b) also found 
that cytochrome P-4-50 was present in yeast grown semi-anaerob- 
ically but was lost on exposure to aerobic conditions. This 
loss paralleled the formation of active micochondria within the 
yeast cells and could be prevented by high concentrations of 
glucose or chloramphenicol, both of which also prevented the 
development of mitochondrial respiration. Rogers & Stewart 
(1973) showed that no cytochrome P-4-50 could be detected in 
yeast grown under strictly anaerobic conditions, but found a 
maximum level of cytochrome P-4-50 was reached at a low oxygen 
concentration (0.25MM) when grown in J±% glucose media, which 
decreased at higher oxygen concentrations. Subsequent work 
has established that cytochrome P-4-50 production in S. cerevisiae 
is associated with the exponential growth phase under conditions 
of repression of mitochrondrial cytochromes, and the enzyme is 
rapidly lost during stationary phase, or when formation of 
active mitochrondria can occur (Woods, 1979; Wiseman 1980b).
Thus cytochrome P-4-50 is produced in £>. cerevisiae under conditions 
which lead to repression, of mitochondrial cytochromes»rsubh as 
semi-anaerobic conditions or at a high glucose concentration 
in aerobic conditions.
Wiseman ejb al. (1978) have shown that d^ e novo synthesis of . 
cytochrome P-4-50 in S. cerevisiae is controlled by the intra­
cellular concentration of cyclic AMP by repression. The level 
of cyclic AMP in the yeast cell is determined by the glucose 
concentration in the medium in an inverse relationship (Sy & 
Richter, 1972). Therefore under conditions of glucose repression
(U)
of mitochrondrial cytochromes, the cyclic AMP concentration 
is low and the repressive effect of cyclic AMP is removed, 
allowing de novo synthesis of cytochrome P-4-50 to occur 
(Wiseman _et al., 1978). As expected, cytochrome a+a^ and 
cyclic AMP show a direct relationship to each other and an 
inverse relationship to cytochrome P-4-50 levels at various 
glucose concentrations (Qureshi et al., 1980). This inverse 
relationship between cytochrome a+a^ and cytochrome P-4-50 has 
also been noted in S. cerevisiae grown semi-anaerobically 
(Schunck ejb al., 1978).
The production of cytochrome P-4-50 during growth of £>. cerevisiae 
on a range of sugars has been studied by K&renlampi et al.
(1981). These workers found that high concentrations of 
cytochrome P-4-50 were produced during growth of yeast on high 
concentrations of a strongly fermentable sugar such as glucose, 
fructose and sucrose. Cytochrome P-4-50 was also produced to 
a lesser extent during growth on galactose or maltose where 
fermentation and respiration occurred concomitantly. However, 
when a non-fermentable carbon source was used for growth (such 
as glycerol, lactate or ethanol), no cytochrome P-4-50 was 
produced. These workers thus linked cytochrome P-4-50 synthesis 
to conditions of rapid growth and fermentation, though not 
necessarily to repression of mitochondrial cytochromes. As 
haem is synthesized during both fermentative and respirative 
conditions (Labbe-Bois & Volland, 1977), it is probable that 
apoprotein synthesis is regulated in these different conditions.
U5)
The presence of a complete electron transport chain in S. 
cerevisiae analogous to that in liver microsomes has been 
demonstrated by Yoshida _et al., who have isolated and purified 
yeast cytochrome P-4-50 (Yoshida et al., 1977), NADPH: cytochrome 
P-4-50 reductase (Kubota eb al. , 1977a; Aoyama et al., 1978), 
cytochrome b^ (Yoshida et al. , 1974-b) and NADH:cytochrome b^ 
reductase (Kubota et al., 1977a). The purified cytochrome 
P-4-50 had a molecular weight of 51>000 and a reduced carbon 
monoxide spectral peak at 4-4-7-4-4-Snm (Yoshida ert al., 1977).
These workers also suggested that most of yeast cytochrome 
P-4-50 is in the. high spin-state in vivo and may therefore be 
substrate bound (Yoshida & Kumaoka, 1975). However, the function 
of cytochrome P-4-50 in S. cerevisiae is still uncertain.
S. cerevisiae cytochrome P-4-50 is thought to be involved in 
the demethylation of lanosterol to zymosterol, which is an 
intermediate in the conversion of lanosterol to ergosterol, 
the major sterol in yeast membranes. This process involves 
three demethylation steps and was inhibited 51% by carbon 
monoxide (Alexander et al., 1974-). It was also shown that 
partially purified low spin yeast cytochrome P-4-50 could be 
partially converted to high spin by adding lanosterol (Yoshida 
& Kumaoka, 1975)- Aoyama & Yoshida (1978a) showed that lanosterol 
stimulated the oxidation of NADPH by purified yeast cytochrome 
P-4-50 and reductase and demonstrated a type I binding spectrum 
for lanosterol with the purified yeast enzyme, indicative of 
a substrate relationship. It was subsequently shown that 
cytochrome P-4-50 is involved in the 14a-demethylation of 
lanosterol, the other two demethylation steps proceeding via a
(46)
cyanide-sensitive monooxygenase (Ohba et al. , 1978; Aoyama 
et al.., 1981b). This 14;a-demethylation step is inhibited by 
antibodies to yeast cytochrome P-4-50, and a reconstituted 
system of purified cytochrome P-4-50 and NADPH:cytochrome P-450 
reductase could 14-a-demethylate lanosterol in the presence of 
NADPH and oxygen (Aoyama & Yoshida, 1978b). The postulation 
of this endogenous role for cytochrome P-4-50 posed the question 
of how ergosterol was synthesized under conditons of aerobic 
growth at low glucose concentrations when no cytochrome P-4-50 
could be detected. Recently however, Aoyama ejb al. (1981a) 
have shown that a small amount of cytochrome P-4-50, not 
detectable by usual methods, may be present under these conditions 
and be responsible for ergosterol biosynthesis.
A second role for S.- cerevisiae cytochrome P-4-50 in ergosterol
biosynthesis has recently been reported by Hata jet al. (1981).
These workers claimed that yeast cytochrome P-4-50 may also be 
22involved in A  -desaturation of ergosta-5,7-dien-3B-ol to form 
ergosterol, a step later in the same pathway. This role was 
postulated on the basis of studies with the cytochrome P-4-50 
inhibitors carbon monoxide and metyrapone.
The metabolism of benzo(a)pyrene by the cytochrome P-4-50 
monooxygenase system from _S. cerevisiae is now well established 
(Wiseman & Woods, 1979; Woods & Wiseman, 1980). Benzo(a)pyrene 
is hydroxylated by this enzyme to a range of products, predomin­
antly 3-hydroxybenzo(a)pyrene, 9-hydroxybenzo(a)pyrene and 
7,8-dihydro-7,8-dihydroxybenzo(a)pyrene. (Wiseman & Woods, 1979). 
The involvement of yeast cytochrome P-450 in this activity has
(47)
been demonstrated by thermal stability experiments and inhibition 
of benzo(a)pyrene hydroxylase by carbon monoxide (Woods, 1979). 
Studies using tritium NMR on substrate-haem interactions in a 
partially pure enzyme preparation also supported the involvement 
of cytochrome P-4-50 in benzo(a)pyrene hydroxylation (Libor 
et al., 1980). Recently, Azari & Wiseman (1982a) have established 
unequivocally that cytochrome P-4-50 is involved in this reaction 
by the reconstitution of an active benzo(a)pyrene hydroxylase 
using highly purified yeast cytochrome P-4-50, purified 
NADPH:cytochrome P-4-50(c) reductase and phospholipid. Purified 
cytochrome P-4-50 from £>. cerevisiae had a molecular weight of 
55*500 and a Sor.et peak in the reduced carbon monoxide spectrum 
at 44-8nm, and can therefore be called a cytochrome P-4-4-8 
(Azari & Wiseman, 1982a). In addition, the metabolites of 
benzo(a)pyrene produced by the yeast enzyme are more similar 
to those produced by .a mammalian cytochrome P-4-4-8 than by a 
mammalian cytochrome P-4-50 (Gozukara et al., 1981).
The binding of benzo (a)pyrene to yeast cytochrome P-4-50 has 
been studied extensively (Woods & Wiseman, 1980; Azari &
Wiseman, 1982a, 1982b, 1982c, Wiseman & Azari, 1982). Benzo(a)- 
pyrene gives rise to a type I binding spectrum containing an 
extra peak with cytochrome P-4-50, which has- also been shown 
to occur with benzo(a)pyrene binding to rat liver cytochrome 
P-4-50. (Estabrook et al., 1978). The number of binding sites 
for benzo(a)pyrene with yeast cytochrome P-4-50 is six for 
microsomal enzyme but one for the purified enzyme (Wiseman &
Azari, 1982). Benzo(a)pyrene hydroxylase activity has also 
been demonstrated for immobilized yeast cytochrome P-4-50 
(Azari & Wiseman, 1982d).
(48)
Cytochrome P-450 from S. cerevisiae has also been claimed to 
activate certain promutagens to active mutagenic compounds, 
as shown by an increased yeast mutation rate (Callen & Philpot, 
1977; 1978). These compounds include dimethylnitrosamine, 
aflatoxin B, B-naphthylamine, ethyl carbamate and cyclophos­
phamide. A later report by these workers presented spectral 
evidence for the involvement of cytochrome P-450 in these 
activation reactions (Callen et al., 1980).
(4-9)
CHAPTER 2
STUDIES ON THE BIOSYNTHESIS OF CYTOCHROME P-450 
IN SACCHAROMYCES CEREVISIAE
2.1. Introduction
(50)
Since cytochrome P-450 was first demonstrated in the yeast 
Saccharomyces cerevisiae, several studies have been made to 
investigate the conditions required for. its biosynthesis.
The initial report of the presence of. cytochrome P-450 in a 
bakerTs yeast strain of Saccharomyces cerevisiae found that 
this enzyme was. present under anaerobic growth conditions 
and to a lesser extent when grown aerobically at a high 
glucose concentration (4$ w/v)(Lindenmayer & Smith, 1964)*
The production of yeast cytochrome P-450 under semi-anaerobic 
growth conditions was confirmed,by Ishidate et al. (1969a) 
with only very little cytochrome P-450 (approx. 10$ of the 
semi-anaerobic value) produced under fully aerobic conditions. 
During aerobic growth at low glucose concentration (1$ w/v) 
no cytochrome. P-450 was observed. These, workers also found 
that cytochrome P-450 in semi-anaerobically grown yeast was 
rapidly lost on exposure to, aerobic conditions. (Ishidate et al. 
1969b). This, loss paralleled the formation of active mito­
chondria within the yeast cells and could be prevented by 
high concentrations, of glucose, or chloramphenicol, both of 
which also prevented the. development, of mitochondrial respir­
ation. Essentially, similar findings were made by Rogers' & 
Stewart (1973)> who found a. maximum cytochrome P-450 level in 
yeast grown in a medium containing 4$ (w/v) glucose at the low 
oxygen concentration of 0.25|JM. The cytochrome P-450 level, 
declined at both lower and higher oxygen concentrations.
1 Since, these early studies, work on cytochrome P-450 from 
Sac charomyc e s .cerevisiae has been, .done largely on the enzyme
(51)
from yeast grown under two sets of conditions. Yoshida at al.. 
(1972, 1975> 1977) have worked on cytochrome P-450 produced 
fromta baker's yeast strain grown semi-anaerobically in a 
medium containing 6$ (w/v) glucose, whereas Wiseman et al.,
(1975» 1976, 1978) have worked on the enzyme produced in brewerfs 
yeast grown, aerobically in a medium containing 20$ (w/v) glucose. 
Both of these sets of conditions achieve repression of mito­
chondrial cytochromes and production of a high level of 
cytochrome P-450.
It has become., well established that cytochrome P-450 production 
in yeast is rapid.during exponential phase of growth but ceases 
at the beginning of stationary phase, (Woods, 1979; Karenlampi 
et al., 1981). . During stationary phase, the enzyme levels 
begin to decline as cytochrome P-450 is degraded in an energy 
and.oxygen requiring, process which also needs mitochondrial 
protein biosynthesis. (Biatiak et al., 1980) . It has also been 
shown, that tween, 8.0 is capable of increasing the level of 
cytochrome P-450. in yeast grown for 48 hours or more, presumably 
due to preventien of degradation, rather than to increased 
biosynthesis after this time (Wiseman, at al., 1976).
Although it is. well established that growth at high glucose 
concentrations or. at. semi-anaerobic growth conditions produces 
a high level of cytochrome. P-450 in S. cerevisiae, no study 
has been attempted on the interaction between these factors.
In this study,, a range, of different glucose concentrations 
under aerobic and semi-anaerobic conditions are looked at in an 
attempt to understand, the process more fully. Also, a study of
(52)
the genetic regulation of cytochrome P-450 production in 
S. cerevisiae is presented. No previous work has been attempted 
in this area.
2.2. Materials and Methods
2.2 .X. Growth of Yeast
Strains of Saccharomyces, cerevisiae. were maintained on slopes 
of Sabouraud-dextrose agar which were subcultured at regular 
intervals. The strain. S.. cerevisiae NCYC No.240 was used unless 
otherwise described* Liquid cultures were inoculated directly 
from slopes with, a wire, loop. The growth, medium consisted of 
yeast, extract .,(1$ w/v), mycological. peptone (2$ w/v), sodium 
chloride (0..5$ w/v) and glucose at. various concentrations.
The cultures, were, grown at 30^ C in a shaking water bath at 
constant speed.. Normally, yeast was grown in 250ml flasks, 
each containing.100ml of medium. The yeast growth medium was 
previously autoclaved. at 1'5 p.s.i. for .15 minutes with glucose 
being autoclaved separately to prevent the formation of 
breakdown, products which interfere with, the cytochrome P-450 
assay (Lim, 1976).
When semi-anaerobic, growth conditions were required, flasks 
were completely filled with growth medium, inoculated with 
yeast and bubbled through with nitrogen, for 10 minutes, after 
which the flasks were sealed. Growth was achieved by putting 
each flask into a 30°C room dnd stirring gently with a 
magnetic stirrer.
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2.2.2. Cytochrome P-450 Assay
Cytochrome P-450 levels were measured .by a modification of the
difference spectrum method, of Omura & Sato (1964). Yeast was
suspended to a concentration of O.lg wet weight/ml in 0.1M
phosphate buffer pH 7.2, and the sample divided into two cuvettes.
Sodium dithionite was. added to. reduce each cuvette and a baseline
was drawn in .the range 400-500nm using either, a Pye-Unicam SP 1800
or a Varian Cary 21.9. spectrophotometer. The sample cuvette was
removed and carbon monoxide bubbled through it for 30 seconds.
The difference spectrum .was. then recorded again between 400-500nm.
A typical yeast,, cytochrome. P-450 assay is . shown in figure 2.1..
The concentration; of. cytochrome P-450. was, calculated from the
difference in absorbance between 450 and.490nm with reference
to the. baseline, .assuming the same extinction coefficient as
-1 -1for mammalian cytochrome P-450. of 91mM cm ... .
2.2.3* Derivative.Spectroscopy
Second derivatives of reduced carbon monoxide difference • 
spectra obtained as described above* were achieved with
a Pye-Unicam SP 1750 spectrophotometer using 1mm slit width 
and a scan speed, of 2nm/sec. The data was. digitised and 
collected, by a. Hewlett-Packard 3353E laboratory automation • 
system and the derivatives calculated.from the collected data 
by means, of a BASIC program, using the. laboratory automation 
system.
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Figure 2.1. A typical yeast reduced carbon monoxide 
difference spectrum. A yeast suspension of O.lg/ml 
(wet weight) was used.
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2 .2 .4.. Mitochondrial.. cytochromes assay
Mitochondrial cytochromes were assayed, by a modification of the 
method of Williams (1964)* least; was suspended at a concentration 
of O.lg wet. weight/ml in 0.1M phosphate buffer pH 7.2, and 
divided into two. cuvettes. The sample cuvette, was reduced with 
sodium dithionite. and. the reference oxidised by the addition of 
50JJ1 of hydrogen, peroxide (20 vol. ). .The spectrum was then 
recorded, from 50,0r640nm using a Pye-Unicam SP 1800 spectro­
photometer. A typical spectrum, obtained.is shown in figure 2.2. 
The absorbance between four wavelength ..pairs . was measured and 
used to. calculate the. concentrations of the. individual cyto­
chromes, cytochrome c, c£, b and a+a^» using four simultaneous 
equations which allow, for. the spectral overlap of the cytochromes.
The four wavelength pairs were;
a15 = 550-535nm 
a25 = 554-540mn 
a35 = 563-577nm 
a . c = 605-630nm
The cytochromes c (X^), c-^ ^ 2^9 ^ ^ 3  ^ an(* a+a3 ^ 4) were
then, calculated from.the simultaneous equations below.
21.0 X1 + 10.3 X2 - 3.12 X^ +0.63 X^ = a15
6.51 X2 +18.8 X2 + 2.55 X3 + 0.95 X^ = a25
-1.16 + 0.91 X2 + 14.3 X3 - 0.326 X^ .= a35
-0.22 Xn -.0.59 X0 + 0  :X0 + 12.0 X. = a f„-L 2 .5 4 45
The calculations were.considerably speeded up by the use of 
a computer program.
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Figure 2.2. A typical yeast reduced-oxidized difference 
spectrum, showing mitochondrial cytochromes. A yeast 
suspension of O.lg/ml (wet weight) was used.
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2.2.5. Assay of cyclic AMP
Considerable difficulty was found in obtaining a reproducible 
sample for cyclic AMP measurement. After extensive tests, the 
following method was found to give the most reproducible results. 
The yeast sample (200mg wet weight) was suspended in 2ml of 
10# (w/v) trichloroacetic acid and sonicated for 1 min. to help 
release of cyclic AMP. The mixture was shaken for five mins. 
and the yeast spun down on a bench centrifuge (10 mins. full 
speed). The supernatant was retained and the yeast re-extracted 
with a further 1ml of 10# (w/v) trichloroacetic acid. The 
supernatants were combined, 1M hydrochloric acid (l/10vol) and 
2 volumes of diethyl ether were added and the solution shaken 
in a cold room (8°C) for 10 mins.. The ether phase was discarded 
and the solution re-extracted with ether as before, five times.
The aqueous phase was then evaporated to dryness at 55°C under 
a stream of nitrogen and the residue re-dissolved in 50mM tris 
buffer pH 7.5 containing 4mM EDTA. The cyclic AMP content was 
measured using a competition protein binding assay with tritium 
labelled cyclic AMP as provided in an assay kit from Amersham 
International Ltd..
2.2.6. Materials
Sac char omy ce s cerevisiae strains NCYC 24-0, 239> 108, 4-06, 700,
753 and 754- were obtained from the National Collection of 
Yeast Cultures, Agricultural Research Souncil, Norwich. Yeast 
extract was obtained from Oxoid Ltd., Basingstoke, Hants.. 
Mycological peptone was from London analytical and bacteriological 
Media Ltd., London. Cyclic AMP assay kit was from
(58)
Amersham International Ltd., Amersham.. Sodium chloride was 
from May & Baker Ltd., Dagenham, Essex.and trizma base for 
tris/HCl buffers. was from Sigma chemical company (London) Ltd., 
Poole., Dorset., Glucose,, hydrogen peroxide.and all other 
chemicals were, from, BDH Chemicals Ltd., Poole, Dorset.
2.3 Results and Discussion
2.3.1. Growth conditions, for Cytochrome .P-4-50. Biosynthesis 
in. Saccharomyces- cerevisiae
Figure 2.3. shows the: results, of an initial experiment to 
determine the be,st. inoculum method, for cytochrome P-4-50 
production in the veasi. Sac.charomvces cerevisiae NCYC 24-0 in 
growth media containing 20# (w/v) glucose as carbon and energy 
source. The two. methods looked at. were direct inoculation from a 
Sabouraud-dextro.se. agar- slope with a. wire loop and inoculation 
with 1ml of a yeast culture grown for 24- hours in 0»5% glucose 
containing media.. Very little differen.ce.,was. observed in the 
maximal production.of • cytochrome. P-4-50 which was approx. 3 nmol/g 
wet weight of yeast or the position, o f ,the peak in the growth 
curve which was at 36^4-0 hours of growth.. However, the yeast 
grown from, slope.appeared to. give a slightly broader peak with 
more consistent results, and this method ..was therefore used- 
for all subsequent .experiments. It should be noted here that 
in later experiments, it was found that the yield of cytochrome 
P-4-50. produced was variable depending.on. the age of the slopes, 
so as far as possible, experiments were conducted on freshly- 
grown slopes.
(59)
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Figure 2.3* Cytochrome P-4-50 production in £>. cerevisiae 
grown in 20# glucose media after inoculation by (a) slope 
method and (b) liquid sub-culture. Values are the mean of 
8 determinations. Bars indicate standard deviations.
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In an attempt to study the interaction of high glucose concen­
trations with semi-anaerobi.c conditions, the level of cytochrome 
P-45.0 produced at various times, of growth was measured during 
growth under aerobic, or semi-anaerobic conditions at glucose 
concentrations of 0.1#, 0.5#> 1#> 5# and 20# (w/v). Semi- 
anaerobic conditions.rather than strictly anaerobic conditions 
were used as this was directly comparable with earlier work 
(Ishidate et al;.', 1969; Yoshida et a l 1974.). Also a small 
amount of oxygen .is required for several biosynthetic reactions 
during yeast growth .and other workers have, reported that 
cytochrome P-450 is. not produced, under strictly anaerobic 
conditions but at. a. low. oxygen concentration (Rogers & Stewart, 
1973).
At glucose concentrations of 0.1# and 0.>5%f no cytochrome P-450 
was produced under either aerobic or semi-anaerobic conditions.
At 1# glucose, no cytochrome P-450 was found after growth in 
aerobic conditions but under semi-anaerobic, conditions 
cytochrome P-450 was produced to . a maximal, concentration of 
2.6 nmol/g wet weight of yeast after, approx.. 62 hours, (figure 2.4* 
The relatively late appearance of this peak is probably due 
to the slow growth rate which occurs. under. these conditions, 
and also to the slowing of degradation of the cytochrome which 
requires oxygen, see on. The lack of any.cytochrome P-450 
produced.aerobically in 1# glucose media is i n .disagreement 
with Wiseman .et ul. (1975> 1976), who have, described a fast 
initial synthesis of cytochrome P-450 under these conditions 
which was rapidly lost. In the experiments reported here, the 
first, time point is. at 24 hours and it is possible therefore
(61)
H
Cytochrome P-4-50 (nmol/g wet weight of yeast).
Figure 2.4-* Time course of cytochrome P-4-50 production 
in yeast grown semi-anaerobically in glucose media. 
Values are the mean of 8 determinations. Bars indicate 
standard deviations.
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that some cytochrome P-4-50 is produced early in growth and lost 
before 24- hours.
Figure 2.5» shows the production of cytochrome P-4-50 in yeast 
grown at 5% glucose concentration. Wiseman et al. (1976) 
reported that. 5% glucose, was sufficient to produce ’high-glucose 
behaviour* at which the cytochrome P-4-50 level was induced 
maximally after approx. 32 hours to a level of 3*5 nmol/g wet 
weight of yeast. The results obtained here show a peak level 
of cytochrome. P-4-50 of only 1.2 nmol/g wet weight of yeast after 
approx. 24- hours in aerobic conditions. The apparent discrepancy 
of these results may reflect a. higher initial growth rate being 
achieved here.. This would result in the cytochrome P-4-50 
reaching the., maximal value, which occurs at the end of the 
exponential growth, earlier. Under semi-anaerobic conditions 
at 5% glucose, growth is much slower and. the cytochrome P-4-50 
peak value .is reached later in growth .at approx. 4-8 hours and 
reaches a higher level. Also, the semi-anaerobically grown 
yeast loses its cytochrome P-4-50 at a slower rate than when 
under aerobic conditions. This probably reflects the oxygen 
requirement for cytochrome P-4-50 degradation in yeast which 
has been demonstrated, by Blatiak etal. (1980). These growth 
conditions (semi-anaerobic, 5% glucose medium) are similar to 
those, used by other workers to produce cytochrome P-4-50 in •
S a c c haromyc es. c e r. e vi si a e * I shidate et'.al. (1969a, 1969b) used 
a medium of glucose under semi-anaerobic .conditions as did 
Lindenmayer & Smith (1964.) and Rogers & Stewart (1973) * whereas 
Yoshida et al./ (1974-) have worked extensively on yeast grown 
semi-anaerobically at 6% glucose.
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Cytochrome P-4-50 (nmol/g wet weight of yeast)
Figure 2.f>. Time course of cytochrome P-4-50 production in 
yeast grown aerobically or semi-anaerobically in 5% glucose 
media. Values are the mean of 8 determinations. Bars 
indicate standard deviations.
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When yeast was grown aerobically at 20$ glucose, a peak in 
cytochrome P-4-50 level was found after 36-4-0 hours at approx.
3 nmol/g wet weight of yeast (figure 2.6.). In later experiments 
it was found that with fresher yeast slopes a peak level of 
approx. 4- nmol/g wet weight of yeast could be reached (results 
not shown). However, the older results are used here to enable 
a strict comparison with the other.. results presented. These 
results agree closely with those, of Wiseman et al. (1975> 1976). 
Under semi-anaerobic conditions at 20$ glucose, very little 
difference was observed in the time course of cytochrome P-4-50 
production with a slightly higher level of cytochrome P-4-50 
(approx. 3*5 nmol/g wet weight.) being observed.
As a check that mitochondrial repres.si.on was occurring in high 
glucose media, the levels of mitochondrial cytochromes were 
measured after. 4-4- hours, aerobic growth in 20$ and 0.5$ glucose 
media (table 2.1 ). In the high glucose .medium, a very low 
concentration of cytochrome, a+a^ was observed compared to the 
value observed in 0.5$ glucose medium. This confirms that 
this yeast was glucose repressed.
These results support the the.or.y of cytochrome P-4-50 being 
synthesised in yeast only under conditions of repression of 
mitochondrial cytochromes. Two ways of achieving this repression 
are by a high.glucose concentration and.by anaerobic conditions. 
From the results observed at 20$ glucose it seems that these 
effects are not additive^ which is consistent with both sets 
of conditions eliciting cytochrome P-4-50 synthesis through a 
similar mechanism. This mechanism, is thought to be regulated
(65)
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Figure 2.6. Time course of cytochrome P-450 production in 
yeast grown aerobically or semi-anaerobically in 20$ glucose 
media. Values are the mean of 8 determinations. Bars 
indicate standard deviations.
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Concentration of Glucose 
in Yeast Growth Medium
Level of Cytochromes 
(nmol/g wet weight of yeast)
a+a^ b C1 c P-450
20$ 7.8 14.8 2.3 9.4 2.3
0.5% 20.^ 14.7 5.3 8.8 0
Table 2*1* Level of Mitochondrial Cytochromes in 
S. cerevisiae grown aerobically for 4-0 hours.
(67)
by the. level of intracellular cyclic AMP (Wiseman et al., 1978). 
Intracellular cyclic AMP levels are inversely related to the 
glucose concentration, in the/ growth medium.; thus at high glucose 
concentrations when the .cytochrome .P-450 level is high, the 
cyclic AMP concentration, is low. This has led to the suggestion 
that cyclic AMP has. a. repressive effect on cytochrome P-450 
synthesis (Wiseman, et; al., 1978). These workers also showed 
a direct.effect, of cyclic.AMP in repressing cytochrome P-450 
synthesis in yeast protoplasts, although 5'-AMP and 2 f-(3,)-AMP 
had no effect.. This means that under, conditions of mitochondrial 
repression by a high glucose.concentration in the growth medium, 
the cyclic.AMP level.is low, therefore the repressive effect of 
cyclic AMP is removed and de novo synthesis of cytochrome P-450 
can occur. . As expected., cytochrome a+a^ and cyclic AMP show 
a direct relationship to each, other and an inverse relationship 
to the cytochrome, P-450 level at various glucose concentrations 
(Qureshi _et al.,. 1980). An inverse relationship between cyto­
chrome ata|.and.cytochrome. P-450 has also been shown in S. 
cerevisiae grown semi-anaerobically (Schunck et al., 1978).
It has been shown above.that semi-anaerobic conditions are not 
able to elicit production of cytochrome P-450 at 0.1$ or 0.5$ 
glucose. It is possible that some cytochrome P-450 is produced 
at .times earlier than 24 hours, the first time point used in 
these experiments.. However, the small amount of growth which 
can occur under these .conditions, makes any measurement of ‘ 
cytochrome P-450 before 24 hours extremely difficult. The 
conclusion must be,drawn, that semi-anaerobic conditions alone 
are not enough to produce cytochrome P-450 without a higher
(68)
glucose concentration in the medium. This may mean that this 
enzyme is only produced at the faster growth rates observed at 
higher glucose concentration. It is also possible that a higher 
glucose concentration is required in order to repress cyclic AMP 
levels sufficiently for cytochrome P-450 synthesis to occur.
Figure 2.7. shows the change in cytochrome P-450 production in 
aerobically growing cultures of £>. cerevisiae when made semi- 
anaerobic during the exponential growth phase (24 hours growth) 
and during the stationary phase (48 hours growth). When a 
yeast culture growing exponentially is made semi-anaerobic the 
biosynthesis of cytochrome P-450 is inhibited with an increase 
in cytochrome P-450 level between 24 and 48 hours of less than 
10$ of that in the aerobic control. This effect is not due to 
an altered growth rate, as very similar growth rates were 
observed under both sets of conditions, with sufficient glucose 
still present (at 24 hours) to ensure actively fermenting yeast 
cells under glucose repression. One effect of oxygen may be 
in acting as a substrate inducer of yeast cytochrome P-450.
This may also explain why cytochrome P-450 cannot be detected 
in yeast grown under strictly anaerobic conditions (Rogers & 
Stewart, 1973)* However, much further work is required to test 
this idea with experiments at a range of carefully controlled 
oxygen concentrations.
When yeast is grown aerobically to stationary phase (48 hours) 
and then made semi-anaerobic and incubated further, cytochrome 
P-450 does not appear to be lost as quickly. At stationary 
phase, the yeast cytochrome level is already falling and the
(69)
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Figure 2.7. Cytochrome P-4-50 production in aerobically
growing yeast (■) made semi-anaerobic after 24- hours (•)
and 4-8 hours (A ). The growth medium contained 20$ glucose.
Values are the-mean of 8 determinations. Bars indicate
standard deviations.
(70)
removal of oxygen at. this time is unlikely to effect cytochrome 
P-4-50 biosynthesis. The slowing of cytochrome P-4-50 loss under 
semi-anaerobic conditions is due to protection of the enzyme 
from’degradation, as. was described by Blatiak et al. (1980).
2.3.2. Cytochrome P-4-50 Production in Other Strains of 
Saccharo-m-y.ces cerevisiae
The occurrence of cytochrome P-4-50 has been shown in several 
different Saccharomyces yeasts.. Cartledge _et al. (1972) 
detected cytochrome. P-4-50 in anaerobically grown Saccharomyces 
carls bar gen sis- (NCYC 7 JjS., now called S. uvarum) in a 10$ (w/v) 
glucose medium, which was. rapidly lost on exposure to aerobic 
conditions at 0.-4-$ glucose. Poole et al. (1974-* 1979) found 
that glucose repressed cells of Schizosaccharomyces pombe 972h 
contained .significant quantities of cytochrome P-4-50. As described 
above, much work has been carried out on this enzyme from the 
brewer's yeast strain Saccharomyces cerevisiae NCYC 24-0 by 
Wiseman.^et ad.. (1975> 1976, 1978) and on a wild type baker's 
yeast , strain by Yoshida _et al. (1972, 1974-> 1977) . Qureshi e_t al. 
(1980) reported, that. S., cerevisiae NCYC 239 gave very high levels 
of cytochrome P-4-50, up to 11 nmol/g wet weight of yeast when 
grown on 20$ glucose, medium.. The range of yeasts reported to 
possess, cytochrome P-4-50 was. greatly extended by KSLrenlampi 
et al. (1980). who surveyed. 16 different yeasts and measured 
the maximal production of cytochrome P-4-50 = during growth on 20$
(71)
glucose. These workers detected high levels of cytochrome P-4-50 
in Brettanomyces anomalus,. Hansen.ula anomala, Saccharomyces 
bayanus, Saccharomyces cerevisiae NCYC 24-0, Torulopsis dattila, 
Torulopsis glabrata and in particular in Saccharomyces italicus. 
Lower rates of cytochrome P-4-50 were detected in 6 other strains 
of yeast.
The production of cytochrome P-4-50 in three strains of Saccharo­
myces italicus (now, renamed S. cerevisiae) is shown in figure 2.8.. 
The maximal yield of cytochrome P-4-50 varied between the three 
strains examined. All of these strains grew faster than S. 
cerevisiae NCYC 24-0 and thus the cytochrome P-4-50 level reached 
its maximum.value earlier, between 16 and 22 hours compared to 
36-4-0 hours for NCYC 24-0. The yield of cytochrome P-4-50 for 
NCYC 700 was similar to that, of NCYC 24-0 but was lower for 
NCYC 108 and 4-06. The high yield reported by K&renlampi et al.
(1980) of 9 nmol/g wet weight of yeast was not observed. This 
may reflect a difference in the strain used or different growth 
conditions.
Figure 2.9. shows the time course of cytochrome P-4-50 production 
in S. cerevisiae NCYC 239 grown in a growth medium containing 20$ 
glucose. This was observed to reach a. maximal value of approx.
6 nmol/g wet weight of yeast at 38-4-0 hours of growth. Although 
the yield of cytochrome P-4-50 is high, it does not approach the 
level of 11 nmol/g reported by Qureshi _et al. (1980). Also, the 
peak occurs at 38-4-0 hours, which is similar to NCYC 24-0, and 
not at 110. hours as reported by Qureshi _et al. . When jS. cerevisiae 
NCYC 239 was grown on 20$ maltose containing growth media with
(72)
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Figure 2.8. Time course of cytochrome P-4-50 production 
in Sac charomyce s cerevisiae NCYC 700, 4-06 & 108 (formerly 
S. italicus) grown on 20# glucose media. Values are the 
mean of 8 determinations. Bars indicate standard deviations.
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Figure 2.9* Time course of cytochrome P-4-50 production 
in S. cerevisiae NCYC 239 grown on 20# glucose media. 
Values are the mean of 8 determinations* Bars indicate 
standard deviations.
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no glucose, the cytochrome P-450 production was as shown in 
figure 2.10.. Maltose is also a fermentable, carbon source and 
had been found to give very high yields of cytochrome P-450 
(A. Blatiak, personal communication). The yields obtained here, 
hox^ever, are only approx. half of the values observed in 20# . 
glucose media. This is consistent with results obtained by 
K&renlampi et al. (1981), using S, cerevisiae NCYC 240» The 
fact that cytochrome P-450 is produced at all in maltose media 
is surprising as a high maltose concentration is usually associated 
with a high cyclic AMP concentration.
Recently, the yeast S. cerevisiae NCYC 240 has been shown to be 
a mixture consisting of two different strains named NCYC 753 
(20# component) and NCYC 754 (80# component) which are different­
iated by their ability to grow on maltotriose (Dr. B. Kirsop, 
personal communication). These two yeast strains have very 
different levels of cytochrome P-450, as can be seen from 
figure 2.11.. The results for NCYC 240, shown in figure 2.11. 
for comparison, show an. intermediate level of cytochrome P-450 
as would be expected from a mixture of the two strains. However, 
as NCYC 240 is made up of approx. 80# of NCYC 754> the levels 
of cytochrome P-450 might be expected to be closer between these 
two yeasts. The reasons for the large difference observed is 
unknown.
(75)
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Figure 2.10. Time course of cytochrome P-450 production in 
S. cerevisiae NCYC 239 grown on 20$ maltose media. Values 
are the mean of 8 determinations. Bars indicate standard 
deviations.
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Figure 2.11. Time course of cytochrome P-4-50 production 
in NCYC 753 & 754- (shown with NCYC 24-0 for comparison) 
grown on 20$ glucose media. Values are the mean of 8 
determinations. Bars indicate standard deviations.
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2.3.3. The Use of Second Derivative Spectroscopy to study 
Cytochrome. P-450 Levels in Saccharomyces cerevisiae
K&renlampi & Hynninen (1981a) reported that second derivatives 
of reduced carbon monoxide difference spectra with respect to 
time were useful in quantifying cytochrome P-450 levels. This 
technique was reported to allow more sensitivity than the normal 
0 derivative spectrum due to the spectral amplitude observed 
being almost twice as large in the second derivative spectrum.
These workers also reported that this technique was useful in 
resolving overlapping spectral bands.
It has been reported that in yeast grown aerobically at low glucose 
concentrations where the concentration of cytochrome a+a^ is 
relatively high, the detection of small quantities of cytochrome 
P-450 may not be possible due to spectral overlap of the large 
spectral trough at 441-445nm produced by cytochrome a+a^ and the 
cytochrome. P-450 peak. Woods (1979) has shown that cytochrome 
a+a^ does not interfere with the cytochrome P-450 assay in yeast 
grown at.high glucose concentration by separating the mitochondrial 
cytochrome a+a^ from the microsomal cytochrome P-450 and showing 
that the presence of cytochrome a+a^ makes no difference to the 
level of the cytochrome P-450 detected. However, at low glucose 
concentration (e.g. 1$), aerobically grown yeast is not glucose 
repressed and has a much larger amount of cytochrome a+a^ present.
An attempt was made to separate mitochondrial cytochrome a+a^ 
from microsomal cytochrome P-450 in an experiment similar to that of 
Woods (1979) but with yeast grown at 1% glucose. No cytochrome 
P-450 could be detected in the microsomal fraction. It is
(78)
possible, however, that as 70% of yeast cytochrome P-4-50 is lost 
during disruption and preparation of a microsomal fraction 
(see chapter 3), a small amount of cytochrome P-4-50 may have 
been ’present before disruption.
In an attempt to resolve the overlapping bands of cytochrome a+a^
and cytochrome P-4-50, second derivative spectra were taken.
Figures 2.12 and 2.13 show.typical second derivative reduced
carbon-monoxide difference spectra of aerobically grown yeast
at high and low glucose concentrations respectively. It should
be noted here that a peak in the normal O^*1 derivative spectrum
n dwill show up as. a. trough in the 2 derivative spectrum and a 
trough as a peak. The second derivative spectra obtained are 
similar to those obtained from yeast by K&renlampi and Hynninen
(1981). It can be seen that at high glucose concentration, a 
large trough in the spectrum is observed, at 4-52nm (figure 2.12). 
This is due to. the presence of cytochrome P-4-50. The wavelength 
of the band is slightly shifted (from 4-50nm to 4-52nm) due to the 
process of taking second derivatives, as was also reported by 
KSLrenlampi and Hynninen (1981). In figure 2.13, the spectrum 
shows a large peak at 4-4-8nm due to the spectral trough of 
cytochrome a+a^ at 4-4-l~5nm. A small trough is seen at 4-54-nm.
It is possible that this trough may indicate the presence of a 
small amount of cytochrome P-4-50 in the yeast grown at low glucose 
concentration which is moved from 4-52nm to 4-54-nm due to the 
large cytochrome a+a^ peak. However, this evidence is not very 
satisfactory as this small trough could easily be an artefact 
of the spectral derivation process.
400 420 440 460 480 500 520
Wavelength (nm)
Figure 2.12. Second derivative reduced carbon monoxide
difference spectrum of yeast grown in 20$ glucose media.
Yeast was used in a suspension of O.lg (wet weight)/ml.
2 2
d A/dt is in arbitrary units.
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Figure 2.13. Second derivative reduced carbon monoxide
difference spectrum of yeast grown aerobically in 1% glucose
media. Yeast was used in a suspension of 0.1g(wet weight)/ml. 
2 2d A/dt is in arbitrary units.
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Aoyama _et al. (1981a) have looked at yeast grown aerobically in 
1% glucose in an attempt to determine the presence or absence of 
cytochrome P-450 under these conditions. These workers have 
reported earlier an endogenous substrate for yeast cytochrome 
P-450, lanosterol, which undergoes 14a-demethylation by a 
cytochrome P-450 mediated reaction in a baker’s yeast strain of 
S. cerevisiae grown semi-anaerobically at a glucose concentration 
of k% (Yoshida & Aoyama, 1980). This reaction is involved in 
the biosynthesis of ergosterol, an essential sterol for yeast 
growth which is produced during growth even at 1% glucose. The 
postulation, of this endogenous role for yeast cytochrome P-450 
therefore requires that cytochrome P-450 should be present under 
all growth conditions.. Aoyama _et ad.. (1981a) showed that micro- ■ 
somal fraction from yeast grown aerobically at 1% glucose could 
catalyze lanosterol 14a-demethylation, though at a much lower 
rate than microsomal fraction from semi-anaerobically grown cells. 
This activity was sensitive to carbon monoxide, a well-known 
inhibitor of cytochrome P-450 mediated reactions. In an 
Ouchterlony double diffusion test, antibodies to purified 
cytochrome P-450. from semi-anaerobically grown yeast formed a 
single precipitin line with microsomal fraction from aerobically 
grown yeast as well as with the purified cytochrome P-450 and 
the two lines fused. Also these antibodies inhibited lanosterol 
demethylation by aerobically produced microsomes. These workers 
also showed some weak second derivative spectral evidence for 
the presence of cytochrome P-450 under aerobic conditions. It 
seems from these results therefore that cytochrome P-450 is, 
present in small amounts even under conditions of aerobic growth 
at a low glucose concentration. This would mean that in the
(82)
normal reduced carbon monoxide difference spectrum, the cyto­
chrome P-4-50 cannot be seen under these conditions due to the 
spectral overlap of the large amount of cytochrome a+a^* It 
seems that when yeast is growing rapidly, large amounts of 
cytochrome P-4-50 are produced and. although it is not known 
whether lanosterol demethylation is rate limiting for ergosterol 
biosynthesis, this may reflect an increased demand for ergosterol. 
However, it is difficult to explain the results obtained semi- 
anaerobically in this way.
2.3*4-* Genetic Analysis of .Cytochrome P-4-50 Production in 
Saccharo.myces cerevisiae
In a study looking at the genetic factors controlling cytochrome 
P-4-50 biosynthesis in S. cerevisiae, initial experiments were 
performed to screen 18 haploid strains of S. cerevisiae for 
cytochrome P-4-50 production using the reduced carbon monoxide 
difference spectrum method.. Of these strains, only 3 were found 
to produce significant quantities of cytochrome P-4-50 under the 
growth conditions used . (growth for 4-2 hours at 30°C). From 
these haploid strains, two were selected for a tetrad analysis 
experiment, one of which was capable of producing a high level 
of cytochrome P-4-50 and one which produced no cytochrome P-4-50.
A cross was made between these two strains and the resultin'g 
diploid isolated. This diploid was then transferred to a 
sporulation medium and allowed to sporulate. Four resulting 
asci were isolated, and the spores, of each tetrad were separated 
by micro-dissection and allowed to grow. (Crossing the yeast 
strains and isolating the tetrad yeast strains was performed by
(83)
Dr. Wilkie of University College London, whom I gratefully 
acknowledge). The resulting yeast strains were analyzed for 
cytochrome P-4-50 content, the results being shown in table 2.2.. 
These results, show that the. cross of a haploid cytochrome P-4-50 
producing strain with a Imploid non-producing strain resulted in 
a diploid non-producing strain. When the diploid sporulates and 
produces haploid spores, two of these are cytochrome P-4-50 prod­
ucers and two non-producers. Of the two tetrad segregants which 
produce cytochrome P-4-50, one appears to produce a higher level 
of cytochrome P-4-50 than the other. It should be noted here 
that the levels of cytochrome P-4-50 reported in table 2.2. are 
not maximal values for each yeast strain but are the levels 
obtained after growth for 24- hours on a fast rotary shaker at 
30 C to reduce yeast flocculation. This was necessary as several 
of the isolated strains, flocculated easily during growth and 
this flocculation.made it impossible to record a value for the 
cytochrome P-4-50 level due to settling of the yeast during the 
spectral assay. The yeast. £>.. cerevisiae NCYC 24-0 gave a yield 
of 0.95 nmol/g under these, conditions compared to its optimal ' 
yield of approx. 3 nmol/g. The only exception to this 2:2 
distribution of cytochrome P-4-50 producers to non-producers 
was in tetrad 4- where a 3:1 ratio was observed.
To confirm the difference in cytochrome P-4-50 levels found, • 
one tetrad.of yeast strains was subjected to a time course of 
cytochrome P-4-50 production analysis along with the parent strains. 
The results obtained are shown in figure 2.14... It can be seen 
that the. difference observed in the cytochrome P-4-50 yields 
of the producing strains of the tetrad are real and not due to
(84)
Yeast Strain Cytochrome P-450
(nmol/g wet weight of yeast)
B/B 0.7
D22 0
Diploid 0
Tetrad 1: la 0.6
lb 0.7
lc o
Id 0
Tetrad 2: 2a 1.35
2b 0
2c 0.44
2d 0
Tetrad 3i 3a 0.9
3b 0
3c 1.75
3d 0
Tetrad 4: 4a 0
4b 0.95
4c 1.1
4d 0.9
NCYC 240 0.95
Values are the average of three runs in duplicate, with 
yeast grown for 24 hours in a rotary shaker (30°C).
Table 2.2. Tetrad Analysis of Cytochrome P-450 Distribution.
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Figure 2.14. Time course of cytochrome P-450 production 
in yeast strains B/B, 2a & 2c. Values are the mean of 8 
determinations. Bars indicate standard deviations.
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experimental error, although the difference between yeast 2b 
and the parent strain B/B is less clear. The yeasts are observed 
to have peak levels of cytochrome P-450 at different times due 
to the growth characteristics of the individual yeast strains.
Each yeast strain reaches a peak cytochrome. P-450 level at about 
the end of the exponential growth phase. These results for the 
segregation.of cytochrome P-450 production amongst the tetrad 
yeast strains lead to the conclusion that production of cytochrome 
P-450 is controlled by a single nuclear gene. This gene is 
obviously under the control of one or more modifying factors 
which result in a small or a larger amount of cytochrome P-450 
being produced. The fact that the diploid yeast produced from 
the two. parents (one of which was a cytochrome P-450 producer 
and one a non-producer) did not produce cytochrome P-450 shows 
that these results do not reflect segregation of the cytochrome 
P-450 structural gene but of a regulatory gene. If all that 
was necessary for cytochrome.P-450 production was the possession 
of the structural gene, then almost certainly the diploid would 
produce cytochrome P-450. These conclusions lead to the proposal 
of a genetic model for the segregation of a regulatory gene for 
cytochrome P-450 production as shown in figure 2.15... This is 
the simplest model which could be proposed to account for the 
observations made. In this model, the presence of the regulatory 
gene allowing cytochrome P-450 to be produced results in prod­
uction of.cytochrome P-450 yet does not determine the level 
produced. This is determined by the presence of a modifier • 
gene (more than one may be involved) which gives rise to one of 
the tetrad yeasts having a small amount of cytochrome P-450 and 
one having a larger amount.
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Figure 2.15* Model for the Segregation of a Gene Controlling 
Cytochrome P-4-50 Production in S. cerevisiae
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The identity of the regulatory gene shown to exist in these 
experiments is unknown. However, since cyclic AMP regulates 
the biosynthesis of cytochrome P-450 (Wiseman e_t al. , 1978), 
the levels of this compound were examined in each of the parent, 
diploid and tetrad yeasts. The results are shown in table 2.3-. 
The levels of cyclic AMP measured 'are consistent with the general 
levels obtained in Saccharomyces yeasts under similar growth 
conditions by Sy and Richter (1972). In general, it was observed 
that a higher level of cyclic AMP was detected in those yeasts 
not producing cytochrome P-450. This work is consistent with 
that of Wiseman et al. (1978) who showed a higher cyclic AMP level 
present under conditions which do not allow cytochrome P-450 
biosynthesis to. occur. As all of these yeasts were grown under 
identical conditions for the same time, the difference probably 
reflects a genetic difference between the yeast strains studied. 
The yeast 2a gave a low result which seems out of the pattern 
observed with the. other yeasts.. These results, must therefore 
be viewed with some caution. However, it seems possible that 
the regulatory gene which is involved in controlling the 
presence/absence.of cytochrome P-450 may also have an effect 
in regulating the level of cyclic AMP. Indeed it is possible 
that the function of the gene, may be to regulate cyclic AMP 
levels which in turn control cytochrome P-450 levels. In this 
respect, the gene may be. coding for adenylate cyclase or 
phosphodiesterase or some other protein involved in regulating 
the intracellular cyclic AMP levels. In an attempt to look 
at this further, theophylline, an inhibitor of cyclic AMP 
phosphodiesterase,was. added to growing cultures of the tetrad 
yeasts in an attempt to alter the cytochrome P-450 level
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Yeast Strain Cytochrome P-4-50 Level 
(nmol/g wet weight of 
yeast)
Cyclic AMP Level 
(pmol/200mg yeast) 
(wet weight)
D22 0 6.25
B/B 0.8 2 .6
Diploid 0 5.2
2a 3.0 3.4-
2b 0 3.6
2c 0.5 3.75
2d 0 8.4-
Table 2.3. The level of cyclic AMP in yeast strains from 
tetrad analysis.
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produced in the producer or non-producer strains. However, no 
effect on enzyme levels was observed after this treatment 
(table 2.4-.). The inability of theophylline to influence cyclic 
AMP levels in yeast has been observed before (Mahler & Lin, 1978), 
and may reflect either a property of the yeast enzyme or poor 
transport of the compound into the cell.
It has been shown that multiple forms of cytochrome P-4-50 exist 
in Saccharomyces cerevisiae, and that an altered profile of 
these forms can be induced by treatment of growing yeast with 
benzo(a)pyrene and several other compounds (see chapter 3 and 
King et al., 1982).. In this respect it was thought that the 
differences observed in the amount of cytochrome P-4-50 produced 
in the tetrad strains may be due to differences in the forms 
of cytochrome P-4-50 present. This was investigated by attempting 
to alter the levels of cytochrome P-4-50 in the tetrad yeasts 
by inducing with benzo (a)pyrene (table 2.4-.). No cytochrome 
P-4-50 could be. induc.ed in the non-producing strains (2b and 2d) 
after benzo.(a )pyrene treatment. It would seem therefore that 
the regulatory gene has an on/off mechanism which cannot be 
altered by benzo.(a)pyrene treatment. Yeast 2a showed no 
significant difference in cytochrome P-4-50 level after benzo (a)- 
pyrene treatment, although this does not rule out the possibility 
that the profile of forms of the enzyme has been altered 
(see chapter 3). Yeast 2c which produces a low level of 
cytochrome P-4-50 gave a significant increase in cytochrome 
P-4-50 level after growth in the presence of benzo (a )pyrene, 
though still only to less than half of the value observed for 
yeast 2a. It is unlikely that any effect of benzo(a)pyrene
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Yeast Strain Cytochrome P-450 Level 
(nmol/g wet weight of yeast)
2a 5. 70+.34-
2b 0
2c 1.10+.22
2d 0
2a + theophylline (1% w/v) 6.15+• 4-4-
2b + theophylline (1% w/v) 0
2a + benzo(a)pyrene (95MM) 5.14+.19
2b + benzo(a)pyrene (95MM) 0
2c■+ benzo(a)pyrene (95MM) 2.26+i 06
2d + benzo(a)pyrene (95hM) 0
Table 2.4-* Attempted induction of cytochrome P-4-50 in 
tetrad 2 yeast strains* Yeast grown 4-0 hours at 30°C 
in a shaking water bath. Benzo(a)pyrene and theophylline 
were added at the beginning of the growth period. Values 
are the mean of 8 determination + standard deviation.
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is occurring at the regulatory gene, though benzo(a)pyrene may 
be altering the effect of the modifier gene(s). The fact that 
2c could not be induced to produce the same level of cytochrome 
P-4-50 as 2a implies that a modifier gene is involved in this 
regulation. Much further work is required before the mechanisms 
involved are discovered.
The absence of cytochrome P-4-50 in the non-producer strains raises 
an interesting question as to how these yeasts carry out lan st­
erol demethylation to.produce ergosterol, necessary for growth 
as mentioned earlier. If indeed lanosterol demethylation is 
catalyzed by cytochrome P-4-50, then it is possible that the 
absence of the regulatory gene allowing cytochrome P-4-50 production 
(or the presence of a gene .not allowing cytochrome P-4-50 production, 
does not stop its biosynthesis completely. Therefore, a small 
amount of the enzyme not detectable by normal techniques is present 
in a situation analogous to that in aerobically grown yeast in 
low glucose media described earlier. It is also possible that 
other enzymes may take over the role of lanosterol 14-a-demethylatio] 
proposed for cytochrome P-4-50. In this respect it is of interest 
that several other monooxygenase enzymes have been shown to be 
involved in the. lanosterol to ergosterol conversion in S.cerevisiae 
(Ohba .et al., 1978; Aoyama _et al. , 1981b).
No previous work has been attempted on the genetics of cytochrome 
P-4-50 production in yeast. However, the group of Nebert _et al. 
have worked extensively on the genetic regulation of cytochrome 
P-4-50 activities, in the mouse (Nebert _et al. , 1981; Nebert, 1979) • 
These workers have looked at the forms of cytochrome P-4-50 induced
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in the mouse by polycyclic aromatic hydrocarbons such as 
3-methylcholanthrene, B-naphthoflavone and benzo(a)pyrene.
They have demonstrated that induction by these compounds is 
mediated through the ’Ah locus' which is a combination of regul­
atory, structural and possibly temporal genes which may or may 
not be linked. These workers have evidence that the process of 
induction by these compounds occurs by binding of the inducer, 
which passively crosses the cell membrane, to a cytosolic Ah 
receptor protein, regarded as the major regulatory gene product 
(Okey ejt al. , 1979). This complex is then translocated into the 
nucleus and results in the activation of structural genes 
coding for forms of cytochrome P.-4-50.- A simplified system 
drawn from the results of Nebert ejb al. on mouse cytochrome P-4-50 
is shown in figure 2.16.. It is of great interest that this scheme 
requires the. presence of at least one regulatory gene giving rise 
to a specific regulatory gene product, in this case the binding 
receptor for polycyclic aromatic hydrocarbons. In the results 
described in this chapter it has been shown that a regulatory 
gene product is involved in the biosynthesis of yeast cytochrome 
P-4-50. Although the nature of the regulatory gene product is 
unknown in the case of yeast cytochrome P-4-50 biosynthesis, it 
may be involved in cyclic AMP regulation. Clearly, much further 
work is needed to. characterize this system more fully.
/
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CHAPTER 3
THE INDUCTION OF CYTOCHROME P-450 AND ITS 
DEPENDENT ACTIVITY BENZO(a)PYRENE HYDROXYLASE 
IN SAOCHAROMYCES OEREVISIAE
/
(96)
3.1. Introduction
The induction of mammalian cytochrome P-4-50 monooxygenase systems 
has been very extensively studied and is now beginning to be 
understood in terms of multiple forms of cytochrome P-4-50 (see 
chapter 1). However, relatively little is known about the 
induction of cytochrome P-4-50 enzymes in microorganisms.
The most widely studied microbial cytochrome P-4-50, that which 
hydroxylates camphor in Pseudomonas putida (cytochrome P-4-50cam) 
is induced by camphor, its substrate (Yu & Gunsalus, 1974-).
This enzyme is only produced when camphor is present and cannot 
be induced by other compounds, except a small range of camphor 
structural analogs. Another bacterial soluble cytochrome P-4-50 
enzyme, the steroid 15-B-hydroxylase from Bacillus megaterium 
ATCC 13368, could not be induced to higher levels of activity 
or of cytochrome P-4-50 by a variety of substrates, substrate 
analogs or several classical mammalian cytochrome P-4-50 inducers 
(Berg & Rafter, 1981). Similarly, the cytochrome P-4-50 from 
Bacillus megaterium ATCC 14-581 which catalyzes the hydroxylation 
of saturated long-chain fatty acids, alcohols and amides at the
■to—19 CU-2 and UJ-3 positions and the hydroxylation and double- bond 
epoxidation of palmitoleic acid and other monounsaturated fatty 
acids* could not be induced in terms , of cytochrome P-4-50 level 
or monooxygenase activity when grown in the presence of any of 
of these substrate.s (Buchanan & Fulco, 1978; Ruet.tinger & Fulco,
1981). Recently however, Narhi & Fulco (1982) have reported 
that this, enzyme system, is inducible by.phenobarbital in terms 
of both cytochrome P-4-50 level and monooxygenase activity.
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In Corynebacterium species, a cytochrome P-4-50 enzyme involved 
in the hydroxylation of n-alkanes is induced by growth on 
n-octane (Cardini & Jurtshuk, 1970). Similarly in Acinetobacter 
species a cytochrome P-4-50 thought to be involved in hydroxylation 
of alkanes was induced by growth on hexadecane (Asperger e_t al. , 
1981).
In eukaryotic microorganisms, many instances of monooxygenase 
activity induction have been described, though few have been 
identified with a cytochrome P-4-50 enzyme (Smith & Rosazza,
1974-J 1975)* The fungus Claviceps purpurea was shown to undergo 
a twofold induction of its cytochrome P-4-50 by phenobarbital, as 
measured, by both cytochrome P-4-50 level and its activity in this 
organism, alkaloid biosynthesis (Ambike _et al. , 1970). Also 
3-methylcholanthrene was observed to produce a spectral shift 
in the reduced carbon monoxide difference spectrum from 4-50nm 
to 4-4-8nm, which was. due to jde novo cytochrome P-4-4-8 synthesis.
In Cunningham.ella bainieri however, neither 3-methylcholanthrene 
nor phenobarbital were able to induce cytochrome P-4-50, yet 
phenanthrene. elicited a tenfold increase in hydroxylase activity 
(Ferris ejt al.., 1976). In Rhizopus nigricans and Rhizopus arrhizus 
it has been shown that the cytochrome P-4-50 dependent progesterone 
hydroxylase is induced by the substrate progesterone, with little 
activity being detected in uninduced cells (Breskvar & Hudnik- 
Plevnik, 1981). Classical inducers of the cytochrome P-4-50 
system in mammals were examined by Cerniglia & Gibson (197.8) 
for their effect on the oxygenation of naphthalene in Cunningham- 
ella elegans. Naphthalene gave rise to a fivefold increase
(98)
in its own metabolism, phenobarbital a threefold increase and 
3-methylcholanthrene a two- to threefold increase in naphthalene 
metalbolism.
Several species of yeasts capable of growth on n-alkanes have 
been reported to contain cytochrome P-4-50 including Candida 
tropicalis (Duppel et, al. , 1973)*. Candida guilliermondi 
(Mauersberger et al., 1980), Lodderomyces elongisporus (Riege 
et al., 1981) and Saccharomycopsis lipolytica (Marchal et al., 
1982). In all of these cases, cytochrome P-4-50 is induced by 
n-alkanes which are the major substrates for these enzymes.
In Saccharomyces cerevisiae grown aerobically at low glucose 
concentration, (conditions under which cytochrome P-4-50 cannot 
normally be detected), it was reported that the addition of 
phenobarbital to the yeast growth medium resulted in the induction 
of cytochrome P-4-50 levels to a level similar to that found in 
yeast grown at high glucose concentration (Wiseman & Lim, 1975). 
However, no effect on cytochrome P-4-50 levels in yeast growing 
at a high glucose concentration was observed after addition of 
phenobarbital.
The aryl hydrocarbon hydroxylase activity of yeast cytochrome 
P-4-50 towards benzo.(a)pyrene is now well documented (Wiseman 
& Woods, 1979; Woods. & Wiseman, 1980). The major metabolites 
produced are 3-hydroxybenzo(a)pyrene, 9-hydroxybenzo(a)pyrene 
and 7,8-dihydro-7,8-dihydroxybenzo(a)pyrene as shown by. analysis 
with high-pressure liquid chromatography (Wiseman & Woods, 1979). 
This metabolite profile is similar to that produced by a
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mammalian cytochrome P-4-4-8 form of the enzyme (Gozukara ejt al. ,
1982). The involvement of cytochrome P-4-50 in this benzo(a)- 
pyrene hydroxylase was demonstrated by thermal stability experi­
ments and inhibition of benzo(a)pyrene hydroxylase by carbon 
monoxide (Woods, 1979). This identity is also supported by 
tritium NMR studies of substrate-haem interactions in a partially 
pure enzyme.preparation (Libor _et al., 1980). This identity 
has been recently established unequivocally by Azari & Wiseman 
(1982a) who reconstituted an. active benzo (a).pyrene hydroxylase 
using highly purified yeast cytochrome P-4-4-8, purified NADPH: 
cytochrome P-4-50 (c) reductase and phospholipid. The induction 
of a form of yeast benzo(a)pyrene hydroxylase with a higher 
affinity for benzo(a)pyrene -by growing yeast in the presence 
of benzo (a-)-pyren,e-was first, achieved - by Wrseman Woods (1979) • 
This induction of benzo(a)pyrene hydroxylase in Saccharomyces 
cerevisiae is.confirmed and greatly extended in the work 
presented here.
3.2. Materials and Methods
3.2.1. Yeast.Growth and Induction
Yeast (Saccharomyces cerevisiae NCYC 24-0 unless otherwise stated) 
was grown aerobically in 20$ glucose containing medium as . 
described, in section 2.2.1.. Growth was normally for 4-4- hours. 
Inducing agents were added at the beginning of the growth period 
dissolved in a small amount of dimethylformamide, with an equiva­
lent amount of dimethylformamide added to control experiments.
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3.2.2. Preparation of Yeast Microsomal Fraction
Yeast was harvested by centrifugation (10 minutes at full speed 
on a bench centrifuge) and transferred to a stainless steel 
Vibro-mill vessel for disruption. The yeast was mixed with glass 
beads . (1.00-1.05mm diameter) in the Vibro-mill vessel and milled 
for a total of 6 minutes in a water-cooled Vibro-mill disruptor. 
The disruptor was stopped after 1 min. for topping up with glass 
beads and then milling was.carried out in one minute bursts, 
allowing a. one minute interval between bursts.for cooling. After 
milling, the .glas.s beads, were washed with 0.1M tris/HCl buffer 
pH 7.2, and the washings centrifuged at 10,000g for 10 minutes 
on an M.S.E.. high speed cnetrifuge to remove unbroken cells, 
debris and large cellular organelles. The supernatant was then 
spun at l60,900g for one hour in a Beckman L5-65 ultracentrifuge 
to obtain a microsomal pellet. The microsomal pellet was then 
resuspended in 0.1M phosphate buffer pH 7.2 containing 20$ (v/v) 
glycerol, ImM EDTA and 0.1$ (w/v) reduced glutathione, by use 
of a hand-held Potter-Elvejhem homogeniser.
3.2.3* Assay of Benzo.(a)pyrene Hydroxylase Activity
The measurement of benzo(a)pyrene hydroxylase activity was 
achieved, by detecting the amount of 3-hydroxybenzo(a)pyrene 
produced in a fluorimetric assay. The hydroxylated metabolite
3-hydroxybenzo(a)pyrene has a characteristic fluorimetric peak 
at 520-525nm whereas, other metabolites of benzo(a)pyrene have 
an emission peak.at approx. 4-4-Onm. This method is modified from 
that of Dehnen _et al. (1973). An incubation mixture was set up
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in a final volume of 1ml containing the following:
0.1M tris/HCl pH 7.0 
Benzo (a)pyrene (20-160 fjM)
NADP+ UmM)
Glucose-6-phosphate (20mM)
Glucose-6-phosphate dehydrogenase (8 units/ml)
MgCl2 ( 6|jM )
Microsomal fraction (varying concentrations)
Tubes of tests, blanks and standards (containing 3-hydroxybenzo- 
(a)pyrene) were, incubated for one hour at 37°C in a shaking 
water bath and the reaction stopped by the addition of 1ml of 
ice-cold acetone. Denatured protein was removed by centrifugation 
for 10 minutes in a bench centrifuge at full speed. Supernatant 
(0.6ml) was.added to l./ml of triethylamine (8.5$ in H^O) in 
fresh tubes and the mixture centrifuged again. The supernatant 
was then used, to measure 3-hydroxybenZo(a)pyrene fluorescence. 
Fluorescence was measured .on a Perkin-Elmer MPF3 fluorimeter at 
4.67nm excitation, 525nm emission (500-560nm scan). Turnover of 
benzo(a)pyrene was calculated using a quinine sulphate reference 
with respect to a 3-hydroxybenzo(a)pyrene standard.
3.2.4.. Assay of NADPH:cytochrome c (P-4-50) reductase
Yeast NADPH: cytochrome c (P-4-50) reductase levels in microsomal 
fractions were measured by the method of Yoshida ejt al. (1974-)* 
which measured the reduction of cytochrome c in a spectr.ophoto- 
metric assay. The reaction mixture was set up in a spectrophoto­
meter cuvette as follows:
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1.8ml phosphate buffer pH 7.6 (50mM)
1.0ml cytochrome c (O.lmM)
0.1ml microsomes 
+ 0.1ml NADPH (30mM)
The reference cuvette contained the above mixture also, except 
that extra buffer was added instead of NADPH. After a steady 
baseline at 550nm had been established, the reaction was started 
by addition of NADPH. The rate of increase in absorbance at 
55Onm was measured using a Pye-Unicam SP 1800 spectrophotometer.
The content of NADPH: cytochrome c (P-4-50) reductase was then 
calculated using the extinction coefficient of 18.5mM”^cm ^ for 
cytochrome c reduced, and expressed as units of activity, where 
one unit of activity converts l|Jmole of cytochrome c to its 
reduced form per minute.
3.2.5- Protein Determination
The protein contents of microsomal samples were determined by 
the method of Lowry ejt al. (1951) modified to include a protein 
precipitation step using trichloroacetic acid as precipitant.
This was necessary to eliminate interference from glycerol and 
possibly other constituents of the buffer used for resuspending 
microsomes.
Protein standards (0-20C>Hg/ml of bovine serum albumin) and samples 
in a volume of 1ml were added to 1ml of ice-cold trichloroacetic 
acid (15$ w/v) and stood on ice for five minutes. The precipitated 
protein was recovered, by centrifugation (10 minutes at 3000 RPM
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on a Beckman J-6 centrifuge) and re-dissolved in 1ml of 0.1M NaOH 
This solution was then used in a standard Lowry procedure.
3.2.6. Materials
Benzo(a)pyrene and 3-hydroxybenzo(a)pyrene were from the Aldrich 
Chemical Co. Ltd., Gillingham. Dimethylnitrosamine was obtained 
from Phase separations Ltd., Queensferry, Flintshire. Cytochrome 
c, NADP, NADPH, glucose-6-phosphate, glucose-6-phosphate dehydrog 
enase, sodium phenobarbitone, lanosterol, B-naphthoflavone and
3-methylcholanthrene were from Sigma Chemical Co. (London) Ltd., 
Poole, Dorset. Glycerol was from May & Baker Ltd., Dagenham, 
Essex. Dimethylformamide,. Folin-Ciocalteau reagent and all other 
chemicals were from BDH Chemicals Ltd., Poole, Dorset.
3.3. Results and Discussion
3.3.1. Benzo(a)pyrene Induction of Cytochrome P-4.50 dependent 
Benzo (a)pyrene Hydroxylase, in Saccharomyces cerevisiae
The addition of benzo(a)pyrene to yeast growing in a medium 
containing 20$ (w/v) glucose affected the apparent kinetics 
of microsomal benzo(a)pyrene hydroxylase and the level of 
cytochrome P-4-50 in the yeast as shown in figure 3.1. and table
3.1.. The level of cytochrome P-4-50 was only slightly higher 
in yeast treated with benzo (a)pyrene at high concentrations.- 
The apparent kinetics of NADPH supported microsomal cytochrome 
P-4-50 dependent benzo (a)pyrene hydroxylase were investigated by 
means of double-reciprocal, Lineweaver-Burk plots (figure 3.1.).
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Figure 3.1- Lineweaver-Burk plot of benzo(a)pyrene 
induced microsomal benzo(a)pyrene hydroxylase.
Control microsomal activity (•) (no benzo(a)pyrene 
added to growth medium) is. shown with plots for 
microsomal activity from yeast treated with benzo(a)- 
pyrene at concentrations of l6y«M(o), 32^M(b ), 63^M(d ) 
95/MM(a) & 190yMM(A).
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Benzo(a)pyrene 
Concentration
(m m )
Cytochrome. 
P-4-50
(nmol/g)
Benzo(a)pyrene Hydroxylase
Km (m M) Vmax (pmol/h/ 
nmol P-4-50)
Correlation
Coefficient
0 3.36+.24- 111 167 .9958
16 3. 66+. 4-1 100 220 .9980
32 3.4-3+.31 65 333 .9964-
63 3.95+.14- 56 50 0 .9965
95 4-. 36+.23 4-2 4M . 94-80
190 32 580 .9013
Table 3.1. Induction of benzo(a)pyrene hydroxylase with 
benzo(a)pyrene. Values of cytochrome P-4-50 in nmol/g wet 
weight of yeast are quoted + standard deviation, n=8.
Kinetic parameters of benzo(a)pyrene hydroxylase determined 
from Lineweaver-Burk plots using a simple linear regression, 
n=5. Vmax values are quoted as pmol 3-hydroxybenzo(a)pyrene/ 
h/nmol cytochrome P-4-50.
* This concentration of benzo(a)pyrene resulted in precip­
itation of benzo(a)pyrene which interfered with the cytochrome 
P-4-50 assays, rendering them invalid.
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The results show clearly that benzo(a)pyrene pretreatment of 
yeast results in a lower Michaelis constant (Km), i.e. higher 
affinity for benzo(a)pyrene, and a higher maximal velocity of 
reaction (Vmax).. These effects were clearly dependent on the 
concentration of benzo(a)pyrene in the growth medium as shown 
in figure 3*2.. The more benzo(a)pyrene was added, the better 
the kinetics observed until a maximal induction level was reached. 
When these results are expressed as Vmax/Km and plotted against 
the concentration of benzo(a)pyrene added as inducer, a straight 
line is obtained (figure 3*3»)» The parameter Vmax/Km can be 
used as a crude measure of enzyme efficiency. It is obvious 
that the more benzo(a)pyrene added to the growth medium, the 
greater the efficiency of the enzyme produced. These results 
therefore indicate that a new enzyme (or enzymes) with a higher 
activity towards benzo(a)pyrene is produced.
The level of NADPH: cytochrome P-4-50 (c) reductase was also 
measured in both benzo(a)pyrene induced and uninduced microsomal 
fraction (table 3.2.). No difference in the levels of this 
enzyme were observed. It seems likely therefore that induction 
is due to the other enzymic component of the benzo(a)pyrene 
hydroxylase system, cytochrome P-4-50.
Benzo(a)pyrene is a well-known inducer of mammalian cytochrome 
P-4-50 dependent benzo (a)pyrene hydroxylase in a similar manner 
to 3-methylcholanthrene. Several groups of workers have shown 
that benzo (a)pyrene induction of mammalian cytochrome P-4-50 has 
resulted in a lower Km and higher Vmax for benzo(a)pyrene hydroxy­
lase (Hansen & Fouts, 1972; Gurtoo & Campbell, 1970;
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Figure 3*2. Benzo(a)pyrene induction of benzo(a)pyrene 
hydroxylase kinetic parameters.
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Figure 3.3- Increase in efficiency of benzo(a)pyrene 
hydroxylase after induction with increasing amounts of 
benzo(a)pyrene.
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Source of Microsomes NADPH: cytochrome P-4-50 (c)reductase 
(Units/mg protein)
Control 34* 9
tBenzo(a)pyrene 95M^ 37.7
+3-Methylcholanthrene 90|JM 38.7
tDimethylnitrosamine 324-MM 29.2
Table 3.2. Microsomal NADPH: cytochrome P-4.50(c)reductase levels
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Schlede et al., 1970). This effect has been shown to be due 
to the selective induction of a form (or forms) of cytochrome 
P-4-50 with high activity towards benzo (a)pyrene hydroxylation, 
often termed cytochrome P-4-4-8. This form of cytochrome P-4-50, 
which is also induced by 3-me.thylcholanthrene,: is known to have 
a relatively narrow substrate specificity and to activate 
carcinogens such as benzo(a)pyrene to metabolically active 
products.
Although the major uninduced form of yeast cytochrome P-4-50 is 
itself a cytochrome P-4-4-8 in terms of its spectral maximum in 
the reduced carbon monoxide difference spectrum (Azari & Wiseman, 
1982a) and in the pattern of metabolites produced from benzo(a)- 
pyrene (Wiseman & Woods, 1979), another cytochrome P-4-4-8 enzyme 
with higher activity towards benzo(a)pyrene is shown to be 
induced here. Multiple forms of cytochrome P-4-4-8 enzymes have 
become well established for mammalian systems (Guengerich, 1979). 
The presence of multiple forms of cytochrome P-4-50 in yeast is 
previously unreported although there is. some evidence from 
purification studies of at least two forms of cytochrome P-4-50 
present in uninduced yeast (Azari & Wiseman, 1982a). It is 
possible that a small amount of the induced form of cytochrome 
P-4-50 is present in uninduced yeast; however, this has not yet 
been detected. The major form in uninduced yeast with a maximum 
in the reduced, carbon monoxide difference spectrum at 4-4-8nm 
has a relatively low turnover for benzo(a)pyrene, and the minor 
form separated out by Azari & Wiseman (1982a) has a spectral 
maximum in the reduced, carbon monoxide difference spectrum at
4-50nm, whereas that of benzo (a)pyrene induced microsomes is at
4-4-8nm.
(Ill)
It should be remembered that the asay used in these experiments 
for measuring benzo(a)pyrene hydroxylase activity is based on 
the measurement of only one metabolite, 3-hydroxybenzo(a)pyrene. 
This is one of the major metabolites produced by uninduced yeast 
microsomes as shown by high pressure liquid chromatography. 
However, the results here for induction of benzo(a)pyrene 
hydroxylase are only valid if the metabolite profile remains 
the same in induced yeast. This has been shown not to be the 
case for mammalian induction by polycyclic aromatic hydrocarbons 
(Jacob e^t al. , 1981; Gozukara et al., 1982). However, work by 
Woods (1979) appeared to show the same profile of benzo(a)pyrene 
metabolites after benzo(a)pyrene induction, hence validating 
the above results. It is interesting that in the case of 
naphthalene metabolism by the fungus Cunninghamella elegans, 
no change in metabolite profile was observed after induction by 
3-methylcholanthrene or phenobarbital, both of which increased 
the rate of naphthalene metabolism.(Cerniglia & Gibson, 1978).
Although the kinetics of benzo (,a)pyrene hydroxylase are greatly 
improved on induction, only a small increase in cytochrome P-4-50 
levels is observed. Two possibilities for this effect exist. 
Firstly, the production of the uninduced form of cytochrome P-4-50 
is not affected and a small amount of very highly efficient 
enzyme is produced, or secondly, the production of the more 
efficient enzyme is induced whilst the production of the 
uninduced, less, efficient, enzyme is decreased. However, the 
large decrease in apparent Km observed after induction makes 
the first of these alternatives unlikely, favouring the second 
as this would be more likely to result in a large effect in Km.
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Therefore it is probable that induction by benzo(a)pyrene results 
in at least one new form of cytochrome P-4-50 being produced 
with compensating non-production of the existing form of the 
enzyme. This is also the case in mammalian benzo(a)pyrene 
induction, as here the characteristic uninduced cytochrome P-4-50 
activities are decreased whilst the cytochrome P-4-4-8 activities 
are greatly increased (Nebert _et al. , 1981). Assuming that 
induction of yeast benzo(a)pyrene hydroxylase takes place at 
a transcriptional level, this might lead to a model whereby a 
high concentration of benzo(a)pyrene is responsible for switching
on one gene and also switching off another, although this need 
not be a direct effect. This would therefore represent both a 
positive and negative control exerted by the inducer over the 
different genes for these cytochrome P-4-50 enzymes.
The mechanism of induction of cytochrome P-4-50 enzymes is not 
fully understood. As mentioned in chapter 2, the group of 
Nebert .et al. have worked extensively on the induction of 
cytochrome P-4-50 enzymes in the mouse by polycyclic aromatic 
hydrocarbons such as. benzo(a)pyrene, 3-methylcholanthrene and 
B-naphthoflavone (Nebert, 1979; Nebert et ad.., 1981). They 
have demonstrated that the inducer binds to a cytosolic receptor 
protein which is then translocated to the nucleus and causes 
transcription of structural genes coding for induced forms of 
the enzyme (see figure 2.16.) although the exact meehanism by 
which this is achieved is as yet unclear . (Nebert ejb al. , 1981).
In the case of the yeast system, a similar mechanism may operate, 
with the inducer-receptor complex causing switching on of some 
genes and switching off of others, although so far there is no 
evidence for this.
(113)
It was suggested that the inductive effect of benzo(a)pyrene 
may be due to its mutagenic action, activated in situ by the 
yeast cytochrome P-4-50 system, causing a mutant form of the 
enzyme in yeast. However, it is very unlikely that more effic­
ient forms of the enzyme would be consistently produced in this 
way.
The only other report of benzo(a)pyrene induction of benzo(a)- 
pyrene hydroxylase in a yeast is for the yeast Neurospora 
crassa which has been shown to produce a benzo(a)pyrene 
hydroxylase enzyme, which metabolises benzo(a)pyrene to 
3-hydroxybenzo(a)pyrene, when the yeast is grown in the presence 
of benzo(a)pyrene (Lin & Kapoor, 1979). However, whether this 
activity is cytochrome P-4-50 dependent has not been reported.
K&renlampi & Hynninen (1981a) grew Saccharomyces cerevisiae 
NCYC 24-0 in the presence of chrysene, 3-methylcholanthrene and 
hexachlorophene. In some cases the second derivatives of the 
reduced carbon monoxide difference spectra revealed a splitting 
of the cytochrome P-4-50 band into two, which may have been due 
to two forms of cytochrome P-4-50. This is unlikely however, as 
a mixture of forms of cytochrome P-4-50 and cytochrome P-4-4-8 as 
induced by Aroclor 1254- in mammalian tissue did not split into 
two bands. In an attempt to look at this, the second derivatives 
of reduced, carbon monoxide difference spectra of induced and 
control yeast were taken as described in section 2.2.3.. The 
second derivative spectrum of control yeast is shown in figure
2.12.. When yeast was induced with benzo(a)pyrene, a typical 
spectrum as shown in figure3.4-. was observed. No splitting of
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Figure 3.4-. Second derivative reduced carbon monoxide 
difference spectrum of yeast grown in 20# glucose media in 
the presence of 95jjM benzo (a )pyrene. Yeast was used in a. 
suspension of 0.1g(wet weight)/ml. d^A/dt^ is in arbitrary 
units.
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the cytochrome P-450 band occurred, yet a change in the position 
of the band from 452nm to 4-49nm on benzo (a)pyrene induction may 
represent a change in the mixture of different forms of cytochrome 
P-450 present. (It should be remembered that the process of 
taking second derivatives results in a small wavelength shift 
of the spectrum).
Yeast grown aerobically, in 0.5$ glucose medium normally contains 
no detectable cytochrome P-450 (see. chapter 2). In an attempt 
to induce cytochrome P-450 and benzo(a)pyrene hydroxylase activity 
in yeast, growing at low glucose concentration, benzo(a)pyrene was 
added. No cytochrome P-450 could.be detected after growing in 
this medium,, even in the presence, of a high concentration (95pM) 
of benzo(a)pyrene.
The inability of benzo(a)pyrene to induce cytochrome P-450 in 
yeast, growing aerobically at low glucose concentration shows 
that a high glucose, concentration, or conditions leading to a 
similar physiological, state such as semi-anaerobic conditions, 
is a prerequisite, for cytochrome.P-450 production. This would 
be expected if the production of cytochrome P-450 was being 
controlled by the presence of cyclic AMP by repression, as has 
been suggested. (.Wiseman .et al. , 1978). It would seem therefore 
that a high glucose concentration lowers the level of cyclic 
AMP which allows cytochrome P-450 to be. produced. The induction 
observed..with benzo.(a)pyrene is. due to an effect on a particular 
form of the cytochrome. P-450 produced. This result disagrees 
with that , of Wiseman. &..Lim (1975)# who found that phenobarbital 
could induce yeast cytochrome P-450 formation at low glucose
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concentration to levels, comparable to those found during 
growth on a high glucose medium.
Experiments to determine the time course of cytochrome P-4-50 
induction in Sac charom yc e s cerevisiae were done by resuspending 
lg samples of uninduced yeast in 20% glucose growth medium (100ml) 
containing 95MM. benzo.(a)pyrene, and incubating for various times 
at 30°C before harvesting and measuring cytochrome P-4-50 level 
and microsomal benzo (a ).pyrene hydroxylase. Controls were run 
at each time point. The results (table 3.3., figures 3*5., 3-6.,
3.7.,) show that after two hours, there is some induction of 
benzo (a ).pyrene hydroxylase but it is not complete. After four 
hours the induction of benzo.(a)pyrene hydroxylase is virtually 
to the maximal .level of induction possible. The control levels 
of Km and Vmax for benzo(a)pyrene hydroxylase vary little during 
this time, course (figures 3.5. and 3.6.). The induction of 
benzo(a)pyrene hydroxylase, is seen to be not instantaneous.
The time period of at least four hours seen before the induction 
of this enzyme.is complete is probably due to the time taken 
for new enzyme synthesis to occur. Figure 3.7. shows the time 
course for the Level of cytochrome P-4-50 produced in control 
and induced yeast. The.addition of benzo(a)pyrene initially 
results in... an increase in/cytochrome. P-4-50 level above the 
control. After 2.4-. hours however, the level of cytochrome P-4-50 
in control and induced, yeast.is the same although benzo(a)pyrene 
hydroxylase is still greatly induced. These results are well in 
agreement with the idea that benzo(a)pyrene causes an increase 
in synthesis, of a more efficient form (or forms) of the enzyme, 
and a decrease, in a. less efficient form. This may result in .
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Incubation time Cytochrome
P-4-50
Benzo(a )pyrene Hydroxylase
(hours) (nmol/g) Km (jjM) Vmax (pmol/h/ 
nmol P-4-50)
Correlation
Coefficient
0 4-.67t.l6 111 167 .9958
2 control 4-.00t.18 100 192 .9979
tbenzo(a)pyrene 5.64-t.U 74- 250 .9921
4- control 3.51+.38 109 233 . 964-4-
tbenzo(a)pyrene 5. 01+. 4.8 4-6 4-55 .9920
8 control 3.08t.38 105 263 .99 53
tbenzo (a.)pyrene 5. 04-+. 54- 39 4-55 . 994-4-
19'control 5.4-4-t. 4.5 111 217 .9912
tbenzo(a)pyrene 6.91+.27 33 4-17 .9728
24- control 4..lOt.35 111 222 .9986
tbenzo (a )p.yrene 3.96+.34 39 4-55 .9829
Table 3.3. Time course of induction by benzo(a)pyrene. 
Values of cytochrome P-4-50 are quoted t standard deviation, 
n=8. Kinetic parameters of benzo(a)pyrene hydroxylase 
determined from Lineweaver-Burk plots using a simple linear 
regression, n=5-
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Figure 3.6. Time course of induction of 
benzo (a )pyrene hydroxylase Vmax by 95f*M 
benzo(a)pyrene.
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an initial increase in cytochrome P-4-50 levels as the gene for 
induced enzyme is switched on. The production of the uninduced 
form is switched off or reduced and the level of uninduced 
enzyme falls as it is replaced with induced enzyme. After 24- 
hours, the cytochrome P-4-50 level has fallen to that of the 
control due to degradation of the uninduced enzyme.
In order to characterize the benzo(a)pyrene induction 
process further, an attempt was made to induce cytochrome P-4-50 
in non-growing yeast. This experiment was carried out on a 
time scale similar to the experiments above, with an incubation 
time of four hours in non-growth medium, containing 95pM 
benzo (a)pyrene. . The results (table 3.4-. » figure 3.8.) show 
that virtually no difference was detected in either cytochrome 
P-4-50 level or benzo (a)pyrene hydroxylase kinetics between the 
control incubation and. that in the presence of benzo(a)pyrene. 
After four hours incubation *of growing yeast under equivalent 
conditions, induction of benzo(a)pyrene hydroxylase was extensive 
(table 3.3.). Therefore, this experiment shows that yeast 
must be growing for induction to occur.
3.3.2. Induction, .of. Cytochrome P-4-50 dependent Benzo (a)pyrene 
Hydroxylase, with Other Compounds
Table 3.5. and figures.3-9. and. 3.10 show the effects of 
3-methylcholanthrene and dimethylnitrosamine when added to 
growing yeast as inducing agents. The carcinogen dimethylnitro­
samine was found to cause, induction in a similar manner to 
benzo (a )pyrene, giving a small increase in cytochrome P-4-50
(122)
Cytochrome
P-4-50
(nmol/g)
Benzo(a)pyrene Hydroxylase
Km (|JM) Vmax (pmol/h/ 
nmol P-4-50)
Correlation
Coefficient
Control 2.18+.24 103 147 .9968
+Benzo(a)pyrene
9 5|JM
2.18+.22 95 169 .9945
Table 3.4-. Attempted induction in non-growing yeast. Values 
of cytochrome P-4-50 are quoted as means of eight determinations 
+ standard deviation, n=8. Kinetic parameters of benzo(a)pyrene 
hydroxylase determined from Lineweaver-Burk plots using a 
simple linear regression, n=5.
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Figure 3-8. Lineweaver-Burk plot of attempted 
induction of non-growing yeast benzo(a)pyrene 
hydroxylase with. 95pM benzo(a)pyrene.
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Inducer Added Cytochrome
P-4-50
Benzo(a)pyrene Hydroxylase
(nmol/g) Km
(m m )
Vmax (pmol/h/ 
nmol P-4-50
Correlation
Coefficient
Control 3.36+.24 111 167 .9958
Dimethylnitrosamine
108MM
3.98+.38 59 588 .8889
Dimethylnitrosamine
324-MM
4-. 64-+. 38 40 4-76 .9954
3-methylcholanthrene
30MM
3.4-8+.27 27 154 .9255
3-methylcholanthrene
90MM
3.32+.35 20
-----
174 .9727
Table 3.5. Induction of cytochrome P-4-50 dependent 
benzo(a)pyrene hydroxylase by 3-methylcholanthrene and 
dimethylnitrosamine* Values of cytochrome P-4-50 are quoted 
+ standard deviation, n=8. Kinetic parameters of benzo(a)- 
pyrene hydroxylase determined from Lineweaver-Burk plots 
using a simple linear regression, n=5.
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Figure 3-9* Lineweaver-Burk plot of the induction of 
benzo(a)pyrene hydroxylase by 3-methylcholanthrene.
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Figure 3*10. Lineweaver-Burk plot of the induction
of benzo (a )pyrene hydroxylase with dimethylnitrosamine
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level, a large decrease in apparent Km for benzo(a)pyrene and 
a large increase, .in benzo (a)pyrene hydroxylase Vmax. Higher 
concentrations of dimethylnitrosamine were necessary to achieve 
the same extent, of induction as with benzo.(a ).pyrene. These 
results seem to suggest that dimethylnitrosamine is inducing 
the same form of the enzyme as benzo(a)pyrene.
3-methylcholanthrene, a classical inducer of cytochrome P-4-4-8 
type, activities .in mammalian, tissues, was found to cause no 
change in cytochrome P-4-50. levels and no change in maximal 
velocity of the benzo(a)pyrene hydroxylase reaction. However, 
a very large decrease in. the apparent Km was observed, suggesting 
the induction of a form of cytochrome P-4-50 with a very high 
affinity for benzo (a).pyrene,. yet low turnover.
Table 3.6. and figures 3.11 and 3.12 show the effects of 
phenobarbital,. B-naphthoflavone and lanosterol when tested as 
inducers. Phenobarbital appeared to. result in a small amount 
of induction of benzo(a)pyrene hydroxylase when added at a 
concentration of 32HM. This is unexpected as phenobarbital is 
well-known as a: classical inducer of cytochrome P-4-50 activities 
and not cytochrome P-4-48 forms, of the enzyme which catalyze 
reactions such.as benzo(a)pyrene hydroxylation. However, 
Cerniglia & Gibson. (1978) reported that phenobarbital was 
capable of inducing metabolism of naphthalene to the same extent 
as 3-methylcholanthrene in the fungus. Cunninghamella elegans. 
Also, other unexpected, cases of induction of cytochrome P-4-50 
activities by phenobarbital have been observed in Claviceps 
purpurea (Ambike et al., 1970) and Bacillus.megaterium (Narhi & 
Fulco, 1982).
(128)
Inducer Added Cytochrome
P-450
Benzo(a )pyrene Hydroxylase
(nmol/g) Km(MM) Vmax
nmol
(pmol/h/
P-450)
Correlation
Coefficient
Control 3.36+.24. 111 167 .9958
Phenobarbital
32|JM
3.50+.2/ 80 278 .9723
B-naphthoflavone
30|JM
3.80+.38 114 182 .9899
Lanosterol
19MM
3. 62+. 4-2 2$0 200 .9594
Table 3.6. Attempted induction of benzo(a)pyrene hydroxylase 
with phenobarbital, B-naphthoflavone and lanosterol. Values 
of cytochrome P-4-50 are quoted + standard deviation, n=8. 
Benzo(a)pyrene hydroxylase kinetics determined from 
Lineweaver-Burk plots using a simple linear regression, n=5.
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Figure 3.11. Lineweaver-Burk plot of the induction 
of benzo(a)pyrene hydroxylase with phenobarbital (32pM) 
and B-naphthoflavone (30f*M).
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Figure 3-12 Lineweaver-Burk plot of the 
induction of benzo(a)pyrene hydroxylase 
with 19pM lanosterol.
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A form of cytochrome P-4-50 with a very high turnover for 
benzo(a)pyrene has been reported to be induced in mammalian 
liver by B-naphthoflavone. This, enzyme has an absorption 
maximum in. the reduced carbon monoxide difference spectrum at 
446nm and was hence, termed cytochrome P-446 (Saito & Strobel, 
1981). However, pretreatm.ent of Saccharomyces cerevisiae with 
this compound was.unable to induce benzo(a)pyrene hydroxylase 
activity or cytochrome P-450 level in this organism (table 3-6, 
figure 3•11•)•
Lanosterol is thought to be an endogenous substrate of 
cytochrome P-450 in S. cerevisiae (Aoyama.S Yoshida, 1978a; 
1978b). The addition of this compound to yeast during growth 
resulted in. an. enzyme with a decreased, affinity for benzo(a)- 
pyrene (table 3-6., figure 3.12.). This may be due to the 
induction of another form of cytochrome P-450, less specific 
for benzo(a)pyrene.
Other compounds, tested as. inducers, were isosafrole, which is 
capable of inducing a unique form, of cytochrome P-450 in rat 
liver (Ryan, ejb al. , 1980), the aromatic .hydrocarbon naphthalene 
and linoleic acid. In none of these, cases was there any effect 
on either yeast cytochrome P-450 or microsomal benzo(a)pyrene 
hydroxylase kinetics.
The above studies with different inducers seem to indicate that 
a range of cytochrome. P-450 enzymes, exist in yeast which are 
capable, of differential induction in a similar manner to 
mammalian cytochrome. P-450 enzymes.
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3.3.3. Induction of Cytochrome P-450 dependent Benzo(a)pyrene 
Hydroxylase in Other Yeast Strains
Table 3.7. and figure 3.13 show the effect of pretreatment of the 
yeast Sacchar omycas cere vis i a e . N C Y C 239. with 95\i¥i benzo (a)pyrene 
as an inducing agent... No difference in cytochrome P-450 levels 
was observed in the presence of inducer. A similar extent of 
induction of benzo(a)pyrene hydroxylase was observed as in 
jS. cerevisiae. NCYC. 240 (table 3.1.). This experiment shows that 
the induction of cytochrome P-450 dependent benzo(a)pyrene 
hydroxylase is not specific to one strain of yeast.
The recent finding that, S. cerevisiae 240 is an impure strain 
consisting of 20$ NCYC 753 and 80$ NCYC 754 (see section 2.3.2.) 
led to the suggestion that benzo(a)pyrene induction in NCYC 240 
might be due to selection of the minor form of yeast which might 
have a higher activity towards benzo (a.)pyrene hydroxylation.
This was tested by measuring the activities of benzo(a)pyrene 
hydroxylase and the. extent of induction by 95MM benzo(a)pyrene 
in the two isolated strains, (table 3.8., figures 3.14 and 3.15). 
As can be seen, from the results presented here, there was no 
difference in the activity of the cytochrome P-450 present in 
these two uninduced yeast, strains towards benzo(a)pyrene 
hydroxylation,with very similar Km and. Vmax values being 
determined. However., there is much less cytochrome P-450 in 
NCYC 753 (see.section. 2.3.2.) and therefore this probably does 
not contribute, much to the. metabolism .seen in NCYC 240. After 
benzo(a)pyrene treatment,, the major form (NCYC 754) behaves in 
a very similar, fashion to NCYC 240 as expected, with little
(133)
Cytochrome
P-4-50
Benzo(a )pyrene hydroxylase
(nmol/g) Km(jjM) Vmax (pmol/h/ 
nmol P-450)
Correlation
Coefficient
Control 6.99+.34 93 235 .9970
Benzo(a)pyrene
95Mm
6.2/+.73 41 422 .9912
Table 3*7. Benzo (a)pyrene induction in jS. cerevisiae NCYC 239- 
Values of cytochrome P-4-50 are quoted + standard deviation, 
n=8. Benzo(a)pyrene hydroxylase kinetics determined from 
Lineweaver-Burk plots using a simple linear regression, n=$.
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Figure 3*13 Lineweaver-Burk plot of the 
induction of benzo(a)pyrene hydroxylase 
from S. cerevisiae NCYC 239 with 95y*M 
benzo(a)pyrene.
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Cytochrome 
P-450
Benzo(a)pyrene hydroxylase
(nmol/g) Km
(m m )
Vmax (pmol/h/ 
nmol P-4-50)
Correlation
Coefficient
753 Control 0.58+.16 109 175 .9957
753 + Benzo(a)pyrene 
95MM
1.19+.16 77 192 .9907
754- Control 8.57+.4-8 102 222 .9902
754- + Benzo (a )pyrene 
95MM
8.56+.28 40 476 .9827
Table 3.8. Induction by benzo(a)pyrene in S. cerevisiae 
NCYC 753 and NCYC 754-* Values of cytochrome P-4-50 quoted 
+ standard deviation, n=8. Benzo(a)pyrene hydroxylase 
kinetics determined from Lineweaver-Burk plots using a 
simple linear regression, n=5.
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Figure 3.14» Lineweaver-Burk plot of the 
induction of benzo(a)pyrene hydroxylase
from S. cerevisiae NCYC 753 with 95pM 
benzo(a)pyrene.
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change in cytochrome P-4-50 level, but a large decrease in Km 
for benzo(a)pyrene and a large increase in Vmax. The induction 
of NCYC 753 however, shows a doubling of cytochrome P-4-50 level 
but only a small improvement in the efficiency of benzo(a)pyrene 
hydroxylation. The reason for this lack of induction of benzo(a)- 
pyrene hydroxylation is unknown, but reflects strain differences 
in the response to induction. The increase in cytochrome P-4-50 
level seen in NCYC 753 on. induction contributes to the small 
increase seen in NCYC 24-0 under these conditions. However, it 
is clear that induction, of benzo (a )pyrene hydroxylase in NCYC 24-0 
is not due to the selection of a highly active minor component 
yeast.
(139)
CHAPTER 4-
STUDIES ON. THE BINDING PROPERTIES OF 
CYTOCHROME P-4-50 FROM SACCHAROMYOES CEREVISIAE
(140)
4.1. Introduction
The technique of difference spectrophotometry has been widely 
used to study the binding of substrates and other chemicals to 
cytochrome P-4-50. Remmer et al. (1966) were the first to report 
the occurrence of two types of spectral change on binding of 
compounds to cytochrome P-4-50 from rat liver microsomes. These 
spectral changes were described in detail by Schenkman e^t al. 
(1967a) and. categorized as type I with an absorption peak at 
385-390nm and a trough at 4-20nm (typically produced by substrates 
of cytochrome P-450 such as hexobarbital & aminopyrine), and 
type II with an absorption maximum at 4-25-4-30nm and a minimum 
at 390-4-05nm (typically produced by compounds such as aniline and 
nicotinamide). Another type of spectral change produced by 
compounds such as acetanilide, phenacetin, ethanol and butanol 
was later characterized with an absorption maximum at 4-20nm 
and a trough at 385-390nm (i.e. the mirror image of the type 
I spectrum). This was originally called a modified type II 
binding spectrum but was later renamed a reverse type I spectrum 
(Schenkman. et al. , 1972).
The type I spectral change has been reported to be produced by 
a wide variety of substrates of cytochrome P-4-50 and is thought 
to be due to the binding of the substrate to the apoprotein, 
probably at the active site (Schenkman eit al., 1981). The 
ability of a substrate to produce a type I spectral change 
has been shown to parallel enzyme activity in rat liver micro­
somes (Schenkman £t al., 1976). Also the induction of rat liver 
microsomal cytochrome P-4-50 by phenobarbital increased the
da)
type I spectral change in parallel with the cytochrome P-4-50 
level. The lack of correlation between the rate of hydroxylation 
of some type I substrates and content of cytochrome P-4-50 
observed by these workers is explained by the presence of 
multiple forms of the haemoprotein (see chapter l).
The type II spectral change is produced by a range of compounds, 
mostly containing amine groups, such as aniline, pyridine, 
nicotinamide and n-octylamine. The type II spectral change 
is thought to be due to ferrihaemochrome formation with cyto­
chrome P-4-50,. the added compound binding to the haem group of 
the enzyme as a sixth ligand (Schenkman. et al., 1967a). The 
evidence for this interaction with the haem group came largely 
from studies showing the displacement of carbon monoxide from 
the sixth ligand position by type II binding compounds 
(Schenkman et al., 1972).
The reverse type I spectral chnge was initially thought of 
as binding of the compound to.,.another., si-t.e..o-f. cytochrome P-4-50, 
eliciting the reverse of the type I spectral change- (Schenkman 
et al., 1972). It was also suggested that this spectrum could 
result from the displacement of endogenous substrates such as 
fatty acids from the cytochrome P-4-50 binding site (Cinti ejt al.., 
1973; Powis et. al.., 1977), the reverse type I spectral change 
thus being attributed to the removal of a type I substrate 
from cytochrome P-4-50. However, Vore et al. (1974-) showed that 
despite extraction of endogenous substrates from microsomes 
with organic solvents, the reverse type I spectrum could still 
be formed. Recently, Schenkman ejb al. (1981) have attributed
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the reverse type I spectrum to direct interaction of the compound 
with cytochrome P-4-50, and it has also been suggested that this 
interaction is due to the binding of a hydroxyl group to the 
haem iron (Yoshida & Kumaoka, 1975)*
As discussed in chapter 1, the cytochrome P-4-50 molecule can 
exist with its haem group in two spin states, high spin or 
low spin. The high spin form is characterized by a Soret peak 
at 390nm in the absolute spectrum and the low spin form by a 
Soret peak at 4-18nm. It has been shown by several groups of 
workers that the interaction of a type I substrate with oxidised 
cytochrome P-4-50 is associated with a spin conversion from the 
low to the high spin state, and that a type II (or reverse type 
I) compound results in a conversion from the high to the low 
spin state (Peterson et al., 1971; Cheng & Hording, 1973;
Nebert _et al.., 1973). Kumaki. et. al. (1978) showed that the 
presence or absence of a spectral change depended largely on
the in vivo spin state of the newly prepared microsomes at the
)
beginning of the experiment. It was also shown that type I 
and reverse.type I spectral changes could be produced without 
the addition of subs.trate, simply by an alteration in temperature 
(Cinti _et al., 1979). This was interpreted in terms of an 
alteration in the temperature-dependent spin state equilibrium 
of the cytochrome.
It is now established that the type I binding spectrum is due 
to the binding of a substrate to the active site, causing a 
change in the spin state from low to high spin, i.e. a change 
in absolute spectrum,, decreasing the 4-20nm absorbance of the
(U3)
low spin enzyme and increasing the 390nm absorbance of the 
high spin enzyme. Similarly, the type II and reverse type I 
binding spectra are due to the modulation of the spin state 
from’a high to low spin, causing a change in absolute absorb­
ance from approx. 390nm to 4-20nm. These spectra (type II and 
reverse type I) are caused by binding of the compound to the 
haem group as a sixth ligand to the iron atom, and the differences 
between the two may reflect differences in the groups binding 
to the haem (amine groups for type II spectra, hydroxyl groups 
for reverse type I ). (Schenkman e_t al., 1981).
The bacterial cytochrome P-4-50cam from Pseudomonas putida can 
also undergo spectral changes on substrate binding which are 
also due to the modulation of the spin state of the cytochrome 
(Sligar, 1976).
The aim of the work reported here is to. define the spectral 
changes observed with cytochrome P-4-50 from Sac char omyces 
cerevisiae. Few previous studies have investigated binding to 
the yeast enzyme,, although Woods & Wiseman (1980) have reported 
a type I binding spectrum with benzo(a)pyrene and yeast micro­
somal enzyme, and Aoyama & Yoshida (1978b) have detected a 
type I binding spectrum with lanosterol and purified yeast 
cytochrome P-4-4-8.
It should be re-emphasised here that cytochrome P-4-50 is a 
general name for a family of enzymes including cytochromes P-4-4-8, 
and that the term cytochrome. P-4-4-8 is used here to describe the 
purified enzyme from yeast (or rat liver) which has a spectral 
maximum in the .reduced carbon monoxide spectrum at 4-4-8nm.
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4..2. Materials and Methods
4.2.1. Solubilization and Purification of Cytochrome P-448 
and NADPH:Cytochrome P-450(c) Reductase from 
Saccharomyces cerevisiae
Cytochrome P-448 from uninduced Saccharomyces cerevisiae 
NCYC 240 was purified to homogeneity by a method slightly 
modified from that of Azari & Wiseman (1982a) hs shown in 
figure 4*1*•
(i) Solubilization
Yeast microsomes were prepared as described in section 3*2.2. 
and resuspended in 0.1M phosphate buffer pH 7.2 containing 
20$ (v/v) glycerol, ImM EDTA and 0.1$ (w/v) reduced gluta­
thione. Microsomal enzynies were solubilized by firstly diluting 
the microsomal fraction to approx. 30mg/ml of protein with the 
microsomal resuspension buffer (as above) and adding sodium 
cholate (1% w/v) followed by stirring under nitrogen for one 
hour at 4°C. This preparation was centrifuged in a Beckman 
L5-65 ultracentrifuge (160,900g for 50 mins) and the supernatant 
collected as a source of solubilized microsomal enzymes.
(ii) Ammonium sulphate fractionation
Ammonium sulphate fractionation was then carried out by firstly 
diluting the solubilized enzymes (x3) and preparing the precip­
itate at 35-65% of saturation at pH 7.0. Initially, ammonium 
sulphate was added to 35% of saturation whilst keeping the pH
(14-5)
Yeast Microsomes
N/
Soluble Enzymes
Purified NADPH:cytochrome 
P-450 (c) reductase
2'5f-ADP agarose
Carboxymethyl Sephadex C50
Hydroxylapatite-cellulose
DEAE Sephacell
Solubilization/Ammonium 
sulphate fractionation
n-aminooctyl Sepharose 4-B
Purified Cytochrome P-448
Figure 4*1* Purification scheme for cytochrome P-448 and 
NADPH:cytochrome P-450(c) reductase from yeast microsomes
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at a constant pH 7 by addition of dilute ammonia solution. The 
precipitate was removed by centrifugation (113,700g for 20mins) 
and the supernatant was then made up to 65$ of saturation of 
ammonium sulphate, also whilst maintaining a constant pH. The 
precipitate was sollected by centrifugation (44>400g for 20mins), 
resuspended in 0.02M phosphate buffer pH 7.0 containing 20$ (v/v) 
glycerol, ImM EDTA, ImM glutathione and 0.5$ (w/v) sodium 
cholate and dialyzed overnight against 30 volumes of 0.01M 
phosphate buffer pH 7.0 containing 20$ (v/v) glycerol, ImM 
EDTA, ImM glutathione and 0.3$ (w/v.) sodium cholate. Insoluble 
material was removed by centrifugation (l60,900g for 50mins) 
and the supernatant mixed with bio-beads SM-2 (prewashed with 
methanol and water) and stirred for 30mins at 4°C before addition 
to a bio-bead column,. Solubilized microsomal enzymes were 
eluted by.washing with one column volume of the dialysis buffer.
(iii) Affinity chromatography
Affinity chromatography was then carried out by firstly adjusting 
the sodium cholate concentration to 0.5$ (w/v) and then applying 
the sample to a column of 8-amino-n-octyl Sepharose 4B pre- 
equilibriated with 0.01M phosphate buffer pH 7.0 containing 
20$ glycerol, ImM EDTA and 0.3$ (w/v) sodium cholate. After 
washing with the same, buffer, cytochrome P-448 was eluted with 
the equilibration buffer also containing 0.1$ (v/v). emulgen 911. 
After elution of cytochrome P-448, NADPH:cytochrome P-450 
reductase, was eluted from the same column using the cytochrome 
P-448 elution buffer also containing 0.2$ (w/v) deoxycholate 
and 2HM FMN.
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(iv) Hydro xylapatit-e and carboxymethyl Sephadex.chromatography
Fractions rich in cytochrome P-448 were applied to a hydroxyl- 
apatite-cellul.ose column (1:1 w/w) pre-equilibrated with 0.01M 
phosphate buffer pH 7.0 containing 20$ (v/v) glycerol. This 
column was washed with 0.03M phosphate buffer pH 7.0 containing 
20$ (v/v) glycerol and 0.2$ (v/v) emulgen 911. Cytochrome P-448 
was then eluted with 0.1M phosphate buffer pH 7.0 (20$ (v/v) 
glycerol, 0.2$ (v/v) emulgen 911). Cytochrome P-448 fractions 
were then combined, diluted (xlO) with 20$ (v/v) glycerol and 
0.2$ (v/v) emulgen and then applied to a carboxymBthyl-Sephadex 
C50 column pre-equilibrated with 0.01M phosphate buffer pH 7.0 
(20$ (v/v) glycerol, 0.2$ (v/v) emulgen).. After washing with 
equilibration buffer and. then 0.04M phosphate buffer pH 7.0 
(20$ v/v glycerol, 0.2$ v/v emulgen), cytochrome P-448 was 
eluted with 0.1M phosphate buffer pH 7^0 (20$ glycerol, 0.2$ 
v/v emulgen).
(v) DEAE-S ephac ell chroma to graphy
Cytochrome P-448 containing fractions from the CM-Sephadex 
column were combined and dialyzed twice against 30 volumes of 
0.005M phosphate buffer pH 7.7 (20$ glycerol, 0.2$ emulgen) 
for 12 hours each time, diluted (x2) with 20$ glycerol and 
0.2$ emulgen, adjusted to pH 7.7.and then applied to a DEAE- 
Sephacell column pre-equilibrated with the above dialysis 
buffer. Most of the cytochrome P-448 did not bind and.was 
eluted with equilibration buffer. The cytochrome P-450 form, 
a minor component distinguished by its peak in the reduced
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carbon monoxide difference spectrum, bound to this column and 
could be eluted with 0.035M phosphate buffer pH 7.7 (20$ v/v 
glycerol, 0.2$ v/v emulgen). Cytochrome P-448 was concentrated 
by ultrafiltration using an Amicon PM-30 membrane.
(vi) Removal, of non-ionic detergent
Emulgen 911 was removed from purified cytochrome P-448 by 
passing it through a column of bio-beads. SM-2 as described 
above. Residual emulgen was removed by binding the enzyme to 
a hydroxylapatite column and washing until no absorption due 
to emulgen in the washings (at 276nm) could be detected, and 
then eluting the enzyme with 0..1M phosphate buffer pH 7.0 
(20$ v/v glycerol, O.lmM dithiothreitol) as described by Saito 
& Strobel (1981).
(vii) Further purification of NADPH:cytochrome P-450(c) 
reductase
After elution from the affinity column (see above), NADPH: 
cytochrome P-450 reductase was purified further on a 
2 1,51-ADP-agarose column. The column was washed with 0.3M 
phosphate buffer (20$ v/v glycerol, 0.1$ v/v emulgen) and the 
reductase, eluted with 0.3M phosphate buffer pH 7.7 containing 
20$ (v/v) glycerol, 0.2$ (w/v) deoxycholate and 0.005M 2 l-AMP. 
Emulgen 9 H  was also: removed from this preparation by the 
method described above for cytochrome P-448.
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4..2.2.. Binding Spectra of Compounds with Yeast Cytochrome 
P-4-4-8
Binding spectra were obtained by recording difference spectra 
between.350nm and 500nm of highly purified yeast cytochrome 
P-4-4-8 (1 nmole/inl) or yeast microsomal fraction (Approx. 
0.5nmole cytochrome. P-448/ml) using a Varian Cary 219 spectro­
photometer. Difference spectra were recorded at various 
concentrations of the added compound with an equivalent volume 
of solvent added^ to the reference cuvette. The solvents used 
for these experiments, dimethylformamide or water, shovred 
no spectral interaction with cytochrome P-4-4-8 on their own.
In the case of benzo(a)pyrene, the split cell technique of 
Azari 6 Wiseman (1982b) was used to eliminate interference 
from the absorbance of benzo (a).pyrene itself in this range. 
Spectral titrations were subjected to double reciprocal plots 
derived from the kinetic equation:
E -f S % C --------> E + P
k2
where E is enzyme, S is substrate and C the enzyme substrate 
complex. Spectra were recorded at room temperature in the 
absence of cofactor and hence the enzyme-substrate complex 
cannot form products (P). The reversibility of this binding 
reaction was demonstrated by Schenkman (1967a). The spectral 
dissociation constant, Ks, is defined by:
Ks = ( [Et] - [C]) [S]
& ]
where Et is the total amount of enzyme.
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By manipulation of this equation 
Ks = [Et] [ s ]  -  [ s ]
f t
and' [c] = [ E t ]  [ s ]
Ks+[S]
the reciprocal of this equation 
1 = Ks 1 + 1
[c] [ E t ]  [ S ]  [ E t ]
is the equation of a straight line. When the reciprocal of 
the spectral change —g— is plotted against the reciprocal of 
the substrate concentration the y intercept is —^  or the
reciprocal of C max, and the x intercept is (Schenkman
et al., 1967a).
Thus double reciprocal plots of absorbance against substrate 
concentration were used to find values for Ks and Amax (maximal 
absorbance change). These values were calculated by means of 
a simple linear regression analysis finding the best fit for 
the line and are quoted together with the correlation coefficient 
for the points to this line.
4.2.3. Determination of the Midpoint Redox Potential of highly 
purified Yeast Cytochrome P-448
The midpoint redox potential of highly purified enzyme was 
measured by a dye photoreduction technique modified from that 
of Sligar et al. (1979). Safranine T was used as a redox-
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indicator and mediator, with its midpoint redox potential known 
to be -289mV.
A final volume of 3ml containing highly purified enzyme (2 nmoles) 
and dye (safranine T, 4 nmoles) in 50mM phosphate buffer pH 7.25> 
containing 20$ (v/v) glycerol and lOmM EDTA plus a glucose/glucose 
oxidase/catalase system was made anaerobic in thunberg cuvettes 
by repeated evacuation and flushing with deoxygenated argon.
A fully oxidised spectrum (350nm - 600nm) was recorded. The 
system potential was then set by irradiation of the cuvette 
from a 100 Watt bulb for 30 second intervals, the spectrum being 
re-recorded each time... Absorbance values, were determined by 
scanning between the wavelengths until a constant reading was 
reached at each point.. Finally a 100$ reduced spectrum was 
achieved by adding sodium dithionite. The fraction of haemo- 
protein and dye reduced were determined, from the absorbance at 
420nm and 518nm respectively, using the 100$ reduced, oxidized 
values as determined above. Safranine T has negligible absorb­
ance at 420nm and. cytochrome P-448 is isosbestic (oxidized- 
reduced) at 518nm, thus deconvolution of the cytochrome P-448 
and dye. absorbances at these.wavelengths was unnecessary. Data 
was then displayed as standard Nernst plots, enabling calculation 
of the midpoint redox potential of the cytochrome using the 
equation:
Ep = Em(dye) - RT In f^r = Em(protein) - RT In ,£ T
where E^ is the system potential, Em the midpoint redox potential, 
fp1*, fp° fp° are the fractions (f) of protein (p) and
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dye (d) reduced (r) and oxidized (o) respectively. R is the 
gas constant, T the absolute temperature and F the Faraday 
constant. Thus the values of E^ can be calculated from the 
fraction of dye reduced and oxidized and the known midpoint
Vredox potential, enabling a Nernst plot of In f^ against E^
f 0 
p
to be produced with the intersect on the x axis equivalent to 
the midpoint redox potential of the protein.
4.'. 2.4-« Materials
Carboxymethyl-Sephadex C50, 2 ,5 -ADP agarose and DEAE-Sephacell 
were obtained from Pharmacia fine chemicals, Uppsala, Sweden. 
Hydroxylapatite and bio-beads SM-2 were from Bio-Rad laboratories, 
Richmond, California, USA. Emulgen: 911 was from the Kao-Atlas 
Company and n-aminooctyl Sepharose 4-B was a generous gift from 
Paul Tamburini . and . Dr-'G. Gibson,. University of Surrey. Sodium 
cholate, deoxycholate, FMN, imidazole, perhydrofluorene, 
lauric acid, 7-ethoxycoumarin, glucose oxidase and hexobarbital 
were from the Sigma Chemical Co. (London) Ltd., Poole, Dorset. 
7-ethoxyresorufin was from Pierce Chemicals, Rockford, Illinois, 
USA., and aminopyrine from Aldrich Chemical Co., Gillingham. 
Biphenyl, aniline and all other chemicals were from BDH Chemicals 
Ltd., Poole, Dorset.
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4.3. Results and Discussion
4.3.1. The Purification of Yeast Cytochrome P-448
Yeast cytochrome P-448 (absorption maximum at 448nm in the 
reduced carbon monoxide difference spectrum) was purified from 
uninduced yeast as described in materials and methods. The 
specific content of the final preparation was 16-17.5nmol/mg 
protein. The homogeneous nature of the protein was shown by 
SDS-polyacrylamide. gel electrophoresis by M.. R. Azari. No 
contaminating bands could be detected. This technique also 
allows an estimation of molecular weight by reference to known 
molecular weight standards. The molecular weight of yeast 
cytochrome. P-448 was found to be. 55*500, identical to the value 
reported for the same protein from yeast by Azari & Wiseman 
(1982a). This value is also similar to that reported for 
cytochrome P-448 from liver microsomes. of 3-methylcholanthrene 
treated rats by Bothelo _et al.. (1979) > but larger than that 
reported for cytochrome P-448 from semi-anaerobicaliy grown 
baker’s yeast (51*000) by Yoshida _et al. (1977).
Using the molecular weight value determined as 55*500, the 
specific content of a 100$ pure sample of cytochrome P-448 is 
18nmol/mg protein. Therefore, the cytochrome P-448 purified 
here was 88-97$ pure. This protein was.also shown .to be free 
from contamination by cytochrome P-420, cytochrome b*. and 
NADPH:cytochrome P-450 reductase.
The absolute spectrum of the purified enzyme is shown in figure
4.2.. The preparation had a Soret peak at 417nm and showed no
(154)
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Figure 4*2. Absolute spectrum of purified yeast cytochrome 
P-44-8 (oxidized form).
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absorbance in the 650nm region. This spectrum is characteristic 
of a cytochrome P-4-50 protein largely in the low-spin state.
The reduced carbon monoxide difference spectrum of purified 
cytochrome P-4-50. showed a Soret peak at 4-4-Snm, suggesting a 
similarity between this, cytochrome and. that induced by polycyclic 
hydrocarbons .in mammalian hepatic tissue, (see chapter 1).
Jefcoate eiy al.. (1.969a; 1969b) reported that cytochrome P-4-4-8 
from hepatic microsomal fraction of 3-methylcholanthrene 
pretreated animals,consisted largely of the high spin form of 
the enzyme. In yeast,, the cytochrome P-4-4-8 was probably initially 
in a mixed spin state., but. as. has been reported by Yoshida & 
Kumaoka (1975) and, by Fujita et. al. (1973)> the pretreatment of 
cytochromes. P-4-50 with non-ionic detergents (such as emulgen 911) 
changes the spin state of the enzyme from high to predominantly 
low spin form.
4-.3»2. The Binding, of some Compounds, to. Yeast Microsomes
Yeast cytochrome. P-4-50 in microsomal form was used to test for 
the binding of a number of compounds to this enzyme. A major 
problem was encountered with the turbidity of the microsomal 
fraction, due . to the relatively low content of cytochrome P-4-50 
in yeast microsomes (approx. 0.04-nmol/mg protein) compared to 
rat liver microsomes (approx. 0.8nmol/mg protein for control 
rats). The consequence, of this turbidity was that only a low 
sensitivity can be use.d whilst running binding spectra; otherwise 
an unacceptable, noise level is produced.. Therefore only very 
strong spectral interactions with yeast .microsomal cytochrome 
P-4-50 can be detected.
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Only three compounds have previously been reported to produce 
binding spectra with yeast microsomal cytochrome P-4-50. Woods 
(1979) reported that imidazole and sodium phenobarbitone gave 
type II spectral interactions with yeast microsomal cytochrome 
P-4-50, with spectral dissociation constant (Ks) values of 
350|jM and 5*8mM respectively.. Benzo (a )py.rene, a well character­
ized, substrate of the. yeast enzyme,, gave, an unusual type I 
binding spectrum with yeast microsomes., an extra peak in the 
spectrum being observed at 365nm (Woods & Wiseman, 1980). A 
similar extra .peak has .also, been observed for the spectral 
interaction of benzo(a)pyrene with rat liver cytochrome P-4-50 
(Estabrook ^t al., 1978).
Attempts to record binding spectra were made using lanosterol, 
pheno barbital,. benzphetamine., dimethylnitrosamine, biphenyl, 
aminopyrine,. imidazole and benzo(a)pyrene. Of these, only 
imidazole,and benzo(a)pyrene gave any detectable binding spectrum 
(table 4-• 2..). Benzo(a)pyrene was found to give a type I binding 
spectrum with an extra peak at 365nm, a peak at 385nm and a 
a trough at 4-15nm* thus confirming the result of Woods &
Wiseman (1980). A Ks value of 18JJM was found compared to a 
value of 32pM found by. Woods and Wiseman.
Imidazole was found to give rise to a type II spectrum with
yeast microsomes with a. spectral maximum at. 4-25nm and minimum
at 385nm.,. thus confirming the result, of Woods (1979)* A
spectral, dissociation constant of 1.15mM was found for imidazole
as compared to. 0..35mM by Woods. The reason, for this disagreement
in Ks values is unknown; however, the. difficulties in taking
yeast microsomal.binding spectra as stated above should be 
noted.
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4-.3.3* The Binding of Compounds to Highly Purified Cytochrome 
P-448 from Saccharomyces cerevisiae
The .binding properties of several compounds including benzo(a)- 
pyrene and other putative substrates with highly purified yeast 
cytochrome .P-448 were examined, with the results summarised in 
table 4.1..
The binding of benzo(a)pyrene to purified yeast cytochrome P-448 
is as shown in figure 4.3. • Similar to the. microsomal spectrum, 
two peaks are observed with maxima at 367nm and 387nm and a 
minimum at 418nm. This type I binding is as expected from a 
substrate of the enzyme,, and is further evidence for the involve­
ment of yeast, cytochrome. P-448 with this compound. The double 
reciprocal.plot-of benzo(a)pyrene binding to yeast cytochrome 
P-448 (figure 4-4«) shows the maximal absorbance change, Amax, 
to be 0.122 and the spectral dissociation constant, Ks, to be 
50|jM (.correlation coefficient 0.9939). In an• equivalent 
experiment with purified cytochrome P-450 from phenobarbital 
induced.rat liver (donated by Paul Tamburini), a very similar 
spectrum was observed with a Ks value for benzo(a)pyrene of 
31JJM and. an Amax of 0.065 with a correlation coefficient of 
0.9894 (figure 4*5.).
When the binding of benzo(a)pyrene to purified yeast cytochrome 
P-448 is compared to its binding to microsomal enzyme (Ks .values 
of 50pM and 18J1M respectively), it can be seen that some high 
affinity binding appears to be lost on purification. These 
Ks values show that although the affinity of yeast cytochrome
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Figure 4-* 3. The binding spectrum of benzo(a)pyrene 
with purified yeast cytochrome P-4-4-8 measured using 
a split cell technique.
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P-448 for benzo (a )pyrene is high, the unusual ability to 
achieve stoichiometric titration of cytochrome P-448 by 
benzo(a)pyrene which was demonstrated for the rat liver enzyme 
by Estabrook jet al. (1978) is not acheived here. A stoichio­
metric titration (1:1 molar ratio) would require a Ks value 
of approx. 0 ..4m m -for benzo (a )pyrene binding to cytochrome P-4-4-8 
from yeast. Stoichiometric titration was not observed either 
with the. purified cytochrome P-450 from phenobarbital induced 
rat liver (Ks 3lHM)» a Ks of 0.2pM being required in this case.
The comparison, of the absorbance of the benzo(a)pyrene-enzyme
complex with. the. le.v.el of cytochrome P-4-4-8 detected in the
reduced carbon,monoxide difference spectrum . allows a calculation
of the proportion of enzyme•bound- to benzo(a)pyrene, using
-1 -1an extinction coefficient of 57mM cm: for AA4-15-50Onm of
the enzyme-benzo. (a)pyrene complex. This, extinction coefficient 
is a function of the haemoprotein spin equilibrium and is not 
altered by the source of the enzyme, or the substrate used 
(Cinti .et al., 1979)* It was found that almost 100$ of purified 
yeast cyto;chrome P-4-4-8 bound, to benzo (a )pyrene as compared 
to 53$ of. purified rat liver cytochrome P-450.-- Not surprisingly, 
the binding of benzo(a)pyrene to rat liver cytochrome P-4-50 
is low.as this enzyme was purified from, phenobarbital induced 
rats.. If a rat liver cytochrome P-4-4-8. form., from 3-methylchol- 
anthrene. or benzo(a)pyrene induced rats had been used, a 
higher proportion of the enzyme would be expected to bind this 
compound. The fact that a high percentage of purified yeast 
cytochrome P-448 binds, to benzo(a)pyrene is not surprising as 
this enzyme is largely in the low spin form (see section 4*3*1*
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and 4.3.4.) which readily combines with type I substrates such 
as benzo(a)pyrene.
Lanosterol was also found to give a type I spectral change with 
purified yeast cytochrome P-448 as shown in figure 4*6.. Similar 
to benzo(a)pyrene, an extra peak in the spectrum was found at 
367nm, showing that this extra peak is not specific to the inter­
action with benzo(a)pyrene. A double reciprocal plot (figure 
4.7.) revealed a high affinity for this compound with a Ks 
value of 80jjM but a relatively low extent of binding,. with an 
Amax value of 0.019 (correlation coefficient 0.9813). Aoyama 
& Yoshida (1978a, 1978b) have reported that lanosterol is a 
substrate of yeast cytochrome P-448, so a type I spectrum is 
expected. The type I spectrum was not able to be detected with 
microsomal fraction (section 4.3.2.), probably due to its low 
spectral Amax. A type I spectral interaction of lanosterol with 
purified cytochrome P-448 from a baker’s yeast strain of Saccharo­
myces cerevisiae has previously been reported by Aoyama & Yoshida 
(1978b), although no values for Ks or Amax were quoted.
Type I binding spectra were also observed with phenobarbital 
(figure 4*8.), ethylmorphine (figure 4*10), dimethylnitrosamine 
(figure 4*12) and perhydrofluorene (figure 4*14)• Phenobarbital 
resulted in a trough at 417nm and peaks at 387nm and 367nm, 
thus producing an extra peak in the difference spectrum similar 
to lanosterol and benzo(a)pyrene already described. Ethylmorphine 
also gave an extra peak in the binding spectrum, although in this 
case the wavelength was at 355nm, with the other binding spectrum 
maximum at 382nm and a minimum at 412nm (figure 4-10). As can
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Figure J+, 6. Lanosterol binding spectrum
to purified yeast cytochrome P-4-4-8.
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Figure 4--8. Binding spectrum of phenobarbital
to purified yeast cytochrome P-4-4-8.
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Figure 4.10 Binding spectrum of ethylmorphine
to purified yeast cytochrome P-4.4-8.
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Figure 4..12. Binding spectrum of dimethylnitrosamine
to purified yeast cytochrome P-44-8.
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Figure 4-*14-» Binding spectrum of perhydrofluorene
with purified yeast cytochrome P-44.8.
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be seen from the summary of results in table 4-l«> the exact 
position of the spectral peaks and troughs varies with the 
different compounds used. This is a well-known phenomenon 
for* all types of cytochrome P-450 binding spectra (Schenkman 
et al., 1981). The double reciprocal plots for these compounds 
revealed Ks values of 66jjM for phenobarbital (figure 4* 9»)> 
l66pM for ethylmorphine (figure 4*H-) and 220pM for dimethyl- 
nitrosamine (figure 4«13). A double-reciprocal plot for 
perhydrofluorene could not be constructed due to practical 
problems concerning the miscibility of this compound with the 
enzyme solution. Although the type I binding spectrum is 
normally indicative of substrate binding to the enzyme, no 
metabolism of any of these compounds except benzo(a)pyrene has 
so far been detected in a reconstituted system (chapter $), 
although it should be noted that only a relatively insensitive 
technique has been used. However, phenobarbital and dimethyl- 
nitrosamine have been shown to be inducers of cytochrome P-448 
dependent benzo(a)pyrene hydroxylase activity, as is benzo(a)- 
pyrene itself (chapter 3; King et al., 1982).
Type II binding spectra were observed for the interaction of 
purified yeast cytochrome P-448 with imidazole (figure 4*15»)> 
aniline (figure 4*17.) and weakly with benzphetamine (figure 
4-.19.). Benzphetamine showed a poor affinity for yeast cyto­
chrome P-448 with a Ks of 1.66mM (figure 4*20.). This compound 
is a substrate of mammalian cytochrome P-450 which gives rise 
to a type I spectrum with this enzyme (Goujon et al., 1972). 
Benzphetamine does not appear to be a substrate of yeast cyto­
chrome P-448 and thus gives rise to a weak type II spectral
(175)
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Figure 4-. 15. Binding spectrum of imidazole to
purified yeast cytochrome P-4.4.8.
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Figure 4*17. Binding spectrum of aniline to
purified yeast cytochrome P-448.
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Figure 4-*18. Double reciprocal plo
for aniline binding to purified yea
cytochrome P-4-4-8.
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Figure 4-.19. Binding spectrum of benzphetamine
with purified yeast cytochrome P-44-8,
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interaction. Aniline and imidazole are classical type II 
binding compounds with cytochrome P-4-50 enzymes (Schenkman _et al. , 
1967a). These compounds bind to yeast cytochrome P-4-4-8 with 
very high affinity, with Ks values of 5pM for aniline (figure 
■4.18. ) and 8pM for imidazole (figure 4--16. ). The extent of 
binding of these compounds as measured by the Amax values was 
lower than that of benzo(a)pyrene but higher than the other 
type I binding compounds. These results show that yeast cyto­
chrome P-4-4-8 is also capable of undergoing a type II spectral 
change due to binding of the compound to the haem iron. Aniline 
is a known substrate of the mammalian cytochrome P-4-50 monooxy­
genase system. However, although aniline bound very tightly, 
no metabolism could be detected in a reconstituted yeast 
cytochrome P-4-4-8 monooxygenase system (see chapter 5)*
Several compounds which give rise to spectral interactions with 
mammalian liver cytochrome P-4-50 enzymes did not show any 
interaction with yeast cytochrome P-4-4-8. These compounds include 
biphenyl, aminopyrine, 7-ethoxyresorufin, B-naphthoflavone, 
lauric acid, ethoxycoumarin, isosafrole and hexobarbital.
The range of compounds shown to give rise to binding spectra 
with highly purified yeast cytochrome P-4-4-8 is large compared 
to those reported for yeast microsomal enzyme in section 4-* 3*2. 
and by Woods (1979)* This reflects the difficulties mentioned 
earlier in detecting small absorbance changes in noisy microsomal 
spectra which are necessarily run at a high protein concentration 
in order to achieve an acceptable cytochrome P-4-50 level 
(usually 0.5nmol/ml). The use of highly purified enzyme allows
(182)
the recording of difference spectra at far lower protein 
concentration and thus enables a higher sensitivity to be used.
4-. 3• -4- The Mid-Point Redox Potential of Highly Purified Yeast 
Cytochrome P-4.4-8
As mentioned in section 4-»3.1-> purified yeast cytochrome P-4-4-8 
was isolated as a.: largely low spin protein, as seen by the 
absolute spectrum (figure U.2.), This has been analyzed further 
by M. R. Azari (personal communication) who has studied the 
temperature-dependent spin state equilibrium of the cytochrome. 
Purified yeast cytochrome P-4-4-8 was shown to be 94-$ low spin 
at 22°C. The binding of the substrate benzo(a)pyrene to this 
enzyme results in a shift to higher spin state (18% high spin 
at 22°C). This modulation to high spin by substrate binding 
is thought to be important in the catalytic mechanism of cyto­
chrome P-4-50 enzymes by controlling the redox potential of the 
cytochromes (see chapter 1). The low to high spin transition 
by substrate binding.results in a less negative redox potential, 
allowing electrons to flow to the cytochrome P-4-50 more easily, 
hence facilitating the catalytic mechanism (Sligar e_t al. , 1979)- 
Therefore the mid-point redox potential of yeast cytochrome 
P-4-4-8 was measured in an attempt to see if the yeast enzyme 
is regulated by a similar mechanism to that reported for rat 
liver cytochrome P-4-50 and cytochrome P-4-50cam from Pseudomonas 
puti'da (Gibson _et al., 1980).
Figure 4--21. shows the Nerust plot for yeast cytochrome P-4-4-8 
and for yeast cytochrome P-4-4-8 plus triton X-100 obtained as
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Figure 4-«21. Nernst plot for yeast cytochrome 
P-44.8 in the presence and absence of triton 
X-100 for the determination of the mid-point 
redox potential.
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described in materials and methods. These graphs give values 
of the mid-point redox potential as -305mV for the free enzyme 
(correlation coefficient 0.94-72) and -334mV for the enzyme plus 
triton X-100 (correlation coefficient 0.9744)* An attempt was 
made to measure the mid-point redox potential of cytochrome P-448 
in the presence of the substrate benzo(a)pyrene. However, the 
absorbance of benzo(aJpyrene itself interfered with the spectral 
determination of the fraction of cytochrome P-448 oxidized or 
reduced, making it impossible to determine the redox potential.
The value for the mid-point redox potential of -305mV determined 
for yeast cytochrome P-448 is close to the value of -300mV 
determined for rat liver cytochrome P-450 (Sligar _et al. , 1979) 
and to the value of -303mV determined for cytochrome P-450cam 
(Sligar, 1976).
The addition of triton X-100 to yeast cytochrome P-448 results 
in stabilization of the cytochrome (Azari & Wiseman, 1980).
This stabilization is thought to be partly due to triton X-100 
binding, causing a change in the spin state of the enzyme to 
low spin which may protect the sulphydryl ligand of the haem 
iron. The modulation of the spin state of yeast cytochrome 
P-448 from high to low spin by triton X-100 has also been shown 
by Tamura et al. (1976). Azari & Wiseman (1981) also reported 
that triton X-100 acts as a type II substrate in causing a 
slow reduction of cytochrome P-448 due to its modulation of 
cytochrome P-448 to a lower spin state. The lower value of 
mid-point redox potential recorded here is consistent with all 
of these observations that.a lower spin state is produced on
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triton X-100 binding. This results in a lower mid-point redox 
potential of the cytochrome which therefore makes the enzyme 
harder to reduce.
The similarity of the redox potential of yeast cytochrome P-448 
to that of rat liver cytochrome P-450 and cytochrome P-450cam 
implies that this enzyme may be regulated by a similar mechanism. 
However, evidence that substrate binding causes a shift to a 
higher mid-point redox potential on substrate addition which 
occurs in cytochrome P-450cam and ra-k liver enzyme could not 
be obtained. Nevertheless, it has been shown that yeast cyton 
chrome P-448 achieves a higher spin state on substrate binding 
(M. R. Azari, personal communication) and this is associated 
with a higher mid-point redox potential in the enzymes from 
other sources, so a similar mechanism allowing electron flow 
seems likely.
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CHAPTER 5
STUDIES ON THE SUBSTRATE SPECIFICITY OF 
THE YEAST CYTOCHROME P-450 DEPENDENT 
MONOOXYGENASE SYSTEM
5.1. Introduction
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Cytochrome P-448 forms of mammalian liver cytochrome P-450, 
induced for example by 3-niethylcholanthrene» have a relatively 
narrow substrate specificity when compared to the cytochrome 
P-450 forms of the enzyme which can catalyze the oxygenation 
of several hundred widely differing substrates (see chapter 1). 
The major form of cytochrome P-450 in Saccharomyces cerevisiae 
has a reduced carbon monoxide difference spectral peak at 
448nm, similar to that of the narrow specificity forms of 
cytochrome P-450 induced by 3-methylcholanthrene in mammalian 
liver. Very few substrates of yeast cytochrome P-448 have 
been demonstrated and the specificity of this enzyme appears 
to be narrower than that of cytochrome P-448 forms of the 
enzyme from mammalian hepatic microsomes.
Two substrates of the microsomal monobxygenase system of S. 
cerevisiae are well characterized. Benzo(a)pyrene is hydroxy- 
lated by this enzyme to form a range of products, predominantly
3-hydroxybenzo(a)pyrene, 9-hydroxybenzo(a)pyrene and 7,8-dihydr 
7,8-dihydroxybenzo(a)pyrene (Wiseman & Woods, 1979; chapter 3). 
Lanosterol undergoes 14a-demethylation due to an initial 
oxygenation step catalyzed by the yeast cytochrome P-448 
dependent monooxygenase system. This is the first stage in 
the biosynthesis of ergosterol from lanosterol by this organism 
(Aoyama & Yoshida, 1978a; 1978b). Other reported reactions of 
this enzyme have included, -hydroxylation of aniline (Yoshida 
et al., 1977), demethylation of aminopyrine (Sauer et al., 1982 
Yoshida et al., 1977) and also the hydroxylation of biphenyl 
(Wiseman et al., 1975b).
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Biphenyl is widely used as a model substrate for cytochrome 
P-450 catalyzed aromatic hydroxylation reactions. In mammals, 
biphenyl is initially oxygenated to phenols by the microsomal 
monooxygenase system (Meyer & Scheline, 1976; Weibkin et al., 
1976). Many metabolites are formed with the proportions of 
each metabolite dependent on factors such as age, sex and the 
species used (Creaven _et al., 1965; Burke & Bridges, 1975). 
However, quantitatively the most important metabolite is
4-hydroxybiphenyl with less hydroxylation occurring at the 2 
and 3 positions. Additional oxidation leads to the formation 
of 4>4*-dihydroxybiphenyl, 3>4 1-dihydroxybiphenyl, 3,4-dihydroxy 
biphenyl, 2,5-dihydroxybiphenyl, 3>4>4 1-trihydroxybiphenyl, 
hydroxymethoxybiphenyls and other minor metabolites (Meyer & 
Scheline, 1976). Different forms of cytochrome P-450 produce 
different patterns of biphenyl metabolites. It is thought that 
cytochrome P-448 forms of the enzyme produce mainly 2-hydroxy- 
biphenyl whereas cytochrome P-450 forms produce mainly 4-hydroxy 
biphenyl (Creaven & Parke, 1966; Billings & McMahon, 1978). 
Biphenyl 3-hydroxylation reacts to inducers in a mixed fashion 
(Haugen, 1981).
Biphenyl is also metabolised by various bacterial species.
Lunt & Evans (1970) isolated an unidentified Gram negative 
species capable of using biphenyl as sole carbon source. Other 
workers have isolated strains of Bei.ierinckia (Gibson et al. , 
1973)> Arthrobacter simplex (Tittman & Lingens, 1980) and 
Pseudomonas putida (Catelani & Colombi, 1974) capable of meta­
bolising biphenyl. However, these organisms use dioxygenases 
to achieve biphenyl hydroxylation as shown by the production
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of cis-dihydrodiols as primary metabolites. A report by 
Cerniglia et al. (1980) described formation of 4-hydroxybiphenyl 
as the major metabolite by the Cyanobacterium Oscillatoria sp. 
strain JCM, which could be due to a monooxygenase reaction.
Eukaryotic microorganisms oxidize biphenyl using monooxygenase 
enzymes forming similar metabolites to mammalian systems. In 
many cases these monooxygenases are thought to be cytochrome 
P-450 enzymes, though as yet this has been demonstrated for 
only a few reactions (Cerniglia & Gibson, 1978). Smith &
Rosazza (1974) showed 4-hydroxybiphenyl to be the major metabolite 
of biphenyl in six fungal species, with 2-hydroxybiphenyl the 
major metabolite in just one species. Dodge _et al. (1979) 
surveyed twelve fungal species for their ability to metabolise 
biphenyl. The most efficient of these were Cunninghamella 
elegans, Absidia sp. and Cunninghamella echinulata. These and 
several other species formed predominantly 4-hydroxybiphenyl 
with 2-hydroxybiphenyl and 4>4*-dihydroxybiphenyl as minor 
metabolites. These studies were confirmed by Schwartz et al. 
(1980) who examined 15 fungal species of which ten hydroxylated 
biphenyl with 4-hydroxybiphenyl as the major product. In an 
extensive study of 66 fungi by Smith _et al. (1980), only seven 
organisms produced significant quantities of metabolites with 
monohydr.oxylated products in all cases. Further work by these 
authors (Smith _et al. , 1981) showed that a 1,2-hydride (NIH) shift 
occurred during the 4-hydroxylation of biphenyl by Cunningham­
ella echinulata, showing that an epoxide intermediate is 
involved in a mechanism similar to that observed with mammalian 
systems (Billings & McMahon, 1978). This mechanism was also
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supported by Cerniglia & Crow (1981) who found six species of 
Candida yeasts capable of monohydroxylating biphenyl.
In contrast to the vast literature of the metabolism of benzo(a)- 
pyrene by mammalian systems, little is known of the microbial 
metabolism of this compound. In a manner similar to biphenyl, 
bacteria such as Be.i.jerinckia sp. oxidize this compound using 
dioxygenase enzymes to form cis-dihydrodiols as opposed to 
mammalian monooxygenase systems which produce trans-dihydrodiols 
(Gibson et al., 1975)* Several studies of the fungus Cunningham­
ella elegans have shown that this organism can mono-hydroxylate 
benzo(a)pyrene to a range of products similar to those formed 
by mammalian systems (Cerniglia & Gibson, 1979; 1980). This 
organism (which is also capable of biphenyl hydroxylation - see 
above) has also been shown by spectral means to possess a 
cytochrome P-450 and this enzyme is thought to be responsible 
for the observed metabolism of benzo(a)pyrene (Ferris _et al. , 
1976). The metabolism of benzo(aJpyrene by a microsomal cyto­
chrome P-450 system from S. cerevisiae has been described in 
chapter 3 and in this chapter the metabolism of this compound 
by a reconstituted monooxygenase system containing purified 
cytochrome P-448 is described.
Aminopyrine and aniline are both recognised largely as substrates 
of mammalian cytochrome P-450 forms of the enzyme,and therefore 
activity towards these compounds by a purified yeast cytochrome 
P-448 enzyme would be surprising. However, Yoshida _et al. (1977) 
reported that a purified cytochrome P-448 monooxygenase system 
from a baker’s yeast strain of S. cerevisiae could both demethyl- 
ate aminopyrine and hydroxylate aniline. Recently, Sauer _et al.
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(1982) have compared the cytochrome P-4-50 systems of the yeast 
Saccharomyces uvarum and Candida tropicalis. Only _C. tropicalis 
was capable of aliphatic hydroxylation yet both yeasts were 
reported capable of aminopyrine demethylation.
Callen & Philpot (1977) reported that strains of £>. cerevisiae 
containing cytochrome P-4-50 were capable of metabolizing 
several compounds to active mutagens in the same cell. These 
included dimethylnitrosamine, aflatoxin B^, B-naphthylamine, 
ethyl carbamate and cyclophosphamide. A later report by these 
workers (Callen ^t al., 1980) presented some indirect spectral 
evidence for the involvement of yeast cytochrome P-450 enzymes 
in these activation reactions.
5.2. Materials and Methods
5.2.1. Preparation :of Yeast. Spheroplasts
Yeast spheroplasts (protoplasts) were prepared by a method 
modified from that of Eddy & Williamson (1959)• Yeast was 
harvested by centrifugation (full speed on bench centrifuge 
for 10 mins.), washed in 0..1M citrate-phosphate buffer pH 5*6, 
and resuspended in the same buffer containing 0.14-M dithiothreitol 
and 0.04-M EDTA to a concentration of O.lg (wet weight) per ml.
The yeast was incubated at 30°C for 30 mins., harvested and 
washed three times with 0.1M citrate-phosphate buffer pH 5.6.
After resuspending the yeast to a concentration of approx lg/ml.» 
snail gut enzyme was added (0.4ml/g yeast) and the mixture 
incubated at 30°C for J+5 mins.. Spheroplasts were harvested
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by centrifugation, washed and resuspended in 50mM phosphate 
buffer pH 7.0. To disrupt the spheroplasts, a short (30 second) 
ultrasonic treatment was used. This disruptate could then be 
used to prepare subcellular fractions in the same way as for 
milled yeast cells.(section 3-2.1.).
5.2.2. Assay of Benzo(a)pyrene Hydroxylase Activity
The measurement of benzo(a)pyrene hydroxylase activity was 
carried out by the fluorimetric determination of 3-hydroxybenzo-- 
(a)pyrene as described in section 3.2.3..
Benzo(a)pyrene
OH
3-hydroxybenzo(a)pyrene
For purified enzyme,.a reconstituted.enzyme system of 1 nmole/ml 
cytochrome P-4-4-8, 1 Unit/ml NADPH:cytochrome P-4-50 reductase and 
30 Mg/m1 dilauroylphosphatidylcholine was used. When the cofactor 
requirement was replaced by cumene hydroperoxide, a concentration 
of 2.4-mM was used.. Hydrogen peroxide was generated in situ 
from a glucose oxidase system of 2mM glucose and 2 units/ml 
glucose oxidase as described by Schubert et al. (1980).
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5.2.3. Detection' of phenolic metabolites of biphenyl by 
ferric chloride/2,2'-dipyridyl method
This' is a general method for detection of phenolic compounds 
derived from a thin-layer chromatography spray developed by 
Barton (1965). A red complex of the phenol with ferric chloride 
and methanolic 2,2’-dipyridyl is formed in a light dependent 
reaction. The peak absorption of this complex was found to be 
at 525nm.
The enzyme fraction to be assayed was made lOmM in nicotinamide 
and sodium pyrophosphate to inhibit NADPH breakdown. An NADPH 
generating system of lOmM isocitrate, ImM NADPH and O.lmg/ml 
isocitrate dehydrogenase was added.. The incubation mixture 
was warmed up to 30°c and the reaction started by the addition 
of biphenyl (solution in 1$ tween 80). To look at a time course 
twin samples were removed into stoppered test tubes at time 
intervals of up to two hours, including one sampling before 
adding substrate to act as a blank, and plunged into ice to 
stop the reaction. To each tube was added 1.8ml of 0.3$ (w/v) 
ferric chloride (in imidazole buffer pH 6.5) and 1.8ml of 
0.3$ (w/v) 2,2f-dipyridyl in methanol. Precipitated protein 
was removed by centrifugation and the tubes then put under a 
100 Watt tungsten lamp for thirty minutes. Absorbance was 
measured at 525nm on a Cecil CE 272 spectrophotometer.
Standard curves were prepared using 4— and 2-hydroxybiphenyls. 
Biphenyl did not affect colour production. In early experiments 
it was found that.during the time course of the reaction, the
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amount of colour produced declined. This was thought to be 
due to endogenous phenolic compounds being lost during the 
incubation. To combat this problem, two incubations were set 
up in parallel, one with substrate present and one without. 
Duplicate samples were then withdrawn from both incubations at 
the same time, hence enabling the decreasing absorbance to be 
blanked off.
5.2.4. Fluorimetric Assay for Biphenyl Hydroxylase
This method allows the separate measurement of 4- and 2-hydroxy- 
biphenyl production, and is modified from that of Creaven _et al.,
(1965).
4-hydroxybiphenyl
Biphenyl
2-hydroxybiphenyl
Incubation mixture contained 0.1M phosphate buffer pH 7.6,
NADPH (ImM) glucose-6-phosphate (7.5 mM), glucose-6-phosphate 
dehydrogenase (l unit/ml) and biphenyl (0.5mM) in a final 
reaction volume of 2ml. Reaction was started by addition of 
0.2ml of the appropriate enzyme fraction. Tubes of tests, 
blanks and standards (2- and 4-hydroxybiphenyls) were incubated 
at 37°C for 20 minutes. The reaction was stopped by removing 
the tubes into ice and adding 4M HC1 (0.4ml). After addition 
of biphenyl to control tubes, the incubation mixtures were
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extracted with 7ml of n-heptane containing 1% iso-amyl alcohol 
to prevent emulsification, for 10 minutes on a rotary shaker. 
Layers were separated by centrifugation and 2ml of the upper 
heptane layer were aliquoted into fresh tubes. Sodium hydroxide 
(5ml of 0.1M) was added and the mixture extracted for 10 mins. 
After centrifugation, the upper heptane layer was removed and 
2ml of the aqueous layer pipetted into a fluorimeter cuvette.
The pH was adjusted to approx 5*5 by addition of 0.5ml of 0.25M 
succinic acid and fluorescence was measured on a Perkin-Elmer 
MPF3 fluorimeter at 275nm excitation, 330nm emission for detection 
of 4-hydroxybiphenyl and at 290nm excitation, 4-15nm emission for 
detection of 2-hydroxybiphenyl.
5.2.5. Attempted Hydroxylation of 2, 4.-diamino-6-methylpyrimidine
Yeast fractions were assayed directly for their ability to 
hydroxylate 2, 4--diamino-6-methylpyrimidine to 2, 4-diamino-5- 
hydroxy-6-methylpyrimidine, using repetitive scanning spectro­
photometry.
■NH, NH
OH
H CH2
2,4.-diamino-6-methyl- 2 4.-diamino- 5-hydroxy- 6-me thyl-
pyrimidine pyrimidine
The sample holder of the spectrophotometer was thermostatted at 
37°C. Incubation mixture contained yeast fraction, 2, ^ .-diamino- 
6-methylpyrimidine and 0.1M phosphate buffer pH 7.0 in various
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proportions and the reaction was started by addition of NADPH 
(lmM) to a final reaction volume of 1ml. Changes in absorbance 
were measured by repetitive scanning from 4-5Onm to 250nm using 
a Pye-Unicam SP 1800 spectrophotometer.
5.2.6. Aniline' Hydroxylase Assay
The measurement of aniline hydroxylase activity was made using 
a reconsituted system of purified cytochrome P-44-8 (1 nmole/ml), 
NADPH: cytochrome P-450(c) reductase (1 unit/ml) and phospholipid 
(30Mg/ml of dilauroylphosphatidylcholine).
NH
OH
aniline p-aminophenol
An incubation mixture (final volume 2ml) was set up containing 
tris/HCl buffer pH 7.6 (0.1M), aniline hydrochloride pH 7.6 
(lOmM), magnesium chloride (5mM), NADP (4-mM), glucose-6-phosphate 
(20mM), glucose-6-phosphate dehydrogenase (8 units/ml) and the 
reaction started by addition of the reconstituted enzyme 
system. After incubation at 3-7°C for 45 minutes, tubes of 
tests, blanks and p-aminophenol standards (0-0.5ijmoles/ml) 
had approx lg each of solid sodium chloride added to stop the 
reaction. Ether containing 1.5$ (v/v) iso-amyl alcohol was 
added (12ml) and p-aminophenol extracted on a rotary shaker for 
20 minutes. Ether aliquots (10ml) were subsequently added to 
4ml alkali phenol (0.5M tripotassium orthophosphate <
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containing 1% w/v phenol) and extracted for 30 minutes on a 
rotary shaker. The blue colour of the aqueous layer was measured 
at 620nm using a Cecil CE 272 spectrophotometer.
5.2.7. Ethoxyresorufin-O-deethylase Assay
Ethoxyresorufin-O-deethylase activity was assayed by the method 
of Burke et al. (1977). Ethoxyresorufin is 0-deethylated to 
resorufin, both of which are fluorescent with excitation maxima 
at 456nm and 560nm respectively and emission maxima at 570nm 
and 586nm respectively. Therefore when the fluorimeter is set 
at excitation wavelength 586nm, the formation of resorufin can 
be detected by a progressive increase in fluorescence.
ethoxyresorufin resorufin
An incubation mixture (final volume 2ml) was set up containing 
0.1M tris buffer pH 7.6, ethoxyresorufin (0.1|jM), reconstituted 
purified enzyme system (1 nmole cytochrome P-44-8: 1 unit NADPH: 
cytochrome P-450(c) reductase: 30Mg dilauroylphosphatidylcholine) 
and NADPH (0.25 mM). The fluorimeter was firstly calibrated by 
adding IOjjI aliquots of resorufin (O.OlmM in ethanol) successively 
to 2ml buffer. Incubation mixture was then put into a fluori­
meter cuvette and a baseline recorded. The reaction was started 
with NADPH and the initial rate was measured from the increase 
in fluorescence using a Perkin-Elmer MPF3 fluorimeter.
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5.2.8. Nash Assay for demethylase activity
The demethylation of aminopyrine, ethylmorphine, dimethylnitro- 
samine, lanosterol or benzphetamine by a reconstituted purified 
yeast cytochrome P-44-8 monooxygenase system: was measured by 
following the formaldehyde produced from the demethylation reaction 
using the Nash reagent (Nash, 1953).
(c h 3)2n
h u c t ^ n
aminopyrine
CHq 
I *
OH
5C2
N2
P
OH
ethylmorphine
HO
lanosterol
HO
(19 8)
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Incubations were set up in a final volume of 2.5ml containing 
0.3M tris/HCl buffer pH 7.6, magnesium chloride (/mM), NADP (/mM), 
glucose-6-phosphate (20mM), glucose-6-phosphate dehydrogenase 
(8 units/ml), semicarbazide hydrochloride (0.2$ w/v), substrate 
(various concentrations) and the reconstituted enzyme system.
After incubation at 37°C for one hour, the reaction was stopped 
by the addition of 15$ (w/v) zinc sulphate (lml) followed by 
lml of la :2':i mixture of saturated solutions of barium hydroxide 
and disodium tetraborate. Protein was removed by centrifugation 
and 2ml aliquots of supernatant added to 2ml of fresh Nash reagent. 
The mixture was incubated at 37°C for /0 minutes and the absorb­
ance at 4-20nm measured on a Cecil CE 272 spectrophotometer.
Nash reagent was prepared by dissolving 150g ammonium acetate 
in water (900ml), adding 2ml of acetyl acetone, adjusting pH to 
6.0 with glacial acetic acid and finally making up to one litre 
with water.
5.2.9• The Detection of mutagenic metabolites of benzo(a)pyrene 
using the Ames test
Ames testing using the preincubation variant method of Ames ejfc al. 
(1975) was carried out. Salmonella typhimurium strain TA 100
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was used as the test strain. This is a histidine requiring 
mutant which can be reverted to wild type by the active forms 
of many mutagens, including benzo(a)pyrene. This enables the 
ability of an enzyme system to produce reactive metabolites of 
promutagens to be estimated from the number of reversions, which 
can be counted as colonies on plates of minimal medium. These 
plates contain trace amounts of histidine and biotin sufficient 
for only a couple of divisions of the auxotroph, which is often 
necessary before mutations can occur. The activation system 
tested consisted of partially purified yeast cytochrome P-4-4-8, 
NADPH:cytochrome P-4-50(c) reductase and dilauroylphosphatidyl- 
choline (1 nmolrl unit:30^ig). Benzo (a )pyrene was used at a 
concentration of 4.0jjig/plate, and was substituted by an equal 
volume of solvent (dimethylformamide) in blank plates, to enable 
an estimate of the spontaneous mutation rate. Also ’buffer 
controls1 in which buffer replaces the activation system were 
run to see if the activating system affects the spontaneous 
mutation rate or the viability of the bacteria. The activating 
system, bacteria, benzo(a)pyrene and NADPH (5mM) were incubated 
at 37°C for 4.5 or 90 minutes followed by addition of agar, 
mixing and pouring over minimal agar plates. Plates are incub­
ated for 4-8 hours at 37°C to allow colonies to develop.
Viability of bacteria was estimated by removing a lOOjil sample 
at the end of the incubation period, diluting with nutrient 
broth (xlO ) and plated out onto agar plates supplemented with 
histidine and biotin to allow all bacteria present to grow.
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5.2.10 Materials
Snail gut enzyme was obtained from Pharmindustrie, Clichy, France. 
Biphenyl was obtained from BDH Chemicals Ltd., Poole, Dorset and 
recrystallised from 96$ ethanol. 2- and /-hydroxybiphenyls 
were also obtained from BDH Chemicals and recrystallised from 
petroleum spirit (100-120° b.p.). Aniline and p-aminophenol 
were from the Eastman Chemical Co. and pyrimidine compounds were 
from May & Baker Ltd., Dagenham, Essex. Other chemicals were 
obtained from sources already described.
5*3. Results and Discussion
5.3*1. The metabolism of benzo (a )pyrene by the cytochrome P-4-4-8 
dependent monooxygenase system of Saccharomyces cerevisiae
The hydroxylation of bnezo(a)pyrene by the yeast microsomal 
monooxygenase system has been described in chapter 3. The 
components necessary for benzo(a)pyrene hydroxylase activity 
were examined in a series of reconstitution experiments with 
the purified components (table 5.1.). Full benzo(a)pyrene 
hydroxylase activity was obtained wity a reconstituted system 
of purified cytochrome P-4-4-8, purified NADPH: cytochrome P-4-50 
(c) reductase and dilauroylphosphatidylcholine. The omission 
of cytochrome P-4-4-8 or NADPH: cytochrome P-4-50(c) reductase 
results in only a small residual rate of hydroxylation being 
observed, showing that these two protein components are both 
necessary for brnzo(a)pyrene hydroxylase activity. The omission 
of the NADPH generating system also largely abolishes the 
activity. A partial lipid requirement is also seen with the
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- —  . ' " . ................... v (pmol 3-hydroxybenzo- 
(a)pyrene/h/nmol P-44-8)
Full .System
Full system (dilauroylphosphatidyl- 
choline replaced by emulgen 911 (0.1
Full system minus cytochrome P-4-4-8
Full system minus NADPH:cytochrome 
P-4-50(c) reductase
Full system minus NADPH generating 
system
Full system minus lipid (no emulgen)
138
14-2
%)
10
13
2 J, 
75
Table 5«1« Reconstitution of hydroxylase activity of 
purified yeast cytochrome P-4-4-8 using benzo(a)pyrene 
(80pM) as substrate. The full system contains 1 nmole/ml 
cytochrome P-4-4-8, 1 unit/ml NADPH: cytochrome P-4-50(c) 
reductase and 30pg/ml dilauroylphosphatidylcholine, and 
the reaction was. activated by adding an.NADPH generating 
system.
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activity being decreased to approx half of the full rate of 
hdyroxylation by the omission of a phospholipid component.
This requirement for phospholipid can also be fulfilled by the 
non-ionic detergent emulgen 911 suggesting a structural role 
for phospholipid, perhaps in associating the two enzymic com­
ponents together. These results confirm those of Azari &
Wiseman (1982a) and show that benzo(a)pyrene hydroxylase is a 
cytochrome P-4-4-8 dependent activity in jS. cerevisiae with the 
components of the electron transport chain similar to those 
of mammalian liver microsomal monooxygenase activities.
The apparent kinetics of the purified reconstituted cytochrome 
P-4-4-8 dependent monooxygenase system were determined using a 
Lineweaver-Burk plot. The apparent Km was found to be 33^M 
and the Vrnax-208 pmoles 3-hydroxybenzo(a)pyrene/hour/nmole 
cytochrome P-4-4-8 (table 5.2.). This value for the Km is 
similar to the value of 23f*M reported for uninduced rat liver 
enzyme by Rickert & Fouts (1970), although the rate of the yeast 
enzyme is low compared to that from rat liver. When the kinetics 
of the purified reconstituted enzyme system are compared with 
those of the enzyme in microsomal form (chapter 3)> it can be 
seen that the Km is greatly improved on purification, from 
llluM to 33f*M. This may be attributable to diffusional problems 
with the ’immobilised1 enzyme system in microsomal fraction.
Table 5-2. also shows that the NADPH requirement of yeast 
benzo(a)pyrene hydroxylase could be replaced by cumene hydro­
peroxide or a glucose/glucose oxidase system generating hydrogen 
peroxide in situ. The replacement of the NADPH requirement of
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•
Km
(pM)
Vmax (pmol/h/ 
nmole P-4-4-8)
NADPH supported 33 208
Cumene hydroperoxide 125 329
Hydrogen peroxide 
(in situ)
200 506
Table 5.2. Benzo(a)pyrene hydroxylase activity of yeast 
cytochrome P-4-4-8 in a reconstituted system. The reconstituted 
system was as described in materials and methods. Benzo(a)- 
pyrene used in the range 0-l60pM.
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mammalian cytochrome P-450 enzymes by peroxides is well known 
(chapter 1). These compounds donate electrons and oxygen 
directly to the cytochrome, hence bypassing the reductase enzyme 
and removing the requirement for NADPH and molecular oxygen.
Both of these artificial electron donor systems gave higher 
Vmax values for the reaction. However, the affinity of the 
enzyme for benzo(a)pyrene was lowered as measured by an increased 
Km value. In both the cumene hydroperoxide and hydrogen peroxide 
supported systems, the production of 3-hydroxybenzo(a)pyrene 
is accompanied by an increased production of a fluorescent peak 
at 54-Onm. The 54-Onm peak is identified as a mixture of benzo- 
(a)pyrene metabolites including phenols, diols and quinones 
(Rho, 1980). Therefore the pattern of metabolites produced 
by the peroxide supported reactions is probably somewhat different 
from the NADPH supported case. This agrees with results obtained 
using cytochrome P-450 of phenobarbital pretreated rats, 
described by Renneberg at al.. (1981). These authors reported 
that the production of quinones from peroxide supported systems 
was much higher than the production of these metabolites in 
the NADPH supported case.
The optimal temperature for benzo(a)pyrene hydroxylase was the 
same for all three systems with yeast cytochrome P-44-8 at approx 
37°C, although the in situ hydrogen peroxide supported system 
had a better rate at slightly higher pH than the optimal pH 
for the cumene hydroperoxide and NADPH supported cases, which 
was at pH 6.5-7.
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Table 5.3» compares the values of the Km for benzo(a)pyrene with 
the spectral dissociation constant, Ks, as determined in chapter
4. The purified enzyme gives a very good agreement between Km 
and Ks. The small difference observed is probably a reflection 
of the complexity of the multicomponent benzo(a)pyrene hydroxy­
lase system. The agreement in these values is fortuitous as 
Ks is obtained from spectral changes which are determined for 
the ferric protein in the absence of reducing equivalents, 
whereas Km is obtained from an actively metabolizing system.
Only if substrate dissociation is far from rate limiting is a 
comparison between Ks and Km valid. A larger difference is 
observed with microsomal enzyme with a Km of I I I jaM and a Ks 
of 18pM.
5.3*2. The Detection of- Mutagenic Metabolites of Benzo(a)pyrene
using the Ames- test after Activation with Yeast Cytochrome 
P - U 8
The ability of yeast cytochrome P-44-8 to produce mutagenic 
metabolites of benzo(a)pyrene was examined using the Ames test. 
Initial experiments with partially pure cytochrome P.-448 and 
reductase from uninduced yeast resulted in no increase in reversion 
rate of the bacteria above the spontaneous rate. In an attempt 
to increase the rate of benzo(a)pyrene activation, preparations 
of partially pure enzyme from yeast induced with benzo(a)pyrene, 
highly active in benzo(a)pyrene metabolism (as described in 
chapter 3) were made and used to activate benzo(a)pyrene in the 
Ames test.
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• Michaelis 
constant, Km 
(pM)
Spectral 
dissociation 
constant, Ks (pM).
Microsomal 111 18
cytochrome P-4-4-8
Purified 33 50
cytochrome P-4-4-8
Table 5«3^ Comparison of Michaelis constants and spectral 
dissociation constants for the interaction of benzo(a)pyrene 
with yeast cytochrome P-4-4-8 in microsomal and highly purified 
forms. Km values were determined from Lineweaver-Burk plots 
as described in chapter 3. Ks values were determined from 
double-reciprocal plots as described in chapter 4-*
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Table 5.4-- shows the results of two runs of the Ames test with 
partially pure benzo(a)pyrene induced cytochrome P-4-48 from
S. cerevisiae. As can be seen, the results were not very clear 
cut as a doubling of mutation rate is usually required before 
activation can be said to have occurred. The addition of the 
enzyme system itself (no benzo(a)pyrene added ) resulted in an 
increase in reversion rate above that of the buffer controls, and 
the addition of benzo(a)pyrene gave only a small increase above 
this rate. These results suggest that some activation of benzo- 
(a)pyrene is occurring, although this is on the lower limit of 
detection. The high levels of reversion caused by the enzyme 
system alone suggest that some of the benzo(a)pyrene used to 
induce the enzyme may still be present, possibly bound to the 
enzyme, hence' giving a high rate of reversion due to the active 
metabolites produced from this bound benzo(a)pyrene when a source 
of reducing equivalents is available.
The activation of carcinogens such as benzo(a)pyrene is known 
to occur through cytochrome P-4-4-8 type activities in mammalian 
tissues whereas cytochrome P-4-50 type activities tend to detoxify 
rather than activate carcinogens (Levin _et al., 1977; Yang ejfc al. ,
1978). The major active carcinogenic metabolite of benzo(a)pyrene 
is benzo(a)pyrene-7,8-dihydrodiol-9>10-epoxide, and this is one
of the major products responsible for its mutagenicity in the 
Ames test (Wood et. al., 1976; Wislocki _et al., 1975). The major 
products of benzo(a)pyrene hydroxylase activity in S. cerevisiae 
resemble those produced by mammalian cytochrome P-4-4-8 forms and 
include 7,8-dihydro-7,8-dihydroxybenzo(a)pyrene, an intermediate 
in the formation of the active diol-epoxide (Wiseman & Woods,
1979). Therefore this enzyme is expected to give a positive
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(A) Ames test with 90 minute preincubation
Viability
Counts Assay Counts
Buffer control+dimethylformamide 
it + benzo(a)pyrene 
Complete system+dimethylformamide 
tt +benzo(a)pyrene
25,38
27,30
14,10
11,24'
mean
32
29
12*
17*
. .al
100, 84, 95 
97,116, 98 
171, 99,131 
216,189,162
mean
.93
104
134
189
* some killing of bacteria by residual detergent in 
enzyme preparation
(B) Ames test with 45 and 90 minute preincubation
Viability
Counts Assay Counts
Buffer control+dimethylformamide 3, 7
mean 
1 5 50, 71, 76
mean
66
t +benzo(a)pyrene 10,15 13 62, 44, 82 63
Complete system+dimethylformamide
(45f)
12,12 12 97,104,111 104
+benzo(a)pyrene
(45’)
6,20 13 134,109,107 115
„ +dimethylformamide
(90')
8, 8 8 112, 82 98 97
n +benzo(aJpyrene
(90')
9,18 14 151,147,100 135
Table 5»4» Ames testing of benzo(a)pyrene with an activation 
system of partially purified yeast cytochrome P-448. 
Experimental details as in materials and methods. Count values 
are number of histidine revertants per plate. Viability counts 
are of a 10 dilution and therefore the number of viable 
bacteria applied to each plate is the viability count xlO^ .
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result in this Ames test system, as has been shown for cytochrome 
P-44.8 from 3-methylcholanthrene pretreated animals, but not for 
cytochrome P-4-50 from phenobarbital pretreated animals (Ioannides 
et al., 1981). The low level of activation of benzo(a)pyrene 
seen compared to that from mammalian cytochrome P-4-4-8 is probably 
due to the low turnover of the yeast enzyme compared to that from 
mammalian liver.
5.3.3* The Attempted Hydroxylation of Biphenyl
Hydroxylation of biphenyl by the monooxygenase system from S. 
cerevisiae- was first investigated using a general spectrophoto- 
metric assay for the detection of phenolic compounds. This 
method measures the production of a red complex between the 
phenol produced, ferric chloride and methanolic 2,2f-dipyridyl 
and was developed from the thin layer chromatography spray of 
Barton (1965) as described in materials and methods.
Standard curves with 2- and 4--hydroxybiphenyls gave identical
-1 -1colour yields, the extinction coefficient being 32mM cm 
(figure 5*1*)* The presence of biphenyl did not affect colour 
yield and although this method could not separate the phenolic 
products, it was hoped that an estimate of the total level of 
phenolic metabolites of biphenyl could be made.
Repeated assays on yeast microsomal fraction showed no production 
of biphenyl metabolites with incubation times up to two hours.
The assay was also attempted using whole yeast, spheroplasts, 
whole disruptate and 10,000g supernatant from yeast. In all
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cases, no phenols were detected. As tween 80 (used for dissolving 
biphenyl) may inhibit biphenyl hydroxylase (Burke & Bridges, 1975) 
and the biphenyl solvent is known to be important in the rate of 
metabolism (Haugen, 1981), methanol was also tried as a solvent 
for biphenyl. However, still no metabolites were detected.
Raising the cytochrome P-450 concentration to 2 nmoles/ml made 
no difference.
This assay was also attempted on rat liver microsomal fraction at 
37°C, and again no hydroxybiphenyls could be detected. This 
was surprising as rat liver microsomal fraction is known to be 
active in biphenyl hydroxylation (Creaven .et al., 1965). It 
seemed therefore that this method was not sensitive enough to 
detect any phenols produced. The practical lower limit of 
sensitivity of this assay is approx. 50mM phenol (absorbance = 
0.10) or in the 0.4ml sample volume used in this assay,
20 nmoles of phenol. Under the conditions used, rat liver 
microsomal fraction would be expected to produce a combined 
rate of hydroxylation of approx. 2 nmoles/min/nmole cytochrome 
P-450 see work reported below). For typical values used in 
this assay, i.e. a 1 hour incubation at 1 nmole/ml cytochome- 
P-450 in a 10ml reaction volume, approx. 120 nmoles of phenol 
would be expected to be produced, or 5 nmoles in a 0.4ml sample 
volume. This method is therefore just not sensitive enough to 
detect biphenyl metabolites in this system.
The fluorimetric assay for biphenyl hydroxylation of Creaven 
et' -aT. (1965) was then used for further studies, as this method 
provides a fairly sensitive assay for 4- and 2-hydroxybiphenyl.
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Any 3-hydroxybiphenyl being produced is detected in the 2-hydroxy- 
biphenyl peak as this method cannot distinguish between these 
two isomers.
By this method, biphenyl hydroxylation was demonstrated in rat 
liver microsomal preparations, the rate being shown in table
5.5.. No biphenyl hydroxylation could be detected in whole 
yeast or from any subcellular fraction of vibro-mill disrupted 
yeast, including 10,000g supernatant and microsomal fraction, 
although these contained cytochrome P-450 as determined spectro- 
photometrically. No activity could be detected with solubilized 
yeast cytochrome P-448, nor in a reconstituted system of purified 
yeast cytochrome P-448 which was capable of benzo(a)pyrene 
hydroxylation. However, spheroplasts prepared from yeast cells 
using snail gut enzyme did show a consistent rate of biphenyl 
hydroxylation. Both 4- and 2-hydroxybiphenyls were produced at 
rates shown in table 5*5**
All detectable biphenyl hydroxylase activity was lost on disruption 
of the spheroplasts by gentle sonication, with no activity being 
detected in any subcellular fraction prepared from disrupted 
spheroplasts. The reason for this is not known, although there 
are several possibilities. The enzyme responsible for biphenyl 
hydroxylation may be highly labile, and lost during sonication 
of the spheroplasts, or the enzyme may be located at the plasma 
membrane of the cell, requiring an intact membrane for activity.
In the second respect it is interesting that Stasiecki _et al.
(1980) have shown that the plasma membrane of mammalian liver 
cells contains monooxygenase activity and cytochrome P-450
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■
4-hydroxybiphenyl 
(nmol/min/nmol P-450)
2-hydroxybiphenyl 
(nmol/min/nmol P-450)
. j
Liver microsomal 
fraction (uninduced)
1.46+0.06 0.19+0.02
Yeast spheroplasts 1 1.21+0.26 0.60+0.28
2 1.41+0.29 0.79+0.22
3 0.81+0.34 0.25+0.08
4 1.24+0.25 0.04+0.05
5 0.86+0.27 0.45+0.16
6 1.23+0.14 0.66+0.27
Average result for 
yeast spheroplasts
1.13+0.20 0.47+0.20
Table 5*5. Biphenyl hydroxylation by liver microsomal 
fraction and yeast spheroplasts. Values are the mean of 
4 determinations, + standard deviation.
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levels up to 30% of microsomal levels. The reason why 
spheroolasts showed activity whilst whole yeast cells did not 
is probably due to either biphenyl or its metabolites being 
unable to enter or leave the intact cell.
Attempts to induce yeast biphenyl hydroxylase activity by growing 
the yeast in medium containing 0.1$ (w/v) biphenyl were unsuccess' 
ful as the same rate of biphenyl hydroxylation was observed in 
these spheroplasts as in the uninduced case. Yeast growth was 
not affected by this concentration of biphenyl.
The level of yeast spheroplast biphenyl hydroxylation reported 
here is almost the same as. for uninduced rat liver microsomal 
fraction when compared on a cytochrome P-450 content basis 
(table 5*5*). However, although cytochrome P-450 enzymes are 
established as the enzymes responsible for biphenyl hydroxylation 
in rat liver microsomal fraction, the involvement of cytochrome 
P-450 enzymes in biphenyl hydroxylase of yeast is not certain.
The results presented here seem to suggest that cytochrome P-450 
enzymes are not involved in yeast, as no activity could be 
detected with yeast fractions containing cytochrome P-450 nor 
with the purified reconstituted system.. However, it is possible 
that a small sub-population of cytochrome P-450 which is highly 
labile, is responsible for this activity.
Previous work on biphenyl hydroxylase of the yeast S. cerevisiae 
has been contradictory. Wiseman et al. (1975b) reported 
biphenyl hydroxylase activity from vibro-milled yeast microsomal 
fraction. However, this work was contradicted by Woods (1979)
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who could find no biphenyl hydroxylase activity in microsomal 
fraction from S. cerevisiae, although several different detection 
methods were used. Spheroplasts were not studied by either of 
these workers. Dodge ejt . al. (1979) could detect only trace 
production of 2- and 4-hydroxybiphenyls after growing yeast in 
the presence of biphenyl. Smith ejt al. (1980) were also unable 
to detect metabolites of biphenyl after growing S. cerevisiae 
in biphenyl containing meduim.
The results reported here refute those of Wiseman _et al. (1975b) 
but support those of Woods (1979)> Dodge e_t al. (I979):and 
Smith et al* (1980). It is interesting that Dodge _et al. (1979) 
detected a highly active biphenyl hydroxylase in the fungus 
Cunninghamella elegans but were unable to detect any activity 
in a microsomal fraction from this organism. However, the 
same microsomal fraction contained a cytochrome P-4-50 and could 
hydroxylate naphthalene and benzo(a)pyrene. This is similar to 
the case with S. cerevisiae where a microsomal fraction capable 
of benzo(a)pyrene hydroxylation is unable, to hydroxylate biphenyl, 
although some activity is detected in spheroplasts.
A recent report by K&renlampi & Hynninen (1981b) has demonstrated 
that S. cerevisiae can produce benzoic acid from biphenyl and 
that hydroxylated biphenyl intermediates could not be detected, 
although equivocal results with the fluorimetric biphenyl 
hydroxylase assay (used in the experiments above) were obtained. 
These workers suggested that biphenyl might be rapidly degraded 
to benzoic acid or that the intermediates between biphenyl and 
benzoic acid might decompose during sample preparation, in either
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case rendering the detection of hydroxylated biphenyls difficult. 
Another possibility, suggested by the work above, might be that 
it is diffucult for hydroxybiphenyls to leave the complete cell 
which was used in the experiments by these workers.
5-3-4-. Attempted Hydroxyl at ion of 2, 4--diamino-6~methylpyrimidine
Extensive attempts were made to detect hydroxylation of 
2,4--diamino-6-methylpyrimidine by yeast fractions. The method 
used was devised to exploit the difference in the absorption 
spectra of 2,4.-diamino-6-methylpyrimidine and the hydroxylated 
derivative 2,4.-diamino-5-hydroxy-6-methylpyrimidine (figure 5-2.). 
These spectra were pH dependent and so a constant pH (pH 7.0) 
was used. As can be seen from figure 5. 2., 2,4--diamino-6- 
methylpyrimidine absorbs.maximally at 278nm at pH 7 whereas the 
hydroxylated compound absorbs maximally at 282nm at pH 7, and 
at 300nm there is absorption by the hydroxylated compound but 
very little by 2,4--diamino-6-methyl-pyrimidine. It was therefore 
hoped to follow the production of the hydroxylated compound at 
300nm. Repetitive scanning of an incubation mixture containing 
yeast 10,000g supernatant or microsomes showed an increase in 
absorbance at 300nm and also a larger increase at 34-Onm. However 
further study revealed that the increase in absorbance at 300nm 
was unreliable and no reproducible results could be obtained.
The increase at 34-Onm was found to be due to a differential rate 
of loss of NADPH between the reference and the sample cuvette, 
with NADPH being lost faster in the reference cuvette, hence 
causing an apparent increase in absorbance at 34-Onm. This 
apparent increase could be prevented by the addition of an 
NADPH regenerating system to the reference cuvette.
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Figure 5.2. Spectra of 2 r 4-“diamino-6-methylpyrimidine 
and 2,4.-diamino-5-hydroxy-6-methylpyrimidine (B)
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Attempts to devise a discontinuous assay system were also 
unsuccessful. This attempted to make use of the even larger 
differences in the spectra of these two compounds at very 
alkaline pH, where 2, 4--diamino-6-methylpyrimidine has an 
absorption maximum at 282nm and 2,4.-diamino-5-hydroxy-6-methyl- 
pyrimidine at 320nm.. Therefore after incubation of substrate, 
NADPH and enzyme fractions for various times, the reaction 
was stopped and protein precipitated using 10$ trichloroacetic 
acid. The incubation mixture pH was then adjusted to pH 12-13 
using concentrated sodium hydroxide (10M) and the absorbance 
at 320nm measured. An increase in with time of incubation
was found but this was later shown to be non-enzymic.
5.3*5. Attempted Hydroxylation of Other Compounds with 
Yeast Cytochrome P-44-8
In an attempt to further define the substrate specificity of 
yeast cytochrome P-4-4-8> several other known substrates of 
mammalian cytochrome P-4-50 enzymes were tested for metabolism 
with yeast enzyme in a purified reconstituted system of cytochrome 
P-4-4-8 (1 nmole/ml), NADPH:cytochrome P-450(c) reductase 
(1 unit/ml) and dilauroylphosphatidylcholine (30fig/ml).
Aniline is a well characterized substrate of rat liver cytochrome 
P-450 and has been reported to be hydroxylated by cytochrome 
P-448 from S.' cerevisiae (Yoshida et al. , 1977). Also this 
compound binds to yeast cytochrome P-44-8 with a very high 
affinity to give a type II spectral interaction (chapter 4). 
However, no hydroxylation of this compound could be detected.
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Ethoxyresorufin-O-deethylase is a .well characterized substrate 
of rat liver cytochrome P-4-4-8, induced for example by 3-methyl- 
cholanthrene or benzo(a)pyrene. However, no activity could be 
detected with this compound and a yeast cytochrome P-4-4-8 
reconstituted monooxygenase system. A sample of benzo(a)pyrene 
induced yeast microsomal fraction with very high activity 
toward benzo(a)pyrene hydroxylation was also unable to show 
any activity towards ethoxyresorufin-O-deethylation.
Cytochrome P-4-50 catalyzed N-demethylation is a well character­
ized activity of mammalian microsomal enzymes. The N-demethyl- 
ation of aminopyrine by yeast cytochrome P-4-50 has been reported 
by Yoshida e_t al.' (1977) and more recently by Sauer ejt al.
(1982). Aminopyrine, benzphetamine, ethylmorphine and dimethyl­
nitrosamine were all tested for N-demethylase activity with a 
yeast cytochrome P-4-4-8 purified system. No metabolism of any 
of these compounds could be detected (although:equivocal results 
were obtained with dimethylnitrosamine) even though dimethyl- 
nitrosamine and ethylmorphine give rise to type I binding 
spectra with the yeast enzyme and benzphetamine a type II binding 
spectrum (chapter 4-)* Dimethylnitrosamine has been reported 
to be activated to an active mutagen by _S. cerevisiae cells 
containing cytochrome P-4-50 (Callen & Philpot, 1977). It 
should be noted that the technique used here measures formalde­
hyde production with the Nash reagent. This is not a very 
sensitive technique and a low rate of metabolism may go 
undetected.
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Lanosterol also binds to yeast cytochrome P-4-4-8 with high 
affinity producing a type I binding spectrum, indicative of 
an enzyme-substrate interaction (chapter 4-)* Aoyama & Yoshida 
(1978a; 1978b) have shown that a reconstituted purified cytochrome 
P-4-4-8 monooxygenase system from baker’s yeast is capable of 
lanosterol 14.a-demethylation using a sensitive radiometric 
technique. An attempt was made to detect the metabolism of 
lanosterol by the purified reconstituted yeast cytochrome P-4-4-8 
system using the rather insensitive Nash assay. However, no 
detectable rate of demethylation was observed, probably due to 
the relatively low sensitivity of this method.
5.3*6. The Inhibition of Yeast Benzo(a)pyrene Hydroxylase
Benzo(a)pyrene hydroxylase activity of the purified yeast 
monooxygenase system was inhibited by compounds which bind to 
cytochrome P-4-4-8 as shown in table 5*6.. Large differences 
were found in the extent of inhibition by these compounds which 
were added at concentrations sufficient to cause saturation of 
binding (except for lanosterol, due to solubility reasons, arid 
phenobarbital). Lanosterol and dimethylnitrosamine both result 
in a high degree of inhibition of benzo(a)pyrene hydroxylase.
These compounds both give rise to type I binding spectra with 
purified yeast cytochrome P-4-4-8 with Ks values of 80jaM and.
220|aM respectively, suggesting that these compounds bind at c 
the active site of the. enzyme, and thus would be expected to 
inhibit benzo(a)pyrene hydroxylase activity. The inhibition 
of benzo(a)pyrene hydroxylase by cytochrome P-4-4-8 binding 
compounds is further evidence for the cytochrome P-4-4-8 dependent 
nature of this enzymic activity.
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3
Concentration 
of inhibitor
jbenzo(a)pyrene 
hydroxylase 
activity
spectral 
dissociation 
constant, Ks
None - 100 -
Dimethylnitrosamine 2. 5mM 50 220j*M
Lanosterol 77^M 55 80|*M
Ethylmorphine 1.25mM 73 166j*M
Phenobarbital 77j*M 80 6 6 jaM
Perhydrofluorene lOmM 0* -
Aniline 0. 5mM 78 5pM
Imidazole ImM 79 8 | aM
Benzphetamine 20mM 81 1.66mM
* perhydrofluorene resulted in total inhibition of activity 
but it was later found that this compound destroyed the 
cytochrome P-4-50 present
Table 5.6. Inhibition of yeast benzo(a)pyrene hydroxylase 
by compounds binding to yeast cytochrome P-4-4-8. Experiments 
carried out at 80jaM benzo (a)pyrene.
(222)
Mammalian cytochrome P-4-48 activities are inhibited to a large 
extent by 9-hydroxyellipticine (Delaforge _et al. , 1980) but 
this compound showed no inhibition of the benzo(a)pyrene 
hydroxylase activity of the yeast purified enzyme system.
The interaction of flavonoid compounds with benzo(a)pyrene 
hydroxylase from mammalian hepatic tissue has been studied 
by Huang et al. (1981a; 1981b). These workers found that flavone 
stimulated the benzo(a)pyrene hydroxylase activity of rabbit 
liver isozymes cytochrome P-4-50 LM 3c or LM 4- .yet inhibited the 
same activity when cytochrome P-4-50 LM 2, LM 3b or LM 6 was 
used. In addition, 7,8-benzoflavone stimulated benzo(a)pyrene 
hydroxylase activity of cytochrome P-4-50 LM 3c yet inhibited 
cytochrome P-4-50 LM 6.
Flavone and 7,8-benzoflavone were tested for their effect on 
the yeast cytochrome P-4-4-8 dependent benzo (a )pyrene hydroxylase 
system, and both compounds were found to strongly inhibit the 
activity of this system (table 5.7.). 7,8-benzoflavone is a
more potent inhibitor than flavone. Double reciprocal plots 
of initial velocity against benzo(a)pyrene concentration at 
various concentrations of 7,8-benzoflavone show that the Km 
for benzo(aJpyrene is unchanged in the presence of 7,8-benzo- 
flavone whereas the Vmax is decreased (figure 5*3*)> showing 
that 7,8-benzoflavone inhibition of this activity is non­
competitive. The inhibition constant, Ki, was calculated 
from the double reciprocal plot using the known value for 
Vmax of the enzyme without inhibitor present, and was found to 
be 176jaM.
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Compound added
Concentration required 
, for 50$ inhibition
Flavone
7,8-benzoflavone
600 jaM
176jaM
Table 5-7. Inhibition of benzo(a)pyrene hydroxylase from 
yeast with flavonoid compounds. Benzo(a)pyrene was used 
at 80jaM. Other experimental details as in materials and 
methods.
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1/V (pmol/h/nmol P-4-50)
Figure 5»3« Lineweaver-Burk plots of purified 
benzo(a)pyrene hydroxylase; control and in the 
presence of 300jaM 7,8-benzoflavone.
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The difference between rabbit liver cytochrome P-4-50 LM 4-> 
the major cytochrome P-4-4-8 form of the rabbit liver enzyme, 
and the yeast cytochrome P-44-8 is shown by the different 
effects of flavonoid compounds on the benzo(a)pyrene hydroxylas 
activity of these systems. In this respect, yeast cytochrome 
P-4-4-8 appears to resemble cytochrome P-4-50 LM 6, another 
cytochrome P-4-4-8 form which is produced in rabbit liver after 
induction with 2,3>7,8-tetrachlorodibenzo-p-dioxin (TCDD), 
particularly in neonatal rabbits (Norman et al., 1978).
For further discussion of these results see chapter 7.
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CHAPTER 6
STUDIES ON THE THERMAL STABILITY OF 
CYTOCHROME P-4-50 FROM SACCHAROMYCES CEREVISIAE
(227)
6.1. Introduction
Cytochrome P-4-50 enzymes are integral membrane proteins and 
several studies have shown that these enzymes are more stable 
when in the microsomal membrane than when they are solubilized 
using detergents. Bachmanova <et al. (1981) showed that cytochrome 
P-4-50 from rabbit liver was more stable towards thermal and 
proteolytic inactivation when membrane bound in the form of 
microsomes than when solubilized. The incorporation of the 
solubilized enzyme into liposomal membranes restored the 
stability of this enzyme to almost the same level as in micro­
somal membranes. The stability was therefore shown to be 
dependent on the phospholipid environment of the protein.
These workers also demonstrated that the reduced form of 
cytochrome P-4-50 is far less stable than the oxidized form.
It was later shown that the increase in stability of solubilized 
cytochrome P-4-50 on incorporation into a phospholipid bilayer 
is not due to an increase in the a-helical content of the 
protein, but to an increase in tigidity which was observed 
using circular dichroism spectroscopy (Archakov ejb ad.., 1981).
This increased stability of the enzyme when membrane bound leads 
to an increase in the enzymic life-time of hydroxylation reactions 
by this enzyme (Archakov, 1982).
Many stabilizing agents of cytochrome P-4-50 enzymes have been 
studied and several of these are routinely used during solubil­
ization and purification of these enzymes (Sato & Omura, 1978). 
Glycerol and other polyol compounds are widely used for the 
stabilization of cytochrome P-4-50 enzymes. The protective
(228)
role of glycerol is thought to be due to the protection of the 
hydrophobic environment of the protein, through its effect on 
the structure of water (Back jet al. , 1979)- The ability of 
glycerol to stabilize cytochrome P-4-50 from rabbit liver micro- 
somes has recently been studied by Metelitza et al. (1982).
These workers demonstrated a linear relationship between the 
rate of thermal inactivation of the enzyme and the glycerol 
concentration present. This effect was also assigned to the 
protection of hydrophobic groups of the protein.
Wiseman _et al> (1975b) demonstrated that reduced cytochrome 
P-4-50 from rat liver microsomes or yeast microsomes was less 
stable towards thermal denaturation than the oxidized form, as 
was later described for cytochrome P-4-50 from rabbit liver by 
Bachmanova jet al. (1981). Wiseman jet al. (1975b) also demonstr­
ated that cytochrome P-4-50 in yeast microsomal fraction was 
less stable towards thermal denaturation than that in rabbit 
liver microsomal fraction. The relative instability of the 
yeast enzyme was also described by Azari & Wiseman (1980).
These workers used triton X-100 as a stabilizer for yeast cyto­
chrome P-4-50 during its solubilization from the microsomal 
membrane. This stabilization was attributed to the protection 
of hydrophobic regions of the enzyme and also in part due to a 
conversion of the spin-state of the protein from high to low 
spin. Agents such as sulphydryl reagents and high ionic strength 
cause a spin-state change from low to high spin and also prompt 
the inactivation of cytochrome P-450 by destroying or removing 
the sulphydryl ligand of the haem group (Murakami & Mason,
1967; Yoshida & Kumaoka, 1972).. This suggests that triton
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X-100, which changes the spin-state of cytochrome P-4-50 from 
high to low spin (Tamura et al., 1976) and retains it in the 
low spin form, may protect the sulphydryl ligand of the cytoe. 
chrome P-4-50 haem group, thus stabilizing the enzyme.
In this chapter, studies on the relative stability of cytochrome 
P-4-4.8 from Sac char omyces cerevisiae in microsomal, solubilized 
and highly purified forms are described. Also the effects of 
benzo(a)pyrene and triton X-100 on the stability of the 
solubilized enzyme are examined and the use of fluorescence of 
the protein as a means of studying stability is evaluated.
6.2. Materials and Methods
6.2.1. Thermal Stability Experiments
The thermal stability of yeast cytochrome P-4-50 or benzo (a)- 
pyrene hydroxylase was studied using enzyme samples of different 
degrees of purification prepared as previously described.
Enzyme samples were divided into aliquots and incubated (in 
duplicate) at a range of temperature points (0-75°C) for five 
minutes. The samples were then cooled to room temperature 
(22°C) and the level of cytochrome P-4-50 or the benzo (a )pyrene 
hydroxylase activity determined as quickly as possible using 
methods already described. All samples were in O.iM phosphate 
buffer pH 7.2, containing 20$ glycerol, ImM dithiothreitol and 
ImM EDTA. When benzo(a)pyrene was used as a stabilizing agent, 
no further benzo(a)pyrene was added in the benzo(a)pyrene 
hydroxylase activity assay.
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6.2.2. Fluorescence measurements
Fluorescence spectra were recorded using a Perkin-Elmer MPF 3 
fluorimeter. The intrinsic protein fluorescence of the samples 
due to their tryptophan content was measured at an excitation 
wavelength of 290nm and an emission wavelength of 330nm. 
Microsomal samples were highly quenched at high protein concen­
tration and were therefore diluted to the optimal value for 
fluorescence measurements of approx. 0.4-mg protein/ml (see 
results). The protein concentration in purified enzyme samples 
was not high enough, to cause any quenching of the protein 
fluorescence.
6.3. Results and.. ■Discussion
6.3.1* The Thermal Stability of Cytochrome P-4-50 from _S.
cerevisiae in Microsomal, Solubilized and highly 
Purified Forms
The thermal stability of oxidized yeast cytochrome P-4-50 was 
studied with the enzyme in microsomal, solubilized and highly 
purified forms (figure 6.1.). The enzyme in microsomal fraction 
is more stable than either solubilized or purified enzyme, with 
50$ of microsomal enzyme being lost at 50°C as opposed to '50$ 
of solubilized enzyme lost at 35°C and 50$ of purified enzyme 
lost at 4-l°C. This is as expected, the loss of the microsomal 
lipid membrane resulting in a decrease in the stability of 
this integral membrane protein, due to the exposure of the 
enzyme to the aqueous environment. It should be noted that
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Figure 6.1. Comparison of the thermal stability 
of cytochrome P-4-50 in microsomal (A), solubilized 
(B) and highly purified (C) forms. Protein contents 
were microsomal 6.5mg/ml, solubilized 30mg/ml, 
purified 50|Ag/ml. Cytochrome P-4-50 level was the 
same in all preparations (0.3nmol /ml).
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these enzyme preparations were used in buffer containing the 
stabilizer glycerol which has a marked protective effect on 
this enzyme, as is well known for mammalian cytochrome P-4-50 
enzymes. In the absence of glycerol, all of the yeast enzyme 
is lost during solubilization. The action of lipid in stabilizing 
cytochrome P-4-50 enzymes from mammalian sources is well known 
and has been studied widely. The.reconstitution of cytochrome 
P-450 enzymes into lipid bilayers has been shown to protect the 
conformation of the enzyme., leading to an increase in conform­
ational rigidity (Archakov, 1982). The incorporation of cyto­
chrome P-4-50 into vesicles prepared from microsomal lipids 
resulted in a more stable enzyme than when incorporated into 
vesicles prepared from other phospholipids (Uvarov at al., 1980).
When highly purified,, cytochrome P-4-50 (P-4-4-8) was more stable 
towards thermal denaturation than when only solubilized, even 
when studied at. a lower protein concentration. This may be 
due to the absence of ionic detergent (cholate) and the presence 
of a small residual amount of emulgen 911 used during purific­
ation, which may be firmly bound to the purified enzyme. Cholate 
is known to assist denaturation of cytochrome P-4-50 (Azari & 
Wiseman, 1980) and emulgen is thought to stabilize the enzyme, 
probably due to protecting hydrophobic regions from the aqueous 
environment (Azari & Wiseman, 1980). It is also possible that 
other substances which affect stability may be present in the 
solubilized preparation.
Figure 6.2. shows the stability of yeast microsomal cytochrome 
P-4-50 to incubation at 4-5°0. At this temperature, little of
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cytochrome P-4-50 at 4-5°C.
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the enzyme was lost after five minutes incubation, but then the 
enzyme was steadily lost until after 30 minutes no cytochrome 
P-4-50 could be detected. This result is consistent with that 
of Wiseman _et al. (1975b). These workers reported that the 
oxidized form of cytochrome P-4-50 from yeast was 50$ lost 
after approx. 8 minutes incubation at 4-6°C. This compares to 
approx. 13 minutes for 50$ loss of oxidized yeast microsomal 
cytochrome P-4.50 reported, here. The difference in these values 
is probably due. to two factors, the 1°C higher temperature used 
by Wiseman et alv, and the fact that in the experiments shown 
in figure 6.2., the buffer contained 20$ glycerol, ImM EDTA and 
ImM ditiothreitol, whereas the buffer used.by Wiseman et al. 
contained, no additives. In this case of microsomal enzyme, the 
glycerol and other additives do not have a dramatic effect on 
stability as is the case, for solubilized.enzyme (see above).
Wiseman et' al. (1975b) also reported that the yeast enzyme was 
much less stable to heating than that from rat liver. This was 
confimed by heating, a sample of both yeast and rat liver micro­
somal cytochrome P-4-50 (in glycerol containing buffer) to 50°C 
for five minutes. The. yeast enzyme was 50$ lost under these 
conditions whereas no detectable loss of the rat liver cytochrome 
occurred.
6.3*2. The Thermal Stability of Purified Reconstituted Cyto­
chrome P-4-4-8: /dependent Benzo.(a.)pyrene Hydroxylase Activity
Figure 6.3* shows the thermal stability of highly purified yeast 
cytochrome P-4-50 (P-^4-8) as in figure 6.1., compared to the
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Figure 6.3. Comparison of the thermal, stability 
of cytochrome P-4-4-8 and benzo (a)pyrene hydroxylase 
activity of the enzyme in highly purified form.
Benzo(a)pyrene hydroxylase activity was determined 
at 80^M benzo (a )pyrene., cytochrome P-4-4-8 level 
was originally 0.35nmoles/ml.
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thermal stability profile of the benzo(a)pyrene hydroxylase 
activity of the purified enzyme. After incubation at various 
temperatures, the cytochrome P-4-4-8 wa.s reconstituted with 
NADPH: cytochrome P-4-50(c) reducta.se. and dilauroylphosphatidyl- 
choline. fcr the. benzo(a.).pyrene hydroxylase assay. The thermal 
stability profiles of the cytochrome P-4-4-8 detected spectro- 
photometrically and-the benzo(a)pyrene hydroxylase activity 
are very similar. This correlation indicates that the cyto­
chrome P-4-4-8 component is probably the most labile component of 
the benzo.(a)pyrene hydroxylase system,.as the activity only 
goes down as the cytochrome. P-4-4-8 level decreases. This is 
further evidence for. the cytochrome P-4-4-8 dependent nature 
of this activity.
6.3.3. The Effect, of. B.enzo..(a)pyrene, and. Triton X-100 on the 
Thermal1 Stability of Solubilized:. Cytochrome P-4-50 
and its Benzo(a)pyrene Hydroxylase Activity
The effect of benzo(a)pyrene and triton X-100 on the thermal
stability of solubilized yeast cytochrome P-4-50 is shown in
figure 6.’4-.« The addition of 0.1$ (v/v) triton X-100 had
only a slight effect on the temperature at which 50$ of the
cytochrome P-4-50 was lost in a five minute incubation, yet
was successful in preventing 100$ loss of cytochrome P-4-50
o
in five minutes until an incubation temperature of 60 C was 
reached. Solubilized cytochrome P-4-4-8 was 100$ lost after. 5 
minutes incubation at 4-5°C when triton X-100 was present.
Triton X-100 was not able to return the stability of the enzyme
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Figure 6.J+. Thermal stability of solubilized yeast 
cytochrome P-4-50 in the presence of triton X-100 (0.1%) 
and benzo (a)pyrene (80|*M), 5 min. incubation at each 
temperature.
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to that of the enzyme in microsomal fraction. The addition 
of the substrate benzo (a )pyrene at a concentration of 80yuM 
had no significant effect on the thermal stability of the 
solubilized enzyme.
Although the thermal stability of cytochrome P-4-50 and benzo- 
(a)pyrene hydroxylase activity in solubilized form do not 
correspond as well as expected, the benzo(a)pyrene hydroxylase 
activity is also stabilized by 0.1$ (v/v) triton X-100 and 
not affected by 80jaM benzo (a )pyrene (figure 6.5.)* The reason 
for the disagreement between thermal stability of solubilized 
cytochrome P-450 and its benzo(a)pyrene hydroxylase activity 
is not known.
Triton X-100 is known to protect enzymes by protecting the 
hydrophobic regions (Takeda _et al. , 1972), and thus the 
stabilization of cytochrome P-450 by this compound may be due 
to substituting for lipid removed during solubilization and 
hence protecting the enzyme conformation. Triton X-100 also 
binds to cytochrome P-450 as a reverse type I substrate, 
modulating the spin state of cytochrome P-450 from high to 
low-spin (Tamura e^t al., 1976). Thiol reagents or high ionic 
strength cause a cytochrome P-450 spin state change from 
low to high-spin and also cause inactivation of this enzyme 
by destroying or removing the thiol (6th) ligand of the 
cytochrome P-450 haem group (Murakami & Mason, 1967; Yoshida 
& Kumaoka, 1972). Triton X-100 may therefore owe part of 
its stabilizing effect to keeping the enzyme in a low-spin 
state form and thus protecting the thiol ligand of the haem
s >
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Figure 6.5- Thermal stability of benzo(a)pyrene 
hydroxylase activity of solubilized yeast cytochrome 
P-4-50 in the presence of triton X-100 and benzo (a)pyrene 
(5 min incubation time at each temperature).
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group, which is required for both an active hydroxylating 
enzyme and the presence of the cytochrome P-4-50 spectral peak.
Benzo(a)pyrene gives rise to a type I binding interaction with 
yeast cytochrome P-4-50 and is a well characterized substrate 
for this enzyme. Thus benzo(a)pyrene modulates the spin-state 
of yeast cytochrome P-4-50 from low to high spin. In the 
converse effect to triton X-100, a destabilization of the 
enzyme is expected, but this is not observed. As a substrate, 
benzo(a)pyrene may result in some degree of conformational 
stabilization of the enzyme, as is well known for many other 
enzyme-substrate relationships (Wiseman., 1978). Therefore 
these two effects may cancel each other out to a large degree, 
and thus very little difference in thermal stability is seen 
in the presence and absence of benzo(a)pyrene.
6.3.4-* The Fluorescence of Yeast Cytochrome P-4-50 and its use 
to study Stability of the Enzyme
The fluorescence spectrum of highly purified yeast cytochrome 
P-4-50 (P-4-4-8) was recorded and is shown in figure 6.6.. The 
excitation spectrum of this protein was found to have a maximum 
at 285-290nm and the emission spectrum was found to have a 
maximum at 330nm when excited at 290nm. These spectra are 
characteristic of tryptophan residues in hydrophobic regions 
of the protein (Teale, I960). The amino acid analysis of this 
protein revealed 12 tryptophan residues and 15 tyrosine residues 
(M. Azari, personal communication). In proteins containing 
both tyrosine and tryptophan, it is usual to see only the
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Figure 6.6. Fluorescence spectrum of highly purified 
yeast cytochrome P-448. Cytochrome P-44-8 used at a 
concentration of 2nmol /ml.
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tryptophan fluorescence as that of tyrosine is quenched or the 
energy transferred to tryptophan in the native protein. Also, 
the emission maximum at 330nm instead of the normal tryptophan 
emission maximum at 34-5-350nm is indicative of a hydrophobic 
environment for the tryptophan residues in the protein (Teale, 
I960).
Wang & Kimura (1976) studied the fluorescence of partially 
purified adrenal mitochondrial cytochrome P-4-50 (cytochrome 
P-4-50scc). This cytochrome showed a fluorescent emission peak 
at 335nm when excited at 305nm and emission peaks at 305nm 
and 330nm when excited at 285nm. These workers attributed these 
spectra at 330nm to tryptophan residues buried in hydrophobic 
regions of the enzyme. Chiang & Coon (1979) studied two highly 
purified forms of cytochrome P-4-50 from rabbit liver microsomes, 
cytochrome P-4-50 LM 2 (induced by phenobarbital) and cytochrome 
P-4-50 LM 4- (a cytochrome P-4-4-8 induced by 3-methylcholanthrene). 
Although cytochrome P-4-50 LM 2 contains only 1-3 tryptophan 
residues and cytochrome P-4-50 LM 4- contains 7 tryptophan 
residues, the relative fluorescent intensities of these proteins 
were very similar. The emission maximum of cytochrome P-4-50 
LM 2 was at 320nm and that of cytochrome P-4-50 LM 4- was at 
330am when excited at 285nm, again showing tryptophan residues 
in hydrophobic regions of the enzyme. The fluorescence spectrum 
of cytochrome P-4-50 LM 4 is very similar to that of the yeast 
enzyme reported here, and it is interesting that both of these 
enzymes are cytochrome P-4-4-8 forms.
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Chiang & Coon (1979) also looked at the spectrum of these 
cytochrome P-450 molecules on denaturation. After denaturation 
it was found that the intensity of emission by cytochrome P-450 
LM 4 was greatly increased, though this did not occur for 
cytochrome P-450 LM 2. This indicates a large quenching of 
the tryptophan residues in the native cytochrome P-450 molecule, 
as presumably all of the tryptophan residues are exposed to the 
solvent in the denatured protein, which then exhibit character­
istic fluorescent spectra of tryptophan free in solution, with 
the emission maximum shifted to 350nm.
The fluorescence of yeast cytochrome P-450 due to its tryptophan 
content was used to look at the denaturation of this enzyme on 
heating. Initial studies on microsomes revealed that the 
fluorescence of microsomal fraction was highly dependent on 
protein concentration, with considerable quenching of fluoresc­
ence at high protein concentrations (figure 6.7.). When exp­
eriments on the thermal, stability of microsomal cytochrome 
P-450 were carried out at the optimum protein concentration 
for fluorescent measurements, a decrease in fluorescence was 
observed as the cytochrome P-450 peak was lost (figure 6.8a). 
However, these experiments are of limited value as the fluor­
escent changes could be due to a large number of different 
components of the microsomes, and do not reflect changes in the 
cytochrome P-450 molecule. Therefore the fluorescence of the 
purified yeast cytochrome was studied on thermal denaturation.
As purified yeast cytochrome P-448 was denatured, as monitored 
by the loss of spectrophotometrically detectable enzyme, no
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Figure 6.7. Fluorescence of microsomal fraction at different 
protein concentrations (290nm excitation, 330nm emission).
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change in the position of the fluorescent peak was observed, 
yet an increase in the intensity occurred as shown in figure 
6.8.b. This increase means that some of the quenching effect 
in the native protein is lost, presumably due to an alteration 
in the conformation of the enzyme which may lead to some trypto­
phan residues being exposed to a less hydrophobic environment. 
However, the fact that no change is observed in the position of 
the fluorescent peak implies that the protein chain is not 
completely unfolded under these conditons. If complete unfolding 
of the protein chain was occurring, then the emission maximum 
would be changed to that of free tryptophan in solution (345- 
350nm) as was observed by Chiang & Coon (1979) for cytochrome 
P-450 LM 4 denaturation. The reason for this incomplete 
unfolding as compared to Chaing & Coonfs results may be due to 
the method of denaturation used. In this study, a comparitively 
gentle heat treatment was used, whereas Chiang & Coon (1979) 
treated their enzyme with 6M guanidine and 30mM B-mercapto- 
ethanol as denaturing agents. It seems therefore that the 
gentle thermal inactivation of yeast enzyme used here leads to 
some conformational changes in the enzyme which reduces the 
quenching of tryptophan residues present in hydrophobic domains 
of the native protein. This decreased quenching is probably 
due to the exposure of some of these residues to a less hydro- 
phobic environment. However, the protein chain is not completely 
unfolded by this treatment.
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CHAPTER 7 
FINAL DISCUSSION
(248)
Since the discovery of cytochrome■P-450 in the yeast Saccharo- 
myces cerevisiae (Lindenmayer & Smith, 1964)> it has been 
known that this enzyme can be detected only under certain growth 
conditions. Ishidate et al. (1969b) showed that cytochrome 
P-450, which was present in high quantities in semi-anaerobic- 
ally grown yeast, was rapidly lost on exposure to aerobic 
conditions. This loss could be prevented by chloramphenicol 
or high concentrations of glucose, both of which also prevented 
the development of mitochondrial cytochromes. Thus high 
cytochrome P-450 levels are associated with growth by ferment­
ation and repression of mitochondrial cytochromes. Two sets 
of growth conditions have subsequently been used to obtain 
high levels of cytochrome P-450 in S. cerevisiae. Yoshida 
et al. (1977) and several other workers have studied cytochrome 
P-450 from yeast grown semi-anaerobically in a medium containing 
4-6$ (w/v) glucose, and Wiseman et al. (1975; 1978) have worked 
extensively on this enzyme from yeast grown aerobically in a 
medium containing 20$ (w/v) glucose.
In this thesis it has been shown that semi-anaerobic conditions 
cannot elicit production of detectable cytochrome P-450 in yeast 
growing at low glucose concentrations (0.1$, 0.5$ w/v), although 
some cytochrome P-450 may be produced and lost again before 
24 hours. This suggests that a relatively high glucose concen­
tration (>1$ w/v) is required for cytochrome P-450 production, 
even under semi-anaerobic conditions. This requirement may 
reflect the need to remove in part the repressive effect of 
cyclic AMP on cytochrome P-450 biosynthesis. The production 
of cytochrome P-450 is thought to be regulated by the level of
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intracellular cyclic AMP by repression; a high glucose concen­
tration in the growth medium causes a low cyclic AMP level and 
permits cytochrome P-450 synthesis (Wiseman e_t al. , 1978).
Thus' the relatively high glucose level allows cytochrome P-450 
to be produced. Very recently, support for this work has been 
provided by Trinn ejt al. (1982), working with S. cerevisiae 
in continuous culture. These workers demonstrated that this 
yeast cannot produce cytochrome P-450 during growth under 
oxygen limitation unless also under glucose repression, as was 
also indicated by the work presented here.
Another factor which may be involved in the biosynthesis of 
yeast cytochrome P-450 is the presence of oxygen during growth.
In contrast to the production of cytochrome P-450 under semi- 
anaerobic conditions, oxygen appears to act as a substrate 
inducer of this enzyme. Rogers & Stewart (1973) demonstrated 
that cytochrome P-450 was not produced in yeast grown under 
strictly anaerobic conditions, and results presented here 
suggest that a small amount of oxygen is necessary for production 
of high levels of cytochrome P-450.
The endogenous role of cytochrome P-450 in £>. cerevisiae is 
thought to be in the 14a-demethylation of lanosterol, the 
first step in the biosynthetic pathway of ergosterol, the 
major sterol in yeast membranes (Yoshida & Aoyama, 1980).
Also cytochrome P-450 may be involved later in the same pathway 
for ergosterol biosynthesis, although the evidence for this is 
less convincing at present (Hata et al., 1981). When yeast is 
grown under strictly anaerobic conditions, ergosterol needs to
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be added to the growth medium as a supplement because oxygen 
is required for its biosynthesis. Therefore during growth 
under these conditions, cytochrome P-450 is not required for 
sterol synthesis and does not appear to be produced (Rogers 
& Stewart, 1973). When oxygen is introduced in small quantities, 
cytochrome P-450 is produced, presumably for use in sterol 
biosynthesis. Oxygen may therefore be acting as a substrate 
inducer of cytochrome P-450 in this system.
As sterol synthesis also occurs during yeast growth at low 
glucose concentrations under aerobic conditions, some cytochrome 
P-450 must be present to allow lanosterol demethylation.
Aoyama et al. (1981a) have recently shown that this is indeed 
the case, although the level of this enzyme is very low compared 
to the level produced during growth under glucose repression. 
These workers demonstrated cytochrome P-450 by immunological 
techniques and by its catalytic activity, but not by its 
characteristic peak in the reduced carbon monoxide spectrum. 
Under these conditions of aerobic growth at low glucose concen­
trations, a large amount of cytochrome a+a^ is present which 
may mask the cytochrome P-450 by spectral overlap. Second 
derivatives of reduced carbon monoxide,spectra which resolve 
overlapping spectral bands to some extent did not rule out 
the presence of cytochrome P-450 at low glucose concentration, 
although the occurrence of this enzyme could not be definitely 
proven.
The genetic analysis of cytochrome P-450 production in £3. 
cerevisiae reveals that the production of this enzyme is
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controlled by a single nuclear gene with one or more modifying 
factors. The results obtained in these experiments (section 
2.3.4«) indicate that this gene is regulatory and not a 
structural gene for cytochrome P-450. This regulatory gene 
may code for a protein involved with the regulation of cyclic 
AMP levels withen the cell, although much further work is 
needed to characterize the gene product. The possibility of 
a small amount of cytochrome P-450 being present in those 
haploid yeasts in which this enzyme cannot be detected using 
reduced carbon monoxide spectra has not been investigated, 
although these yeasts grow normally and therefore carry out 
sterol synthesis. The absence of a structural gene for 
cytochrome P-450 in these yeast strains would rule out the 
possibility of cytochrome P-450 in these yeast strains, although 
the effect due to a regulatory gene observed here may allow 
the production of a small quantity of this enzyme.
Benzo(a)pyrene is a well known inducer of cytochrome P-450 in 
mammalian liver, where it induces production of cytochrome 
P-448 in a similar fashion to 3-methylcholanthrene, causing 
an increased Vmax and decreased Km for benzo(a)pyrene hydroxy- 
lation (Hansen & Fouts, 1972; Gurtoo & Campbell, 1970). The 
results described for induction of yeast benzo(a)pyrene 
hydroxylase with benzo(a)pyrene also show increased enzyme 
efficiency by a decreased Km and increased Vmax, and these 
results indicate that more than one form of cytochrome P-450 
can be produced in £>. cerevisiae. The occurrence of at least 
two forms of cytochrome P-450 in uninduced yeast has been 
shown by Azari & Wiseman (1982a), who purified the major form
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of this enzyme with a spectral carbon monoxide peak at 448nm 
and also found a minor component with a spectral carbon 
monoxide peak at 450nm. The occurrence of multiple forms of 
mammalian cytochrome P-450 is well established, yet previously 
unreported in a microorganism. The more efficient benzo(a)- 
pyrene hydroxylase appears to be produced with compensating 
non-production of the less efficient enzyme, suggesting that 
the inducer results not only in switching on the synthesis 
of the more efficient enzyme but also in reducing the amount 
of the less efficient enzyme produced.
Dimethylnitrosamine and other compounds were also able to induce 
yeast benzo(a)pyrene hydroxylase activity to varying degrees, 
showing that this effect is not specific to benzo(a)pyrene.
Also induction could be observed in other yeast strains, 
showing that this effect is not specific to one yeast strain. 
Growth of yeast in the presence of lanosterol was interesting 
as here a less specific enzyme appeared to be produced, suggest­
ing perhaps induction of a different form of the enzyme. This 
however now requires investigation.
The explanation of induction of benzo(a)pyrene hydroxylase by 
the production of a new cytochrome P-450 enzyme suggests 
several lines of investigation for future work. The separation 
of enzyme forms by SDS-polyacrylamide gel electrophoresis could 
confirm the occurrence of a new enzyme form. Also the new 
form could be purified and compared with the major form of the 
enzyme present in uninduced yeast in terms.of its physical and 
chemical characteristics (e.g. molecular weight, catalytic
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ability, amino acid composition). This would provide valuable 
information in comparing not only the yeast enzymes, but also 
those from mammalian and other sources.
Characterization of the major form of uninduced yeast cytochrome 
P-450 which has been purified to homogeneity has revealed that 
this enzyme is a member of the cytochrome P-448 family of enzymes 
on the basis of its spectral properties. Also the molecular 
weight is close to that of a mammalian cytochrome P-448 form 
and the benzo(a)pyrene metabolite profile produced by this enzyme 
is similar to a cytochrome P-448. The amino acid composition of 
yeast cytochrome P-450 is also more similar to a cytochrome P-448 
than a cytochrome P-450. form of the enzyme (King _et al., 1982b). 
The yeast enzyme is therefore revealed as a distinct cytochrome 
P-448 enzyme, similar to but not identical to those of mammalian 
liver.
The detection of binding spectra of yeast cytochrome P-450 with 
several compounds is of considerable interest. The substrate 
benzo(a)pyrene produces a strong type I binding spectrum as 
expected with a spectral Ks similar to the Km for benzo(a)-
pyrene hydroxylase in the purified system. Lanosterol also 
produces a type I spectrum, although a smaller proportion of the 
enzyme binds lanosterol. Although lanosterol has been shown by 
other workers to be a substrate for yeast cytochrome P-450 
(Aoyama & Yoshida, 1980), no metabolism could be detected using 
the Nash assay technique. This is probably due to the lack of 
sensitivity of this assay technique. Dimethylnitrosamine, 
phenobarbital and ethylmorphine also undergo type I spectral
(254)
interactions with yeast cytochrome P-450, yet no metabolism of 
any of these compounds could be detected. It is interesting 
that both dimethylnitrosamine and phenobarbital act as inducers 
of benzo (a )pyrene hydroxylase in a manner similar to benzo(a)- 
pyrene. This is particularly surprising for phenobarbital, 
which classically induces cytochrome P-450 associated activities 
in mammalian liver, and not cytochrome P-448 activities such 
as benzo (a)pyrene hydroxylase. Callen ert al. (1980) have 
suggested that cytochrome P-450 may be responsible for the 
activation of dimethylnitrosamine in £!. cerevisiae, although 
these workers presented only indirect spectral evidence for 
this involvement. The finding that yeast cytochrome P-450 
can also undergo type II spectral changes and also changes in 
mid-point redox potential imply that this enzyme may operate 
in a fashion similar to the well-characterized enzymes from 
hepatic microsomes.
Although substrate specificity of cytochrome P-450 from mammalian
liver is known to be extremely wide, that of cytochrome-P-448
forms of the enzyme is much more limited. However, the enzyme
isolated from yeast appears to have an even narrower specificity,
with the only substrate found to give a detectable rate of
metabolism being benzo(a)pyrene. This enzyme is also known to
be capable of the 14a-demethylation of lanosterol, although, this
could not be detected here as already mentioned. Yeast cytochrome
22P-450 has also been suggested to be responsible for A  -desatur­
ation of ergosta-5»7-dien-3B-ol to form ergosterol (Hata et al., 
1981). Therefore this enzyme may be involved in both the first 
and the last steps of the pathway of ergosterol biosynthesis 
from lanosterol.
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Some hydroxylation of biphenyl was detected in yeast spheroplasts 
but this could not be recovered in microsomal fraction. Yeast 
cytochrome P-450 dependent demethylation of aminopyrine has 
been reported previously by Yoshida ejb al. > (1977) and by 
Sauer et elL. (1982), but could not be detected here. Also 
aniline has been reported as a substrate for yeast cytochrome 
P-450 (Yoshida et al., 1977) yet no metabolism of this compound 
could be detected here either. Several other putative substrates 
were also tested without success. Recently, yeast cytochrome 
P-450 in microsomal form has been shown to produce metabolites 
of 15>l6-dihydro-ll-methylcyclopenta(a)-phenanthren-17-one 
using an HPLC analysis (J. RusseH & D. Keen, personal communi­
cation). This compound has a similar ring structure to benzo- 
(a)pyrene. However, the metabolites produced have not yet 
been identified.
Yeast cytochrome P-450 thus appears to catalyze only benzo(a)- 
pyrene hydroxylation and lanosterol 14a-demethylation and possibly 
metabolism of closely related compounds. Pasleau e_t al. (1982) 
have reported that.a form of rat liver microsomal cytochrome 
P-450 which is capable of benzo(a)pyrene hydroxylation is also 
involved in the metabolism of steroids, and these compounds act 
as competitive inhibitors of each others* metabolism. It was 
also found for the yeast enzyme that lanosterol is an inhibitor 
of benzo(a)pyrene hydroxylase.
The inhibition of yeast cytochrome P-450 dependent benzo(a)pyrene 
hydroxylase by flavonoid compounds is unlike the major rabbit 
liver cytochrome P-448 enzyme (cytochrome P-450 LM 4) as this
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enzyme is stimulated by flavone. The pattern of inhibition of 
the yeast enzyme by flavone and 7,8-benzoflavone shows more 
resemblance to rabbit liver cytochrome P-450 LM 6, a form 
induced by TCDD, particularly in neonatal rabbits, which also 
has a Soret peak at 448nm in the reduced carbon monoxide 
difference spectrum (Norman _et al. , 1978). It is of interest 
that TCDD induces both cytochrome P-450 LM 4 (major component) 
and LM 6 (minor component) in adult rabbits, but only cytochrome 
P-450 LM 6 in neonatal rabbits. Cytochrome P-450 LM 6 has a 
molecular weight of 57,000 and is capable of benzo(a)pyrene 
hydroxylation (Norman et al. , 1978). Also Atlas _et al. (1977) 
have shown that in neonatal rabbits, 3-methylcholanthrene 
induces a form of cytochrome P-450 which seems to be cytochrome 
P-450 LM 6 on the basis of its molecular weight and catalytic 
activities.
The resemblance of yeast cytochrome P-450 to cytochrome P-450 
LM 6 (which is largely a foetal form of the enzyme) is inter­
esting from an evolutionary point of view. It is thought that 
cytochrome P-450 enzymes have evolved from an enzyme primarily 
concerned with the detoxification of oxygen in bacteria 
(Wickramsinghe & Villee, 1975). In mammals, cytochrome P-448 
enzymes are more abundant in foetal tissues, and it is thought 
that the very wide specificity cytochrome P-450 enzymes may 
have evolved from an enzyme similar to the narrow specificity 
cytochrome P-448 forms (Parke, 1981). In lower animals, 
narrow specificity cytochrome P-448 enzymes are also common 
and have deen demonstrated in mussel (Ade, 1982) and several 
species of fish (Parke, 1981; Hansson jet al., 1982). Two
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cytochrome P-450 enzymes have deen demonstrated in the blue 
crab Callinectes' sapi-dus ,■ one of which hks a spectral carbon 
monoxide peak at 447nm (Conner & Lee, 1982), and a cytochrome 
P-448 has also been demonstrated in the earthworm Lumbricus 
terre'stri'S (Liimatainen & H&nninen, 1982). Multiple forms of 
cytochrome P-450, including cytochrome P-448 forms, have also 
been shown to occur in several species of insects (Agosin, 1982). 
It seems therefore that narrow specificity cytochrome P-448 
forms are more predominant in lower organisms. The major form 
of cytochrome P-450 in £>.■ cerevisiae is also a cytochrome P-448 
and thus a detailed comparison with lower organisms might be 
of interest in a study of the evolution of cytochrome P-450 
enzymes.
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THE INDUCTION OF CYTOCHROME P-448 DEPENDENT BENZO(a)PYRENE 
HYDROXYLASE IN SACCHAROMYCES CEREVISIAE
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When grown in high concentrations of glucose, the yeast Saccharomyces 
cerevisiae produces a microsomal cytochrome P-450 monooxygenase system which 
is capable of hydroxylating benzo(a)pyrene. The addition of benzo(a)pyrene to the 
yeast during growth causes only a small increase in cytochrome P-448 levels but 
results in a dramatic improvement in the apparent kinetics of benzo(a)pyrene 
hydroxylation as measured by a decrease in the Michaelis constant and an increase 
in maximal velocity. Dimethylnitrosamine, phenobarbital and
3-methylcholanthrene also induce this enzyme to various degrees. Yeast 
pretreatment with 8-naphthoflavone did not affect this enzyme, yet pretreatment 
with lanosterol resulted in a decreased affin ity for benzo(a)pyrene. The addition of 
benzo(a)pyrene to yeast growing at low glucose concentration does not induce 
cytochrome P-448. The implications of these findings with regard to the presence 
of multiple forms of cytochromes P -448/P-450 in yeast are briefly discussed.
INTRODUCTION
The yeast Saccharomyces cerevisiae possesses a microsomal cytochrome 
P-450 dependent monooxygenase system with many properties in common with that 
found in mammalian liver (1,2). This yeast enzyme system exhibits aryl 
hydrocarbon hydroxylase activity towards benzo(a)pyrene, the major metabolites 
being 3-hydroxybenzo(a)pyrene, 9-hydroxybenzo(a)pyrene and 7,8-dihydro- 
7,8-dihydroxybenzo(a)pyrene (3). We have found the absorption peak of this 
enzyme in the reduced carbon monoxide difference spectrum to be at 448 nm.
The production of cytochrome P-448/P-450 in Saccharomyces cerevisiae 
occurs under fermentative conditions where mitochondrial cytochrome a+a^ 
formation is repressed, for example anaerobic conditions or at high glucose • 
concentrations (4,5). There is now evidence to suggest that the intracellular 
concentration of cyclic AMP controls the de novo synthesis of cytochrome 
P-448/P -450 in S. cerevisiae by repression, the level of 
cyclic AMP being determined by the glucose concentration in the growth medium
0006-291X/82/G71115-07$01.00/0
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in an inverse relationship (6). This is supported by the direct relationship between 
cyclic AMP and cytochrome a+a^ levels and their inverse relationship to 
cytochrome P-448/P-450 levels at various glucose concentrations (7). Karenlampi, 
et al. (8) have recently supported the need for fermentable sugar to be present 
before cytochrome P-448/P-450 is produced.
The induction of mammalian cytochrome P-450 monooxygenase systems by 
various compounds has been very widely studied and is now beginning to be
explained in terms of multiple forms of the enzyme. Two of the most widely
studied inducers, phenobarbital and 3-methylcholanthrene induce different forms 
of the enzyme. Phenobarbital induces a form with a very wide specificity whereas 
3-methylcholanthrene induces a form with relatively narrow specificity, 
cytochrome P-448 (9). It  is now known that cytochrome P-450 exists in more than 
two different forms. The evidence for this comes, for example, from studies with 
inducers, isolation and purification of different forms, immunological studies and 
kinetic and binding studies (10). Multiple forms of cytochrome P-450 exist with  
different but overlapping substrate specificities.
MATERIALS AND METHODS
Saccharomyces cerevisiae (NCYC No.240) was grown batchwise by the 
method previously described by Wiseman, et al. (6). Growth was for 44 hours in a 
medium containing 1% yeast extract, 2% mycological peptone and usually 20%
glucose. Inducing agents were added at the beginning of the growth period
dissolved in a small amount of dimethylformamide. An equivalent amount of 
dimethylformamide was added to control experiments.
Microsomal preparations were obtained by differential centrifugation after 
disruption of yeast in a Vibromill disruptor by a method already described (11). 
Microsomal preparations were resuspended in 0.1 M potassium phosphate buffer 
pH 7.2 containing 20% glycerol, 0.001 M EDTA and 0.001 M dithiothreitol by use of 
a hand held Potter type homogeniser.
Cytochrome P-448/P-450 was determined by ±he method of Omura, et 
al. (12) using an extinction coefficient o f 91 mM~ cm’  .
The measurement of benzo(a)pyrene hydroxylase was achieved by detecting 
the amount of 3-hydroxybenzo(a)pyrene produced by the fiuorimetric method of 
Dehnen, et al. (13) as modified by Wiseman and Woods (3).
RESULTS
The addition of benzo(a)pyrene to yeast growing in a medium containing 20% 
glucose affected the apparent kinetics of benzo(a)pyrene hydroxylation and also the
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TABLE 1: Induction of Benzo(a)pyrene Hydroxylase with
Benzo(a)pyrene
Benzo(a)pyrene Cytochrome P-448 Km Vmax
Concentration nmoles/g wet weight yeast pM pmoles
3-hydroxybenzo(a)
pM pyrene/hour/n mole
P-448
0 3.36 + .24 111 167
16 3.66 + .41 100 220
32 3.43 + .31 65 333
63 3.95 + .14 56 500
95 4.36 + .23 42 444
190 * 32 580
Values o f cytochrome P-448 are quoted + standard deviation, n = 8.
*  This concentration of benzo(a)pyrene resulted in precipitation of benzo(a)pyrene 
which interfered with the cytochrome P-450 assays rendering them invalid.
level of cytochrome P-448/P-450 in the yeast (Table 1). The level of cytochrome 
P-448/P -450 as measured by carbon monoxide-reduced difference spectra o f yeast 
suspensions was slightly higher in yeast treated with benzo(a)pyrene at high 
concentrations. The kinetics of benzo(a)pyrene hydroxylase activity as supported
120 * V max '  600
100 - • 500
80 - -  400
*300
4 0 * *200
20- -1 0 0
0 50 100 150 200
Benzo(a)pyrene Concentration in  Growth Medium ( »iM)
FIGURE 1: Benzo(a)pyrene Induction of the K inetic  Param eters o f Benzo(a)pyrene Hydroxylase
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TABLE 2: E ffec t of Inducing Agents on Cytochrome P-448 and
Benzo(a)pyrene Hydroxylase in Yeast
Pretreatm ent Cytochrome P-448  
nrnoles/g wet weight yeast If Vmaxpmoles
3-hydroxybenzo(a) 
pyrene/hour/n mole 
P-448
None 3.36 + .24 111 167
Dimethylnitrosamine 108 pM 3.98 + .38 59 588
Dimethylnitrosamine 324 pM 4.64 + .38 40 476
3-Methylcholanthrene 30 pM 3.48 + .27 27 154
3-Methylcholanthrene 90 pM 3.32 + .35 20 174
Phenobarbital 32 pM 3.50 + .24 80 278
B-Naphthoflavone 30 pM 3.80 + .38 114 182
Lanosterol 19 pM 3 .6 2 + .4 2 250 200
Values o f cytochrome P-448 are quoted + standard deviation, n = 8.
by NADPH were investigated in microsomal fraction by means of double-reciprocal 
Lineweaver-Burke plots. The results show clearly that benzo(a)pyrene 
pretreatment of yeast results in a lower Michaelis constant (K m) »*e. higher 
affin ity  for benzo(a)pyrene and a higher maximal velocity (V x). These effects 
were clearly dependant on the concentration of benzo(a)pyrene in the medium 
(Table 1, F ig .l).
Yeast grown in 0.5% glucose containing medium usually contains no 
cytochrome P-448/P -450. In an attempt to induce benzo(a)pyrene hydroxylase 
activity in yeast growing at low glucose concentration we added benzo(a)pyrene. 
We were unable to induce the production o f' cytochrome P -448/P -450 in this 
growth medium even in the presence of a high concentration (95 pM) of 
benzo(a)pyrene.
Table 2 shows the effect of several other compounds on yeast cytochrome. 
P-448/P-450 levels and the kinetics of microsomal benzo(a)pyrene hydroxylase. 
Pretreatment with dimethylnitrosamine appears to ■ have a similar e ffect to 
pretreatment with benzo(a)pyrene in that the level of cytochrome P -448/P -450 is
1118
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slightly increased, the Km for benzo(a)pyrene is decreased and the Vmgx value 
increased. Higher concentrations of dimethylnitrosamine are necessary to achieve 
the same extent of induction as with benzo(a)pyrene. Yeast pretreatment with 
3-methylcholanthrene is interesting as this results in no change in cytochrome 
P-448/P-450 levels and no change in the Vmgx value yet a large decrease in Km 
for benzo(a)pyrene is observed. Phenobarbital also has no effect on yeast 
cytochrome P-448/P-450 levels but improves both Km and Vmgx for this enzyme.
Pretreatment of yeast with (5-naphthoflavone has no effect on either 
cytochrome P-448/P-450 levels or benzo(a)pyrene kinetics. The addition of 
lanosterol to the yeast growth medium results in a higher Km for benzo(a)pyrene 
than the control value and a slightly higher Vmax» 1° this case the affin ity  for 
benzo(a)pyrene is reduced possibly due to induction of a different form of the 
enzyme to that induced by benzo(a)pyrene.
DISCUSSION
Benzo(a)pyrene is well known as an inducer of benzo(a)pyrene hydroxylase in 
mammals, where similar effects to those reported here on the kinetics of this 
enzyme have been shown (14,15). This induction has been shown to be due to the 
selective induction of a form (or forms) of cytochrome P-450 with a high activity  
towards benzo(a)pyrene hydroxylation, cytochrome P-448. This form of 
cytochrome P-450, which is also induced by 3-methylcholanthrene, is known to 
have a relatively narrow substrate specificity and to activate carcinogens such as 
benzo(a)pyrene, to metabolically active products. The results presented in this 
report suggest the induction by benzo(a)pyrene of a similar form of cytochrome 
P-450 with a high activity towards benzo(a)pyrene in the yeast Saccharomyces 
cerevisiae.
The inability of benzo(a)pyrene to induce cytochrome P-448 in yeast grown in 
a low glucose medium shows that a high glucose concentration, or conditions 
leading to a similar physiological state such as anaerobic conditions, is a 
prerequisite for cytochrome P-448 production. This would be as expected if  the 
production of cytochrome P-448/P-450 was being controlled by the presence of 
cyclic AMP by repression as has been suggested (6). It would seem therefore that a
1119
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high glucose concentration lowers the level of cyclic AMP which allows 
cytochrome P-448 to be produced. The induction observed with benzo(a)pyrene is 
due to an effect on the amount of a particular form of cytochrome P-448 
produced.
The addition of dimethylnitrosamine to yeast also showed considerable 
induction of benzo(a)pyrene hydroxylase in a similar manner to benzo(a)pyrene, 
suggesting that this compound was inducing the same form of the enzyme as 
benzo(a)pyrene. 8-Naphthoflavone has been reported to induce a form of 
cytochrome P-450 in mammalian systems with a very high turnover number for 
benzo(a)pyrene which has an absorption maximum in the carbon monoxide-reduced 
difference spectrum at 446 nm and was hence termed cytochrome P-448 (16). 
However, we have been unable to demonstrate any induction of benzo(a)pyrene 
hydroxylase with this compound in Saccharomyces cerevisiae.
Pretreatment of yeast with 3-methylcholanthrene, a classical inducer of the 
cytochrome P-448 system in mammalian liver, was expected to induce 
benzo(a)pyrene hydroxylase also. A large decrease in K m was observed suggesting 
a higher affin ity form of the enzyme yet no change in maximal velocity occurred. 
Phenobarbital, a classical inducer of the wide specificity cytochrome P-450 form  
in mammals did induce benzo(a)pyrene hydroxylase to some extent.
Lanosterol is thought to be an endogenous substrate for cytochrome 
P-448/P-450 in Saccharomyces cerevisiae (17). The addition of this compound to 
yeast media during growth resulted in a decreased affin ity for benzo(a)pyrene, 
showing that the induction of another form of cytochrome P-450 could be 
occurring.
The presence of multiple forms of cytochrome P-448/P -450 in 
Saccharomyces cerevisiae is previously unreported although we have some evidence 
from purification studies of at least two forms present in uninduced yeast (18). • 
The results of this study suggest that multiple forms of cytochrome P -448/P -450  
exist in Saccharomyces cerevisiae and extends the list of properties that the 
enzyme from this eukaryotic source shares with the mammalian system.
1120
Vol. 105, No. 3, 1982 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Acknowledgement
This work was supported in part by an S.E.R.C. C.A.S.E. -studentship award to 
D.J.K. with May & Baker Ltd., Dagenham, Essex under the supervision of Dr. C.J. 
Coulson and Dr. D .I. Dron.
REFERENCES
1. Yoshida, Y ., Kumaoka, H . and Sato, R. (1974) J. Biochem. 75 1201-1210.
2. Yoshida, Y ., Aoyama, Y ., Kumaoka, H . and Kubota, S. (1977) Biochem. 
Biophys. Res. Comm. 78 1005-1010.
3. Wiseman, A . and Woods, L .F .J. (1979) J. Chem. Tech. Biotechnol. 29 320-324.
4. Ishidate, K ., Kawaguchi, K. and Tagawa, T . (1969) J. Biochem. 65 385-392.
5. Ishidate, K ., Kawaguchi, K ., Tagawa, T . and Hagihara, B. (1969) J. Biochem. 
65 375-383.
6. Wiseman, A ., Lim, T .-K . and Woods, L.F.J. (1978) Biochim. Biophys. Acta 544 
615-623.
7. Qureshi, I., Lim , T .-K . and Wiseman, A. (1980) Biochem. Soc. Trans. 8 573- 
574.
8. Karenlampi, S.O., Marin, E. and Hanninen, O.O.P. (1981) Biochem. J. 194 407- 
413.
9. Conney, A .H . (1967) Pharm. Rev. 19 317-366.
10. Guengerich, F.P. (1979) Pharm. Ther. 6 99-121.
11. Wiseman, A ., Gondal, J. and Sims, P. (1975) Biochem. Soc. Trans. 3 278-281.
12. Omura, T ., Sato, R ., Cooper, D ., Rosenthal, D. and Estabrook, R . (1965) Fed. 
Proc. 24 1181-1189.
13. Dehnen, W., Tomingas, R . and Ross, J. (1973) Anal. Biochem. 53 373-381.
14. Gurtoo, H .L . and Campbell, T .C . (1970) Biochem. Pharmacol 19 1729-1735.
15. Schlede, E., Kuntzman, R ., Haber, S. and Conney, A .H . (1970) Cancer Res. 30 
2893-2897.
16. Saito, T . and Strobel, H.W. (1981) J. Biol. Chem. 256 984-988.
17. Yoshida, Y . and Aoyama, Y . (1980) in "Microsomes Drug Oxidations and 
Chemical Carcinogenesis" (ed. M.J. Coon, A .H . Conney, R.W. Estabrook, H.V. 
Gelboin, J.R. G illette, P.J. O'Brien) Vol.2, 761-764, Academic Press, New  
York.
18. Azari, M .R . and Wiseman, A . (1982) Anal. Biochem. in press.
1121
Biochem. Soc. Trans. (1982) 10 .$28-529
Inhibition of highly purified benzo[a]pyrene hydroxylase from Saccharomyces cerevisiae by 
cytochrome P-448 binding compounds and by flavonoids
D AVID  J. K IN G , M AHM O ND  R. A ZA R I and 
A LA N  W ISEMAN
Biochemistry Division. Department o f  Biochemistry, University 
o f Surrey. Guildford. Surrey GU2 SXH, U.K.
Cylochromc P-448 dependent benzofalpyrene hydroxylase has 
been purified to homogeneity and characterized by Azari &  
Wiseman (1982). The kinetics o f NADPH-supportcd 
benzofalpyrene hydroxylation by this enzyme were reported for 
the purified reconstituted system consisting o f the purified 
cytochrome P-448 component, purified N ADPH  :cytochrome 
P-450(c) reductase and a phospholipid component. Using this 
system the Michaelis constant for benzofalpyrene was 33/zm 
and the maximal velocity 208pmol o f 3-hydrobenzofalpyrenc/h 
per nmol o f cytochrome P-448. We have studied the binding o f 
several putative substrates with this highly purified enzyme 
, (Azari et al., 1982) and in this communication we report that 
these compounds can act as inhibitors o f benzofalpyrene 
hydroxylase.
The -mechanism o f inhibition/activation o f mammalian 
benzofalpyrene hydroxylase by flavonoids has been studied by 
Huang et al. (1981a,6). We have examined the effect o f two 
flavonoid compounds, flavone and 7,8-benzoflavone, both o f 
which inhibit yeast cytochrome P-448 dependent 
benzofalpyrene hydroxylase.
Yeast (Saccharomyces cerevisiae N.C.Y.C. no. 240) was 
grown under glucose repression and used to  prepare microsomes 
from which cytochrome P-448 was purified to homogeneity 
(97% pure) as previously described (Azari &  Wiseman. 1982). 
Benzofalpyrene hydroxylation activity was assayed on a
purified reconstituted system by the method o f Dehnen et al. \ 
(1973) as modified by Woods &  Wiseman (1979).
The percentage inhibition o f benzofalpyrene hydroxylase by j 
binding compounds is shown in Table 1. along with the 
corresponding K % values. This table shows that dimethyl- 
nitrosaminc and lanosterol result in a high degree o f inhibition at 
2.5 mM and 11 p n  respectively. Both o f these compounds result j 
in type 1 interactions with purified yeast cytochrome P-448 with 
spectral dissociation constants (K t values) o f 220/At and 80/m 
respectively. Lanosterol has been reported to be an endogenous 
substrate o f yeast cytochrome P-448/P-450 by Aoyama &  
Yoshida (1978). Dimethylnitrosamine is an inducer of 
cytochrome P-448 and binding studies show evidence o f high 
affinity for this enzyme, but so far we have not shown a 
reproducible rate o f demethylation by using the Nash assay 
technique.
Our enzyme was not inhibited by 9-hydroxyeIlipticinc. This 
compound has been found to inhibit mammalian cytochrome 
P-448 in vitro  (Delaforge et al., 1980). j
The interaction o f flavonoid‘compounds with benzofalpyrene 
hydroxylase from mammalian liver has been studied by Huang 
et al. (1981a,b). These workers found that flavone stimulated 
benzofalpyrene hydroxylase activity o f cytochrome P-450 
LM3c or LM4, yet inhibited the same activity catalyzed by 
cytochrome P-450 LM2, LM3b and LM6. 7,8-Benzoflavone 
stimulated benzofalpyrene hydroxylation by cytochrome P-450 
LM3c yet inhibited cytochrome P-450 LM6. We have found 
that both flavone and 7,8-benzoflavone inhibit our enzyme 
strongly in a non-competitive fashion. 7.8-Bcnzoflavonc is. a 
more potent inhibitor than flavone. Double reciprocal plots o f j
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• Table 1. Inhibition ofbenzo\a\pyrene hydroxylase from  yeast
Cytochrome P-448 was used at I nmol per assay in a total 
volume o f I ml. NADPH :cytochrome P-450(c) reductase was 
added to 1 unit ( I unit converts I//m ol o f cytochrome c to 
the reduced form per minute at 22°C); 30pg o f dilauroyl- 
phosphatidylcholine was also added. Benzofalpyrene concen­
tration was 80 pM.
Benzofalpyrene
Concentration hydroxylation Kt
of activity (from Azari
Inhibitor added inhibitor (% o f control) etaL 1982)
None — 100 8 /m
Imidazole ■ 1 mM 79 8/m
Aniline 0.5 mM 78 S/m
Phenobarbital 77/m 80 66 /M
Perhydrofluorene IOmM 0 —
Lanosterol 7/m 55 80/m
Ethylmorphine 1.25 mM 73 166/m
Dimethylnitrosamine 2.5 mM 50 220/m
Benzphetamine 20 mM 81 1.66/m
9-Hydroxyellipticine 600mM 100 —
Flavone 600 mM 50 —
7,8-Benzoflavone 176mM 50 —
initial velocity versus benzofalpyrene concentration at various 
concentrations o f  7,8-benzoflavone have shown that the 
inhibition by this compound is non-competitive, as the K m for 
benzofalpyrene is unchanged whilst maximal velocity is
lowered. The inhibition constant, K,, for 7,8-benzoflavone was 
determined as 176/zm (benzofalpyrene used in the range 
40-160pM).
The inhibition o f benzofalpyrene hydroxylase by cytochrome 
P-448 binding compounds once again confirms the identity o f 
this enzyme as a cytochrome P-448 dependent activity. The 
difference between mammalian cytochrome P-450 LM4 (a 
cytochrome P-448) and yeast cytochrome P-448 is shown by 
the effect o f flavonoid compounds on benzofalpyrene hydroxyl­
ation by these systems. In this respect our yeast enzyme appears 
to resemble cytochrome P-450 LM6 which b  produced in rabbit 
liver after induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
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Studies on the differences in thermal stability and critical temperature of cytochrome P-448 
from Saccharomyces cerevisiae in microsomal, solubilized and highly purified form
M AHM OOD R. A ZA R I. D A V ID  J. K IN G  and 
A LA N  W ISEM AN
Biochemistry Division, Department o f  Biochemistry, University 
o f Surrey. Guildford, Surrey GU2 5XH, U.K.
Studies on cytochrome P-448 from yeast microsomal fraction 
by Wiseman et al. (1975) revealed that this enzyme is less stable 
than that from rat liver toward thermal denaturation. This study 
also revealed that this enzyme from yeast or rat liver is 
considerably more stable toward thermal denaturation in the 
oxidized form than in the reduced form. We have previously 
reported the stabilization effect o f  Triton X-100 on yeast 
cytochrome P-448 during solubilization (Azari &  Wiseman. 
1980, 1982). We now report the differences in thermal stability 
o f cytochrome P-448 from Saccharomyces cerevisiae in the 
form o f microsomal, solubilized and purified enzyme as. 
measured by both the content o f cytochrome P-448 and the 
activity o f benzofalpyrene hydroxylase.
Yeast (Saccharomyces cerevisiae N.C.Y.C. no. 240) was 
grown and microsomes prepared as previously described 
(Wiseman et al.. 1975). Microsomes were resuspended in 
0.1 M-potassium phosphate buffer, p H 7.2, containing 20% (v/v) 
glycerol, 0.00Im-EDTA. 0.001 M-dithiothreitol and 0.1% 
glutathione. Cytochrome P-448 was stabilized by the addition o f 
1% cholate to the microsomes followed by stirring at 4°C  under 
nitrogen for I h. This enzyme was purified to homogeneity by 
using the methods previously described (Azari &  Wiseman. 
1982). Cytochrome P-448 was assayed by the method o f Omura 
et al. (1965) and benzofalpyrene hydroxylase measured by the 
method o f Dehnen et al. (1973) as modified by Woods &
Vol. 10
Wiseman (1979). Yeast cytochrome P-448 was more stable 
toward thermal denaturation when in the form o f microsomes 
than ' when solubilized but not purified. After incubating 
microsomal enzymes even at 50°C,.for 5min only, 50% o f the 
yeast cytochrome P-448 is lost (see Table 1). In an equivalent 
experiment with rat liver microsomal cytochrome P-450 no 
detectable loss was observed after Smin at 50°C. This again 
shows the liver enzyme to be more stable than the yeast enzyme, 
as shown by Wiseman et al. (1975). When yeast microsomes are 
treated with 1% Triton X-100 only 10% o f cytochrome P-448 
dependent benzofalpyrene hydroxylase is lost after lOmin 
incubation at 40°C, whereas untreated microsomes lose 50% o f 
activity under these conditions.
Solubilized yeast cytochrome P-448 is far less resistant to 
thermal denaturation than is microsomal fraction, as is expected 
from the loss o f the lipid membrane (see Table I). The stability 
o f this solubilized enzyme was not significantly affected by the 
addition o f benzofalpyrene, which is a well-characterized 
substrate o f this enzyme (Azari &  Wiseman, 1982). The 
addition o f 0.1% Triton X-100 had only a slight effect on the 
temperature at which 50% o f the cytochrome P-448 was lost in 
Smin incubation (Table la ) yet was successful in preventing 
100% loss o f cytochrome P-448 in Smin until an incubation 
temperature o f 60°C is reached (Table 16). Solubilized 
cytochrome P-448 is 100% lost after Smin incubation at 45°C 
when no Triton X-100 is present. Triton X-100 at 0.1% was hot 
able to return the stability o f the soluble enzyme to that o f the 
enzyme in microsomal fraction. The activity o f benzofalpyrene 
hydroxylase also shows a stabilization effect in the presence o f 
Triton X-100 (Table Ic). This stabilization effect is probably
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Tabic I. Thermal stability o f  different types o f  preparations o f  yeast cytochrome P-448
The enzyme preparations were pre-incubated for Smin at a series o f temperatures (0-75°C ), cooled and assayed for cytochrome 
P-448 level and benzofalpyrene hydroxylase activity. Curves o f activity and cytochrome P-448 level versus temperature w.erc 
constructed and showed a strong temperature dependent effect. Protein contents as determined by the Lowry method were, 
microsomal 6.5 mg/ml, solubilised 30 mg/ml, purified 50//g/ml. Cytochrome P-450 level was the same in all preparations.
(a) (b) (c)
Temperature at which Critical temperature at which Temperature at which
50% of cytochrome P-448 100% of cytochrome P-448 50% of benzolalpyrene
Form of yeast cytochrome P-448 lost (*C) lost (°C) hydroxylase lost (°C)
Microsomal 50 55 —
Solubilized 45 39 —
Solubilized +0.1%Triton X-100 36 60 45
+ 80/<M-benzo|a]pyrene
Solubilized + 80//M-benzo(a|pyrene 35 45 41
Purified 45 65 44
due to Triton X-100 substituting for lipid removed during 
solubilization, and hence protecting the conformation o f  the 
enzyme. Another possible reason for the relative instability o f 
the solubilized enzyme is the presence o f 1% sodium cholate 
used for solubilizing the enzyme.
Surprisingly, purified cytochrome P-448 was more stable than 
solubilized enzyme (even when studied at a lower protein 
concentration) as measured by the temperature at which 50% o f 
cytochrome P-448 is lost (Table la ). This may be due to the 
absence o f ionic detergent (cholate) and the presence o f a 
residual amount o f non-ionic detergent (Emulgen 911) which is 
used during purification. This residual Emulgen may have a 
stabilizing effect due to protecting hydrophobic regions o f the 
enzyme from the aqueous environment.
Triton X-100 is-known to bind to cytochrome P-450 as a 
modified-type II  substrate, modulating the spin state o f 
cytochrome P-450 from high spin to low spin (Tamura et al.. 
1976), and is also-known to protect enzymes by protecting the 
hydrophobic regions (Takeda et al.. 1972). Thiol reagents or 
high ionic strength cause a cytochrome P-450 spin state change 
from low to high spin and also cause a cytochrome P-450 to 
cytochrome P-420 conversion by destroying or removing the 
■thiol ligand (Murakami &  Mason, 1967; Yoshida &  Kumaoka.
1972). Triton X-100 may therefore exert a stabilizing effect by 
retaining the low-spin state form and thus protecting the thiol 
ligand o f the haem group.
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Spectral binding studies on the interaction of some putative substrates with highly purified 
cytochrome P -448 from Saccharomyces cerevisiae
. M AHM O O D R. A ZA R I, D A V ID  J. K IN G  and 
A LA N  W ISEMAN
Biochemistry Division, Department o f  Biochemistry, University 
o f  Surrey. Guildford, Surrey GU2 5XH, U.K.
Cytochromes /M 5 0 //M 4 8  undergo spectral changes due to 
their interaction with many different compounds (Schenkman et 
al., 1981). Two major types o f spectral interactions are 
observed, termed type I  and type II. Type I interactions are 
thought to be due to the binding o f cytochromes P-450/P-448 
substrates to the protein moiety o f the enzyme, possibly at the 
active site. This interaction results in difference spectra with an 
absorption peak at 385-390nm and a trough at approx. 420nm. 
Type I I  interactions arc associated with the binding o f a 
compound to the haem iron o f cytochrome P-450/P-448. often 
via an amino group. The difference spectra resulting from type 
II interactions have an absorption maximum at 425—435 nm and 
a minimum at 390-405 nm. Wc report here the interaction o f 
some compounds which arc known to bind to mammalian
cytochromes P-450/P-448 with highly purified cytochrome 
P-448 from Saccharomyces cerevisiae.
Cytochrome P-448 was solubilized from yeast 
{Saccharomyces cerevisiae N.C.Y.C. no. 240) microsomes and 
purified by using methods previously described by Azari &  
Wiseman (1980) and Azari &  Wiseman (1982a) respectively. 
The microsomes were obtained from yeast cells grown under i 
conditions o f glucose repression as before (Wiseman et al.. j 
1975). The binding characteristics o f  each compound were ! 
determined by recording cytochrome P-448 difference spectra 
between 350 nm and 500 nm at various concentrations o f the 
added compound. A double cell technique was used in several 
cases to eliminate interference, as previously described (Azari &  
Wiseman, 19826).
Tabic I describes the spectral binding type and charac­
teristics o f the interaction o f several compounds, with highly 
purified yeast cytochrome P-448. We have previously described 
the binding o f benzolalpyrene to this enzyme (Azari &  
Wiseman, 1982c). The spectral interaction o f lanosterol. which
i
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Table 1. Binding properties o f various compounds ofyeast cytochrome P-448 j
One nmol o f cytochrome P-448 was used in a volume o f I ml. In the case o f benzolalpyrene a split cell system was used to eliminate j 
the absorption o f benzofalpyrene itself at 350-420nm. K t and values were calculated by double reciprocal plotting o f the 
concentration o f the compounds against the absorbances o f the enzyme-compound complex.
Difference spectrum Difference spectrum Type o f
Compound maxima (nm) minima (nm) binding K, (//m ) Amu,.
Imidazole 429 407 II 8 0.06
Lanosterol 367,387 416 I 80 0.019
Ethylmorphine 355.382 412 1 166 0.006
Aniline 425 408 11 5 0.039
Phenobarbitone . 367,387 417 I 66 0.021
Benzphetamine 422 406 II 1660 0.018
Dimethylnitrosamine 385 420 I 220 0.021
Perhydrofluorene 382 417 I — —
Benzolalpyrene . 367,387 418 I 50 0.122
is thought to be an endogenous substrate for cytochrome 
P-450/P-448 in Saccharomyces cerevisiae. has previously been 
described by Aoyama &  Yoshida (1978). These authors also 
found that this compound gave rise to a type I  interaction with 
purified cytochrome P-450/P-448 from baker’s yeast grown 
semi-anaerobically, although no value for the spectral dis­
sociation constant ( / f t) was quoted.
Type I binding spectra were observed with bcnzo[a|pyrene, 
lanosterol, cthylmorphine, sodium phenobarbitone, dimethyl­
nitrosamine and perhydrofluorene. Benzo[a|pyrene bound to the 
greatest extent (almost 100% binding) and we have previously 
shown that this compound is metabolized by this enzyme, the 
major products being 3-hydroxybenzoIalpyrene, 9-hydroxy- 
benzolalpyrene and 7,8-dihydro-7,8-dihydroxybenzo|alpyrene 
(Woods &  Wiseman, 1979). So far we have been unable to 
detect the metabolism o f any o f the rest o f these compounds 
using a reconstituted ..system,. Type II  spectral change was 
observed with imidazole, aniline and benzphetamine. 
Benzphetamine is a substrate o f mammalian cytochrome P-450, 
which gives rise to a type I spectrum with this enzyme (Goujon 
et al.. 1972). We have also tested aminopyrine, ■ 7-ethoxy- 
resorufin, /?-naphthoflavone, lauric acid, ethoxycoumarin, bi­
phenyl, isosafrole and hexobarbital for a spectral interaction with 
our purified cytochrome P-448, but no interaction was detected 
with these compounds.
We have previously reported the presence o f an extra peak at 
365-375 nm in the difference spectrum with benzolalpyrene 
(Woods &  Wiseman, 1980) and a similar ‘extra peak* has been 
reported for the interaction o f this compound with rat liver 
cytochrome P-^SO (Estabrook et al., 1978). In these experi­
ments a similar'double peak was observed with cthylmorphine, 
lanosterol and phenobarbitone.
Imidazole and aniline, both o f which gave rise to type II
spectral changes, had the highest affinity for yeast cyrochtome 
P-448 with spectral dissociation constants (K t  values) o f 8pM 
and SpM respectively. The 'extent o f binding o f these com­
pounds, as measured by the A mtf values, was lower than that o f 
benzolalpyrene but higher than those o f other type’ I binding 
compounds. The two known substrates o f yeast cytochrome 
P-450/P-448, benzolalpyrene and lanosterol. show high affinity 
for the enzyme, although the extent o f binding o f lanosteroHs 
not very high. \
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CHARACTERIZATION OF CYTOCHROME P-448 FROM SACCHAROMYCES CEREVISIAE.
DAVID J. KING, MAHMOOD R. AZARI AND ALAN WISEMAN
Biochemistry Division, Department of Biochemistry, University of Surrey, 
Guildford, Surrey, GU2 5XH, U.K.
INTRODUCTION
The eucaryotic microorganism Saccharomyces cerevisiae contains a micro- 
somally bound cytochrome P-448 which is part of a microsomal electron transport 
chain with many properties is common with that of mammalian liver (1, 2).
This yeast cytochrome P-448 is produced under fermentative conditions (e.g. 
growth at high glucose concentration) which lead to the repression of mito­
chondrial cytochrome a + a3 formation (3,4). Control of this process is 
thought to occur through cyclic AMP which exerts a repressive effect over 
de novo synthesis of cytochrome P-448, the level of cyclic AMP being determined 
by the glucose concentration in the growth medium in an inverse relationship 
(5).
This cytochrome P-448 system is capable of hydroxylating benzo(a)pyrene 
to a range of metabolites, principally 5-hydroxybenzo(a)pyrene, 9-hydroxy- 
benzo(a)pyrene and 7,8-dihydro-7,8-dihydroxybenzo(a) pyrene (6). We have 
recently shown that this enzyme system can be induced with benzo(a)pyrene and 
several other compounds to produce only slightly higher levels of cytochrome 
P-448 but a great improvement in the efficiency of the enzyme at metabolizing 
benzo(a)pyrene, suggesting that more than one form of cytochrome P-450 can 
occur in this yeast (7). This finding has been backed up by the separation of 
two forms during purification studies (8). We have purified the major form of 
cytochrome P-448 from uninduced yeast to a high degree of purity (88-97% pure) 
and in this study we have undertaken to characterize this enzyme to allow a 
comparison with mammalian systems.
MATERIALS AND METHODS
Saccharomyces cerevisiae NCYC No. 240 was grown under glucose repression 
in a medium containing 1% yeast extract, 2% mycological peptone, 0.5% NaCl and. 
20% glucose for 44 hours at 30°C. Yeast was harvested and microsomes prepared 
from which cytochrome P-448 was purified as previously described (8). SDS- 
polyacrylamide gel electrophoresis was carried out by the method of Laemmli(9). 
Benzo(a)pyrene hydroxylase activity was determined by the fluorimetric method 
of Dehnen et^  a K  (10) as modified by Woods and Wiseman (6). A reconstituted
enzyme system comprising of purified cytochrome P-448, purified NADPH: 
cytochrome P-450 reductase and dilauroylphosphatidylcholine (lnmole cytochrome'; 
P-448 to 1 U of reductase).
RESULTS AND DISCUSSION
Cytochrome.P-448 from uninduced Saccharomyces cerevisiae was purified to a 
specific content of 16-17.5nmole/mg protein. The homogeneity of this enzyme 
was shown by SDS-polyacrylamide gel electrophoresis, the molecular weight being 
determined as 55,500 using this method with several marker proteins. This 
molecular weight is similar to that of cytochrome P-448 from liver microsomes 
of 3-methylcholanthrene treated rats (11). Using this molecular weight the 
purity of our enzyme is 88-97%. Our preparation was free of NADPH:cytochrome 
P-450 reductase, cytochrome bs and cytochrome P-420. Hie soret peak of the 
reduced CO complex was at 448nm similarly to the form induced by polycyclic 
aromatic hydrocarbons in mammalian liver. A similarity to this enzyme is also 
suggested by the benzo(a)pyrene metabolite profile of the yeast enzyme (6).
The amino acid composition of yeast cytochrome P-448 was determined as shown 
in Table 1. This composition reveals 407 amino acid residues per molecule 
which leads to a molecular weight of 53,000 (a difference of 4.5% from the 
value determined by SDS-PAGE). The content of hydrophobic residues is 43% 
which is almost identical to the content of hydrophobic residues in induced 
and uninduced cytochromes P-450 from both rat (11) and rabbit liver (12, 13).
TABLE 1
AMINO ACID COMPOSITION OF YEAST CYTOCHROME P-448
Amino Acid No. Residues/Molecule Amino Acid No. Residues/Molecule
Aspartic acid
Threonine
Serine
Glutamic acid
Proline
Glycine
Alanine
Valine
Tyrosine
41 
21 
24 
37 
23
42 
27 
30 
15
Phenylalanine
Leucine
Isoleucine
Histidine
Methionine
Lysine
Arginine
Tryptophan
Cysteine
Total
20
23
13
17
7
27
20
12
__8
470
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Benzo(a)pyrene gave rise to a type 1 binding spectrum with our purified 
cytochrome P-448 with an apparent spectral dissociation constant (Ks) of SOpM. 
Lanosterol, ethylmorphine, phenobarbital, dimethylnitrosamine and perhydro­
fluorene also gave rise to type 1 binding spectra. Benzo(a)pyrene hydroxylase 
activity of a reconstituted system comprising of purified cytochrome P-448, 
purified NADPH: cytochrome P-450 reductase and diluaroylphosphatidylcholine 
showed a Km of 33yM and a Vmax of 16.7 pmol 3-hydroxybenzo(a)pyrene/min/nmole 
p-448 when supported by NADPH. The requirement for cofactor could be replaced 
by cumene hydroperoxide or hydrogen peroxide generated from a glucose oxidase 
system, in each case the Km and Vmax ar® both increased (Table 2).
TABLE @
BENZO(a)PYRENE HYDROXYLASE ACTIVITY OF CYTOCHROME P-448 IN A RECONSTITUTED 
SYSTEM
Km (PM) Vmax(pmol 3-hydroxybenzo(a)pyrene/ 
min/nmole P-448
NADPH supported 33 16.7
Cumene hydroperoxide 125 21.9
Hydrogen peroxide
(glucose oxidase) 200 33.7
A good agreement between the Km of the NADPH supported reaction (33pM) 
and the benzo(a)pyrene Kg (50pM) was observed. The rate of benzo(a)pyrene 
hydroxylation observed with our enzyme is low compared to 3-methylcholanthrene 
induced (P-448) activities in rat liver, although it is comparable to forms 
isolated from uninduced mammalian sources (14, 15).
Yeast cytochrome P-448 is closely related to the family of enzymes from 
mammalian liver. The form of the enzyme which we have purified and studied 
in this report appears to resemble a cytochrome P-448 type of the mammalian 
enzyme rather than a cytochrome P-450 form, in its soret peak in the reduced 
CO spectrum, narrow substrate specificity and the range of benzo(a)pyrene 
metabolites formed. The molecular weight a amino acid composition are also 
closer to a P-448 form, although the activity towards benzo(a)pyrene hydroxy­
lation is much lower than a mammalian cytochrome P-448.
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